Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",A1BG,Alpha-1B-glycoprotein,10621,28,3.21 [0.40-25.72],0.2711111360433355
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AAMDC,Mth938 domain-containing protein,10345,27,0.94 [0.47-1.88],0.8509356575487499
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AARSD1,Alanyl-tRNA editing protein Aarsd1,12045,33,0.75 [0.43-1.33],0.3273288439484476
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ABCA2,ATP-binding cassette sub-family A member 2,10255,26,2.88 [1.59-5.24],0.0005153509431153
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ABHD14B,Protein ABHD14B,11987,33,0.76 [0.45-1.29],0.309770099034222
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ABL1,Tyrosine-protein kinase ABL1,12045,33,0.81 [0.50-1.33],0.4050836040732007
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ABO,Histo-blood group ABO system transferase,10600,28,1.00 [0.78-1.28],0.98127447169369
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ABRAXAS2,BRISC complex subunit Abraxas 2,10255,26,0.99 [0.55-1.77],0.9717363389608448
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",11821,32,1.10 [0.76-1.59],0.615434842771956
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",10423,26,1.22 [0.82-1.81],0.3249534323279888
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",10597,27,1.03 [0.69-1.55],0.8713014175110523
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACAN,Aggrecan core protein,11994,33,0.83 [0.27-2.49],0.7362370340741937
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACE,Angiotensin-converting enzyme,10600,28,0.69 [0.18-2.67],0.5930653702549447
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACE2,Angiotensin-converting enzyme 2,11858,34,1.02 [0.57-1.82],0.951359521100888
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACHE,Acetylcholinesterase,10385,26,0.39 [0.12-1.32],0.1312207305258112
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACOT13,Acyl-coenzyme A thioesterase 13,10536,26,1.00 [0.72-1.40],0.977614464536272
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,12105,34,1.43 [0.87-2.35],0.1574510472289859
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACP1,Low molecular weight phosphotyrosine protein phosphatase,10292,27,0.45 [0.17-1.20],0.1109860710984993
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACP5,Tartrate-resistant acid phosphatase type 5,12167,34,1.37 [0.55-3.39],0.4931680503407554
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACP6,Lysophosphatidic acid phosphatase type 6,12166,33,1.31 [0.78-2.18],0.3103639269571745
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACRBP,Acrosin-binding protein,10539,27,0.74 [0.27-2.08],0.5709866839279409
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACRV1,Acrosomal protein SP-10,10292,27,1.18 [0.43-3.26],0.7519883883975165
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACSL1,Long-chain-fatty-acid--CoA ligase 1,10255,26,0.93 [0.34-2.54],0.8810533790622262
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACTA2,"Actin, aortic smooth muscle",11858,34,1.53 [0.92-2.55],0.1022880513251117
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACTN2,Alpha-actinin-2,10255,26,0.90 [0.44-1.84],0.7771941625859036
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACTN4,Alpha-actinin-4,11854,32,2.21 [1.42-3.42],0.000398890518951
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACVRL1,Serine/threonine-protein kinase receptor R3,12003,33,1.68 [0.54-5.18],0.3683279428581639
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACY1,Aminoacylase-1,12105,34,1.49 [0.95-2.34],0.0850215267545906
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,10255,26,1.08 [0.55-2.10],0.8318396388340257
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACYP1,Acylphosphatase-1,10343,26,0.89 [0.50-1.60],0.6956169889215846
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADA,Adenosine deaminase,12214,33,0.36 [0.13-0.97],0.0429460048551171
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADA2,Adenosine deaminase 2,12038,33,0.86 [0.41-1.80],0.6965524608483495
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,10292,27,2.19 [0.84-5.72],0.1104061029817748
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,11858,34,0.59 [0.21-1.60],0.2978939889734301
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,12018,33,0.64 [0.27-1.54],0.3236444616873678
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,12214,33,1.10 [0.45-2.67],0.8332846363265031
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,12173,33,0.47 [0.18-1.21],0.1174595520911353
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,10536,26,0.41 [0.12-1.45],0.1659194267405234
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,10292,27,0.83 [0.23-2.96],0.7761888178047626
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,12244,34,1.75 [0.46-6.71],0.4154467945906948
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,12045,33,1.45 [0.70-3.04],0.3206691046000182
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,11858,34,1.04 [0.39-2.72],0.943481245956912
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,10292,27,1.86 [0.78-4.39],0.1595028695207707
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,12156,33,0.56 [0.29-1.10],0.090819595296843
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAMTSL2,ADAMTS-like protein 2,10614,27,0.56 [0.17-1.85],0.3395636677357685
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAMTSL4,ADAMTS-like protein 4,10345,27,2.60 [0.58-11.70],0.2143841621402942
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAMTSL5,ADAMTS-like protein 5,10597,27,1.20 [0.46-3.14],0.7051815193789039
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,11821,32,0.73 [0.23-2.37],0.6055424486732139
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADD1,Alpha-adducin,10385,26,0.86 [0.51-1.46],0.5788187418392213
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADGRB3,Adhesion G protein-coupled receptor B3,12003,33,0.84 [0.33-2.13],0.7127727515197777
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADGRD1,Adhesion G-protein coupled receptor D1,10385,26,1.23 [0.45-3.34],0.6878314208546241
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADGRE1,Adhesion G protein-coupled receptor E1,10536,26,0.70 [0.35-1.41],0.3151176626165961
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADGRE2,Adhesion G protein-coupled receptor E2,12159,32,0.50 [0.16-1.57],0.2319070435517507
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADGRE5,Adhesion G protein-coupled receptor E5,12197,34,0.45 [0.16-1.31],0.1433395843325961
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADGRF5,Adhesion G protein-coupled receptor F5,10597,27,1.06 [0.31-3.59],0.9292328448919228
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADGRG1,Adhesion G-protein coupled receptor G1,12045,33,0.97 [0.59-1.59],0.8931428776207708
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADGRG2,Adhesion G-protein coupled receptor G2,12105,34,0.52 [0.17-1.55],0.2379799154288945
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADGRV1,Adhesion G-protein coupled receptor V1,10232,27,0.44 [0.21-0.92],0.0290803794905509
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADH1B,All-trans-retinol dehydrogenase,10385,26,0.93 [0.55-1.57],0.7928155506487637
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,11858,34,0.98 [0.68-1.41],0.8977787509001443
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADIPOQ,Adiponectin,10621,28,1.15 [0.68-1.97],0.6005239646592395
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADM,Pro-adrenomedullin,12192,33,5.48 [1.73-17.35],0.0037943125594052
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADRA2A,Alpha-2A adrenergic receptor,10255,26,1.36 [0.91-2.01],0.1297031812284423
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AFAP1,Actin filament-associated protein 1,10385,26,1.20 [0.79-1.83],0.3971241453914998
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AFM,Afamin,10621,28,2.19 [0.34-14.17],0.4097568577827933
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AFP,Alpha-fetoprotein,11981,33,1.68 [1.08-2.60],0.0203159375864491
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AGBL2,Cytosolic carboxypeptidase 2,10232,27,0.83 [0.58-1.19],0.3067332928739337
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AGER,Advanced glycosylation end product-specific receptor,12082,31,1.09 [0.52-2.28],0.8121910430305386
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AGR2,Anterior gradient protein 2 homolog,11704,32,1.03 [0.76-1.39],0.859260215872923
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AGR3,Anterior gradient protein 3,11797,32,1.03 [0.61-1.73],0.920851766466246
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AGRN,Agrin,12159,32,1.33 [0.56-3.15],0.5194804166951519
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AGRP,Agouti-related protein,12214,33,0.98 [0.54-1.76],0.945327509641565
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AGT,Angiotensinogen,10600,28,1.16 [0.24-5.75],0.8521287776192168
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AGXT,Serine--pyruvate aminotransferase,12105,34,1.32 [0.92-1.88],0.1281985422991543
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AHCY,Adenosylhomocysteinase,12105,34,0.99 [0.64-1.54],0.9742608613261764
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AHNAK,Neuroblast differentiation-associated protein AHNAK,10345,27,0.32 [0.09-1.15],0.0812787365107357
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AHNAK2,Protein AHNAK2,10345,27,0.54 [0.13-2.15],0.3793907737585474
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,10539,27,0.81 [0.43-1.52],0.5081622568856051
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AHSG,Alpha-2-HS-glycoprotein,10600,28,1.06 [0.29-3.97],0.9258754182329404
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AHSP,Alpha-hemoglobin-stabilizing protein,12092,33,1.05 [0.74-1.49],0.7790539267129982
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AIDA,"Axin interactor, dorsalization-associated protein",10313,27,1.26 [0.89-1.77],0.1906553634891763
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AIF1,Allograft inflammatory factor 1,11821,32,0.86 [0.47-1.60],0.6422191518079658
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AIF1L,Allograft inflammatory factor 1-like,10345,27,0.53 [0.20-1.40],0.1990167928843382
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",12026,33,0.85 [0.63-1.15],0.303309099428436
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AK1,Adenylate kinase isoenzyme 1,12105,34,0.81 [0.50-1.32],0.3991112228929825
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AK2,"Adenylate kinase 2, mitochondrial",10583,26,1.01 [0.71-1.45],0.9361641318967144
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AKAP12,A-kinase anchor protein 12,10385,26,0.93 [0.16-5.47],0.938962040278183
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AKR1B1,Aldo-keto reductase family 1 member B1,11821,32,0.73 [0.48-1.12],0.1509078223683155
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AKR1B10,Aldo-keto reductase family 1 member B10,10313,27,0.98 [0.54-1.78],0.9510698025434352
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AKR1C4,Aldo-keto reductase family 1 member C4,11858,34,1.07 [0.63-1.81],0.806851547052104
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AKR7L,Aflatoxin B1 aldehyde reductase member 4,10292,27,1.25 [0.80-1.96],0.3304529887018764
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AKT1S1,Proline-rich AKT1 substrate 1,11813,32,0.61 [0.38-0.98],0.0401674782877724
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AKT2,RAC-beta serine/threonine-protein kinase,10575,26,0.93 [0.69-1.26],0.6467963163813563
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AKT3,RAC-gamma serine/threonine-protein kinase,11766,32,0.73 [0.41-1.30],0.28088161188502
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ALCAM,CD166 antigen,12244,34,0.52 [0.11-2.53],0.4206764036772084
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ALDH1A1,Retinal dehydrogenase 1,12110,33,0.70 [0.39-1.28],0.2462149077848702
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ALDH2,"Aldehyde dehydrogenase, mitochondrial",10539,27,1.46 [0.97-2.19],0.0702524543273749
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",12051,33,0.88 [0.54-1.44],0.6102804718653607
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",10575,26,0.79 [0.34-1.82],0.5826034134766791
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ALMS1,Alstrom syndrome protein 1,10423,26,1.03 [0.45-2.35],0.9381870133857636
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ALPI,Intestinal-type alkaline phosphatase,10292,27,1.28 [0.95-1.72],0.1028863658825978
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ALPP,"Alkaline phosphatase, placental type",12045,33,0.79 [0.60-1.04],0.093249992479687
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMBN,Ameloblastin,11854,32,0.64 [0.18-2.26],0.4836361335592747
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMBP,Protein AMBP,12171,33,1.55 [0.35-6.87],0.5627477533086682
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,10614,27,1.35 [0.31-5.90],0.6929525776381249
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMFR,E3 ubiquitin-protein ligase AMFR,11813,32,0.67 [0.37-1.20],0.1752667662188823
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMIGO1,Amphoterin-induced protein 1,10313,27,1.05 [0.52-2.13],0.8828449666257356
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMIGO2,Amphoterin-induced protein 2,12045,33,0.64 [0.17-2.43],0.5162022962534457
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMN,Protein amnionless,11854,32,0.99 [0.51-1.91],0.977789785936218
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMOT,Angiomotin,10385,26,0.87 [0.33-2.29],0.778152543051245
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMOTL2,Angiomotin-like protein 2,10496,27,1.34 [0.71-2.53],0.366153292278066
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMPD3,AMP deaminase 3,10583,26,0.64 [0.38-1.06],0.0835776290903564
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,9892,27,1.38 [0.76-2.50],0.2879633551282439
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMY2A,Pancreatic alpha-amylase,11608,31,1.50 [0.77-2.91],0.2349496915740692
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMY2B,Alpha-amylase 2B,11281,31,1.43 [0.75-2.75],0.2770258747462125
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANG,Angiogenin,12080,34,1.89 [0.87-4.12],0.1075309214095107
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANGPT1,Angiopoietin-1,12049,31,1.19 [0.81-1.74],0.3726424417699835
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANGPT2,Angiopoietin-2,12192,33,1.26 [0.57-2.78],0.5602777914119126
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANGPTL1,Angiopoietin-related protein 1,11945,34,1.67 [0.59-4.77],0.336712117481112
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANGPTL2,Angiopoietin-related protein 2,12121,32,0.75 [0.36-1.59],0.455045392768223
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANGPTL3,Angiopoietin-related protein 3,12113,34,0.98 [0.42-2.27],0.964688253623876
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANGPTL4,Angiopoietin-related protein 4,12136,31,1.03 [0.51-2.10],0.9259330967398098
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANGPTL7,Angiopoietin-related protein 7,12192,33,2.35 [1.17-4.72],0.0164002145363775
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANK2,Ankyrin-2,10255,26,1.30 [0.88-1.91],0.1859883484733319
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,10292,27,1.05 [0.66-1.67],0.8421269734008814
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANKRA2,Ankyrin repeat family A protein 2,10205,26,0.57 [0.27-1.22],0.1484395682691303
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANKRD54,Ankyrin repeat domain-containing protein 54,11821,32,0.76 [0.41-1.42],0.3880647232745028
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,10345,27,0.63 [0.19-2.11],0.4516333349751297
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANPEP,Aminopeptidase N,12147,34,0.95 [0.32-2.81],0.9217791003345276
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANXA1,Annexin A1,10322,26,0.64 [0.24-1.68],0.365386255909318
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANXA10,Annexin A10,11813,32,0.86 [0.58-1.28],0.4540460675450234
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANXA11,Annexin A11,12060,33,0.67 [0.45-0.99],0.0439423046375603
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANXA2,Annexin A2,10183,27,0.80 [0.46-1.39],0.436213601546441
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANXA3,Annexin A3,12173,33,0.72 [0.46-1.11],0.1394528483918555
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANXA4,Annexin A4,12051,33,0.93 [0.61-1.43],0.7497320997787221
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANXA5,Annexin A5,11782,32,0.39 [0.13-1.14],0.0858514415415383
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AOC1,Amiloride-sensitive amine oxidase [copper-containing],11854,32,0.89 [0.49-1.62],0.7080973905238332
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AOC3,Membrane primary amine oxidase,12162,34,0.55 [0.20-1.47],0.2332189382959443
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AP1G2,AP-1 complex subunit gamma-like 2,10539,27,0.88 [0.55-1.42],0.6107847239230403
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AP2B1,AP-2 complex subunit beta,10313,27,0.68 [0.29-1.60],0.3764483336488632
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AP3B1,AP-3 complex subunit beta-1,10536,26,0.77 [0.46-1.28],0.3162629090234529
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AP3S2,AP-3 complex subunit sigma-2,10583,26,0.78 [0.33-1.82],0.5671815219988116
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,12045,33,0.90 [0.44-1.87],0.7858971227460239
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APCS,Serum amyloid P-component,10518,28,2.15 [0.75-6.16],0.15565377788776
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,12143,33,0.68 [0.39-1.18],0.1691054395913793
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APLP1,Amyloid-like protein 1,12105,34,0.73 [0.41-1.32],0.3045778175704844
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOA1,Apolipoprotein A-I,10621,28,1.37 [0.43-4.39],0.5973795570297264
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOA2,Apolipoprotein A-II,10600,28,0.95 [0.46-1.98],0.8991953129819475
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOA4,Apolipoprotein A-IV,10621,28,1.75 [0.85-3.59],0.1283536643875341
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOB,Apolipoprotein B-100,10600,28,1.10 [0.22-5.46],0.9061093732730048
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOBR,Apolipoprotein B receptor,10345,27,0.72 [0.31-1.69],0.4512792042858483
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOC1,Apolipoprotein C-I,10600,28,1.90 [0.82-4.41],0.1346155501581548
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOD,Apolipoprotein D,10144,27,1.49 [0.81-2.74],0.2036820106689826
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOE,Apolipoprotein E,10621,28,1.28 [0.91-1.78],0.1514171646010768
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOF,Apolipoprotein F,10600,28,2.22 [0.39-12.77],0.3711310562779581
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOH,Beta-2-glycoprotein 1,12110,33,1.03 [0.43-2.46],0.9476847743629504
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOL1,Apolipoprotein L1,10600,28,0.56 [0.27-1.15],0.1122153488646656
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOM,Apolipoprotein M,12136,34,0.99 [0.32-3.08],0.9918971186163912
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APP,Amyloid-beta precursor protein,12099,33,1.19 [0.76-1.87],0.4393163939149007
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APPL2,DCC-interacting protein 13-beta,10385,26,1.13 [0.80-1.60],0.4905954576102329
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APRT,Adenine phosphoribosyltransferase,12000,33,0.46 [0.26-0.80],0.0064007497677875
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARAF,Serine/threonine-protein kinase A-Raf,10423,26,0.96 [0.54-1.73],0.900928735393484
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AREG,Amphiregulin,12045,33,1.94 [1.13-3.33],0.0167117478261787
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARF6,ADP-ribosylation factor 6,10536,26,0.91 [0.64-1.30],0.6051113471099463
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARFIP1,Arfaptin-1,10575,26,0.94 [0.54-1.62],0.818520831528814
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARG1,Arginase-1,12026,33,0.58 [0.32-1.03],0.0632861887958651
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARG2,"Arginase-2, mitochondrial",10539,27,0.96 [0.41-2.26],0.9325530357570586
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARHGAP1,Rho GTPase-activating protein 1,11821,32,0.68 [0.34-1.36],0.2767481013302639
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARHGAP25,Rho GTPase-activating protein 25,11821,32,0.65 [0.35-1.20],0.1710357979398105
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARHGAP30,Rho GTPase-activating protein 30,10423,26,1.83 [0.95-3.53],0.0698193064048995
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARHGAP45,Rho GTPase-activating protein 45,10385,26,1.06 [0.66-1.69],0.8136821618802592
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARHGAP5,Rho GTPase-activating protein 5,10205,26,0.55 [0.28-1.09],0.0863726858476026
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARHGEF1,Rho guanine nucleotide exchange factor 1,10583,26,0.98 [0.64-1.48],0.9175635760160734
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARHGEF10,Rho guanine nucleotide exchange factor 10,10575,26,1.07 [0.71-1.59],0.7564401706092866
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARHGEF12,Rho guanine nucleotide exchange factor 12,12073,33,0.87 [0.64-1.18],0.3756342866544359
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARHGEF5,Rho guanine nucleotide exchange factor 5,10232,27,0.75 [0.42-1.34],0.3312023731419964
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARID3A,AT-rich interactive domain-containing protein 3A,10232,27,1.15 [0.48-2.77],0.7518704680850441
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARID4B,AT-rich interactive domain-containing protein 4B,11813,32,0.62 [0.24-1.61],0.3285385249155347
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARL13B,ADP-ribosylation factor-like protein 13B,10255,26,1.02 [0.60-1.72],0.9504885076170508
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,10255,26,0.96 [0.38-2.47],0.940143314633286
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARMCX2,Armadillo repeat-containing X-linked protein 2,10232,27,0.95 [0.52-1.76],0.8803841029058117
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARNT,Aryl hydrocarbon receptor nuclear translocator,11854,32,1.15 [0.51-2.59],0.7331767655298715
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,10255,26,0.98 [0.49-1.95],0.9448342523480888
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARSA,Arylsulfatase A,12110,33,1.55 [0.83-2.89],0.1679683546802914
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARSB,Arylsulfatase B,12045,33,0.75 [0.42-1.35],0.3353584898830565
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ART3,Ecto-ADP-ribosyltransferase 3,12162,34,1.33 [0.55-3.23],0.5235485715597199
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ART5,Ecto-ADP-ribosyltransferase 5,10232,27,0.58 [0.24-1.41],0.2284579234341975
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARTN,Artemin,11854,32,1.14 [0.60-2.17],0.6793158332472166
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ASAH1,Acid ceramidase,10496,27,1.01 [0.44-2.32],0.974111896120948
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ASAH2,Neutral ceramidase,12018,33,1.77 [0.90-3.48],0.0996238941890027
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ASGR1,Asialoglycoprotein receptor 1,12018,33,1.74 [0.65-4.61],0.2691619879468944
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ASGR2,Asialoglycoprotein receptor 2,10600,28,1.66 [0.47-5.89],0.4326055247133231
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ASPN,Asporin,10597,27,0.69 [0.17-2.83],0.6020011379280835
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ASPSCR1,Tether containing UBX domain for GLUT4,10575,26,1.02 [0.58-1.78],0.9480768052945762
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ASRGL1,Isoaspartyl peptidase/L-asparaginase,10345,27,1.04 [0.73-1.50],0.813251642764478
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ASS1,Argininosuccinate synthase,10255,26,1.08 [0.67-1.73],0.7513581854906615
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATF2,Cyclic AMP-dependent transcription factor ATF-2,11813,32,0.83 [0.47-1.48],0.5272834150219404
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATF4,Cyclic AMP-dependent transcription factor ATF-4,10205,26,1.31 [0.52-3.27],0.5674397538317871
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATG16L1,Autophagy-related protein 16-1,10536,26,0.95 [0.61-1.50],0.8333578706357491
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATG4A,Cysteine protease ATG4A,11821,32,0.64 [0.37-1.10],0.1029729005972914
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATOX1,Copper transport protein ATOX1,12156,33,0.93 [0.60-1.44],0.747283487538529
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,10255,26,1.07 [0.53-2.16],0.8432899108579401
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,10255,26,1.45 [0.55-3.83],0.457623620210105
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,10255,26,2.11 [1.33-3.36],0.0016426359490101
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP1B4,Protein ATP1B4,10205,26,0.48 [0.17-1.38],0.1738829040318148
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP2B4,Plasma membrane calcium-transporting ATPase 4,10255,26,1.67 [1.16-2.39],0.0054739843769253
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP5F1D,"ATP synthase subunit delta, mitochondrial",10255,26,1.31 [0.84-2.02],0.2309822711376287
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP5IF1,"ATPase inhibitor, mitochondrial",12159,32,0.92 [0.70-1.21],0.545501709138831
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP5PO,"ATP synthase subunit O, mitochondrial",11813,32,0.71 [0.32-1.61],0.4157818836047076
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP6AP2,Renin receptor,11821,32,0.94 [0.42-2.11],0.8816129846054667
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP6V1D,V-type proton ATPase subunit D,12045,33,1.48 [0.62-3.54],0.373787805745682
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP6V1F,V-type proton ATPase subunit F,11792,32,0.99 [0.61-1.59],0.962038014936313
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP6V1G1,V-type proton ATPase subunit G 1,10345,27,1.04 [0.63-1.73],0.8797615439560612
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP6V1G2,V-type proton ATPase subunit G 2,10255,26,0.84 [0.57-1.26],0.4035369759945629
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATRAID,All-trans retinoic acid-induced differentiation factor,10536,26,0.86 [0.22-3.39],0.8310348903730789
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATRN,"Attractin, Isoform 2",10621,28,1.10 [0.12-9.66],0.9331783654603454
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATXN10,Ataxin-10,11813,32,1.07 [0.69-1.67],0.7499299512663287
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATXN2,Ataxin-2,10232,27,0.99 [0.72-1.37],0.96285812269949
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATXN2L,Ataxin-2-like protein,10575,26,1.06 [0.49-2.29],0.8763100938712426
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATXN3,Ataxin-3,10583,26,0.82 [0.44-1.51],0.5182031436061694
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AXIN1,Axin-1,12073,33,0.93 [0.67-1.29],0.6502968202684598
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AXL,Tyrosine-protein kinase receptor UFO,12162,34,0.79 [0.25-2.44],0.6757630291846459
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AZI2,5-azacytidine-induced protein 2,10575,26,0.90 [0.45-1.81],0.7718709655374192
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AZU1,Azurocidin,11716,34,0.88 [0.58-1.33],0.5373967600075386
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",B2M,Beta-2-microglobulin,10621,28,1.12 [0.40-3.17],0.8253323722327894
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,10255,26,1.00 [0.15-6.62],0.9971257670664256
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",10345,27,1.11 [0.39-3.10],0.8476365984710461
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",B4GALT1,"Beta-1,4-galactosyltransferase 1",12159,32,1.55 [0.52-4.60],0.4347218380500892
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",B4GAT1,"Beta-1,4-glucuronyltransferase 1",12110,33,2.76 [0.79-9.69],0.1130905840863578
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BABAM1,BRISC and BRCA1-A complex member 1,10292,27,1.49 [0.51-4.34],0.468047156957767
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BACH1,Transcription regulator protein BACH1,12073,33,0.84 [0.54-1.30],0.430743209607703
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BAG3,BAG family molecular chaperone regulator 3,12003,33,1.53 [0.68-3.42],0.3055514005989086
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BAG4,BAG family molecular chaperone regulator 4,10292,27,1.58 [0.84-2.99],0.1575971027670705
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BAG6,Large proline-rich protein BAG6,11858,34,0.97 [0.40-2.31],0.9378268484438076
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,11821,32,0.67 [0.40-1.14],0.1445046946363985
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BAMBI,BMP and activin membrane-bound inhibitor homolog,11821,32,1.39 [0.51-3.75],0.5207413194702049
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BANK1,B-cell scaffold protein with ankyrin repeats,12073,33,0.90 [0.67-1.20],0.4675154179388602
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BAP18,Chromatin complexes subunit BAP18,10583,26,0.63 [0.32-1.24],0.1801739805988021
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BATF,Basic leucine zipper transcriptional factor ATF-like,10313,27,0.69 [0.37-1.28],0.2419856979499413
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BAX,Apoptosis regulator BAX,11797,32,0.86 [0.60-1.24],0.4339467304797701
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCAM,Basal cell adhesion molecule,12110,33,0.34 [0.09-1.30],0.1149401807939996
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCAN,Brevican core protein,12018,33,1.28 [0.52-3.19],0.5905301820464879
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",10597,27,2.15 [0.96-4.81],0.0617729553954354
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",10232,27,1.02 [0.53-1.97],0.949921648205037
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCHE,Cholinesterase,10416,28,0.88 [0.25-3.14],0.8426283009818503
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCL2,Apoptosis regulator Bcl-2,10536,26,0.89 [0.42-1.87],0.7525039536028681
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCL2L1,Bcl-2-like protein 1,10583,26,1.09 [0.75-1.60],0.6413608212532518
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",12073,33,1.15 [0.56-2.34],0.6987870419994916
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCL2L15,Bcl-2-like protein 15,10292,27,1.10 [0.61-1.99],0.7522304787669232
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCL7A,B-cell CLL/lymphoma 7 protein family member A,10205,26,1.14 [0.68-1.93],0.6139309694916022
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCL7B,B-cell CLL/lymphoma 7 protein family member B,10539,27,1.15 [0.53-2.53],0.7219467406617601
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCR,Breakpoint cluster region protein,12073,33,0.94 [0.67-1.33],0.7251260537729075
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BDNF,Brain-derived neurotrophic factor,10614,27,1.18 [0.76-1.86],0.4605219125177706
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BECN1,Beclin-1,10345,27,0.74 [0.39-1.43],0.3757493712879536
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BEX3,Protein BEX3,10205,26,1.16 [0.55-2.46],0.6949888915691781
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BGLAP,Osteocalcin,10614,27,0.76 [0.53-1.10],0.1469903735133622
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BGN,Biglycan,11793,32,0.98 [0.76-1.28],0.90764868613792
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BHLHE40,Class E basic helix-loop-helix protein 40,10232,27,0.71 [0.40-1.27],0.2518119423913826
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,10255,26,0.84 [0.19-3.73],0.8140544286842226
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BID,BH3-interacting domain death agonist,12073,33,0.61 [0.37-1.01],0.0542708259609857
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BIN2,Bridging integrator 2,12110,33,1.07 [0.76-1.50],0.6977185400882637
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BIRC2,Baculoviral IAP repeat-containing protein 2,11821,32,0.75 [0.44-1.27],0.2871327276141301
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BLMH,Bleomycin hydrolase,12244,34,1.15 [0.45-2.89],0.7733196186413642
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BLNK,B-cell linker protein,10292,27,0.98 [0.37-2.58],0.969572493743323
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,10232,27,1.14 [0.72-1.81],0.5651415539798241
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,10583,26,0.86 [0.32-2.29],0.7593943662229871
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BLVRB,Flavin reductase,12110,33,0.78 [0.48-1.27],0.3181930556918438
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BMP10,Bone morphogenetic protein 10,10385,26,0.32 [0.10-1.03],0.0562256849182558
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BMP4,Bone morphogenetic protein 4,12003,33,1.14 [0.58-2.24],0.6961876957840307
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BMP6,Bone morphogenetic protein 6,11842,34,1.34 [0.64-2.79],0.4365284413562041
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BMPER,BMP-binding endothelial regulator protein,10385,26,0.28 [0.07-1.19],0.0839306569413312
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,10597,27,1.60 [0.64-4.00],0.3116929489455575
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,10292,27,1.61 [0.76-3.41],0.212916323210258
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BOC,Brother of CDO,11858,34,0.58 [0.16-2.15],0.4156609445705606
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BOLA1,BolA-like protein 1,10232,27,1.09 [0.56-2.09],0.8059236371074661
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BOLA2_BOLA2B,BolA-like protein 2,10345,27,0.83 [0.43-1.61],0.584703151511198
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BPIFA2,BPI fold-containing family A member 2,9963,25,0.91 [0.64-1.30],0.6130472481899012
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BPIFB1,BPI fold-containing family B member 1,12050,34,0.96 [0.58-1.58],0.8743568436469845
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BPIFB2,BPI fold-containing family B member 2,10574,27,0.83 [0.49-1.42],0.4985686362635636
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BRAP,BRCA1-associated protein,10438,26,0.92 [0.65-1.30],0.6253521978598917
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BRD1,Bromodomain-containing protein 1,10423,26,0.89 [0.25-3.25],0.8645624006357829
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BRD2,Bromodomain-containing protein 2,10232,27,1.77 [1.00-3.15],0.0513738587715377
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BRD3,Bromodomain-containing protein 3,10255,26,0.88 [0.36-2.11],0.767552893851016
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BRDT,Bromodomain testis-specific protein,10255,26,0.76 [0.26-2.19],0.6064454963526746
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BRK1,Protein BRICK1,11813,32,0.91 [0.44-1.88],0.8029198565506029
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BRME1,Break repair meiotic recombinase recruitment factor 1,10232,27,1.02 [0.41-2.53],0.9666608431148674
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BRSK2,Serine/threonine-protein kinase BRSK2,10575,26,0.98 [0.38-2.53],0.9712528912829776
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BSG,Basigin,12198,33,1.67 [0.39-7.21],0.4907763148053229
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BSND,Barttin,10205,26,1.27 [0.48-3.32],0.632002562030516
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,12199,33,0.64 [0.42-0.97],0.0374735305786056
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BST2,Bone marrow stromal antigen 2,12199,33,1.37 [0.87-2.16],0.1710583954923031
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BTC,Probetacellulin,11821,32,1.09 [0.72-1.63],0.6883259105711401
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BTD,Biotinidase,10621,28,0.66 [0.12-3.56],0.625551994763306
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BTLA,B- and T-lymphocyte attenuator,10205,26,0.82 [0.47-1.43],0.4842605908602669
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BTN1A1,Butyrophilin subfamily 1 member A1,10517,27,0.27 [0.08-0.96],0.0434660690658672
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BTN2A1,Butyrophilin subfamily 2 member A1,12159,32,0.49 [0.15-1.67],0.2552036609141836
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BTN3A2,Butyrophilin subfamily 3 member A2,12073,33,1.55 [0.76-3.16],0.2304808746758422
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BTNL10,Butyrophilin-like protein 10,10205,26,0.66 [0.20-2.14],0.4886979878640396
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C19orf12,Protein C19orf12,11813,32,1.24 [0.82-1.88],0.3110019655939829
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C1GALT1C1,C1GALT1-specific chaperone 1,10255,26,1.11 [0.36-3.42],0.8514140016642382
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C1QA,Complement C1q subcomponent subunit A,12156,33,2.65 [0.66-10.68],0.1716115720656944
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",10575,26,1.36 [1.04-1.77],0.0226774504091224
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C1QL2,Complement C1q-like protein 2,10292,27,1.12 [0.50-2.48],0.7872168684868263
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,12162,34,1.00 [0.49-2.03],0.9938145856922164
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,10385,26,0.85 [0.33-2.17],0.7310454943374798
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,10575,26,1.30 [0.46-3.62],0.6205277716598727
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,10363,26,0.66 [0.32-1.35],0.2537849869718765
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C1R,Complement C1r subcomponent,10621,28,1.91 [0.51-7.06],0.3343909173607993
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C1RL,Complement C1r subcomponent-like protein,10605,28,1.14 [0.18-7.13],0.8883457463638188
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C1S,Complement C1s subcomponent,10621,28,1.10 [0.20-6.18],0.9115294885778168
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C2,Complement C2,12136,34,0.90 [0.25-3.18],0.8678307584699569
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C2CD2L,Phospholipid transfer protein C2CD2L,11792,32,0.62 [0.28-1.36],0.2332822800933913
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C2orf69,UPF0565 protein C2orf69,10313,27,0.65 [0.29-1.45],0.2946789941228613
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C3,Complement C3,10070,25,1.05 [0.44-2.54],0.9076779142089128
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C4BPB,C4b-binding protein beta chain,12156,33,0.96 [0.46-2.01],0.9085044123268112
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C5,Complement C5,10621,28,0.57 [0.05-6.95],0.6587842878392001
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C7,Complement component C7,10356,26,2.53 [0.78-8.21],0.1226992556899714
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C7orf50,Uncharacterized protein C7orf50,10583,26,0.15 [0.01-1.76],0.1321941137383687
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C8B,Complement component C8 beta chain,10621,28,1.02 [0.31-3.40],0.9698034877296522
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C9,Complement component C9,10600,28,1.10 [0.53-2.28],0.8049678334807879
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C9orf40,Uncharacterized protein C9orf40,10536,26,0.86 [0.54-1.36],0.5176477187459113
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA1,Carbonic anhydrase 1,11839,33,0.76 [0.46-1.24],0.2683105277397616
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA11,Carbonic anhydrase-related protein 11,11821,32,0.98 [0.39-2.44],0.9615917268504528
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA12,Carbonic anhydrase 12,12045,33,0.97 [0.37-2.59],0.9589158773205088
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA13,Carbonic anhydrase 13,11997,34,1.00 [0.74-1.34],0.9786254122682024
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA14,Carbonic anhydrase 14,12192,33,2.05 [0.87-4.81],0.1003979371666401
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA2,Carbonic anhydrase 2,12066,33,0.89 [0.58-1.38],0.6131643585261455
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA3,Carbonic anhydrase 3,12222,34,0.70 [0.42-1.19],0.1909239880717711
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA4,Carbonic anhydrase 4,12244,34,0.70 [0.20-2.47],0.579212188259149
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA5A,"Carbonic anhydrase 5A, mitochondrial",11858,34,1.00 [0.72-1.39],0.9945206842737624
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA6,Carbonic anhydrase 6,12069,33,1.53 [0.95-2.45],0.0790179051326974
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA7,Carbonic anhydrase 7,10423,26,0.67 [0.19-2.31],0.5255982222774724
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA8,Carbonic anhydrase-related protein,10292,27,1.35 [0.60-3.06],0.4683156214646544
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA9,Carbonic anhydrase 9,12192,33,0.83 [0.42-1.63],0.5887850776706384
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CABP2,Calcium-binding protein 2,10313,27,1.02 [0.57-1.82],0.9491261398495364
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,10232,27,1.39 [0.55-3.51],0.488888531462102
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,10255,26,1.28 [0.80-2.06],0.3085086908528995
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,10232,27,1.44 [0.90-2.32],0.1288096624825818
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,10575,26,1.00 [0.64-1.57],0.9906860741614836
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CACYBP,Calcyclin-binding protein,10369,26,1.10 [0.76-1.60],0.6205371602889052
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CADPS,Calcium-dependent secretion activator 1,10313,27,0.73 [0.26-2.03],0.5423179995749837
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CALB1,Calbindin,12045,33,1.22 [0.59-2.52],0.5966612352522331
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CALB2,Calretinin,11813,32,1.20 [0.54-2.65],0.6530693874841349
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CALCA,Calcitonin,11997,33,1.52 [1.03-2.22],0.0328002344870943
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CALCB,Calcitonin gene-related peptide 2,10583,26,0.74 [0.26-2.12],0.5697195656048941
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,12147,33,1.00 [0.74-1.35],0.9922524082734824
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,10345,27,1.09 [0.68-1.76],0.7229212453956709
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CALY,Neuron-specific vesicular protein calcyon,10255,26,1.52 [0.86-2.67],0.147923380874871
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,11821,32,0.75 [0.35-1.61],0.4546315994740237
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,10313,27,1.08 [0.56-2.08],0.8116731413427429
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,10575,26,0.95 [0.67-1.35],0.7749608998852786
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CANT1,Soluble calcium-activated nucleotidase 1,12064,34,0.83 [0.19-3.69],0.8084459223825564
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CAPG,Macrophage-capping protein,11987,33,1.13 [0.67-1.88],0.6515580938571954
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CAPN3,Calpain-3,10539,27,0.97 [0.36-2.59],0.9471304256212676
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CAPS,Calcyphosin,10583,26,0.56 [0.26-1.21],0.1407049685561118
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CARHSP1,Calcium-regulated heat-stable protein 1,11813,32,0.62 [0.33-1.19],0.1496994339703947
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CASC3,Protein CASC3,10313,27,0.98 [0.39-2.47],0.9739378909983152
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CASP1,Caspase-1,11813,32,0.75 [0.46-1.21],0.2326037097537128
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CASP10,Caspase-10,11813,32,1.03 [0.66-1.60],0.9123068357326574
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CASP2,Caspase-2,12073,33,0.81 [0.51-1.30],0.3840910150948834
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CASP3,Caspase-3,12244,34,0.98 [0.69-1.39],0.910402013417847
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CASP4,Caspase-4,10423,26,0.99 [0.80-1.24],0.9452645662175576
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CASP7,Caspase-7,10583,26,1.07 [0.68-1.67],0.7746089059243592
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CASP8,Caspase-8,12145,33,0.65 [0.38-1.11],0.1178073074603058
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CASP9,Caspase-9,10292,27,1.56 [0.98-2.48],0.0630413494819196
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CASQ2,Calsequestrin-2,10255,26,0.95 [0.43-2.12],0.9064302465200174
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CAT,Catalase,10444,28,0.90 [0.46-1.76],0.7503059819764519
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CBLIF,Cobalamin binding intrinsic factor,12082,34,0.83 [0.58-1.20],0.3270491562835904
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CBLN1,Cerebellin-1,10232,27,0.66 [0.36-1.19],0.1673714531439636
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CBLN4,Cerebellin-4,12192,33,0.56 [0.22-1.44],0.2266781130503938
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CBS,Cystathionine beta-synthase,10345,27,1.16 [0.59-2.28],0.667198667996545
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CBX2,Chromobox protein homolog 2,10255,26,1.48 [0.77-2.84],0.2407051796325814
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,12018,33,0.74 [0.47-1.15],0.1850018698907373
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCAR2,Cell cycle and apoptosis regulator protein 2,10583,26,0.72 [0.29-1.82],0.4895574763691213
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCDC134,Coiled-coil domain-containing protein 134,10539,27,0.83 [0.38-1.79],0.6287561699361484
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCDC28A,Coiled-coil domain-containing protein 28A,10313,27,0.73 [0.21-2.55],0.6256254282876937
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCDC50,Coiled-coil domain-containing protein 50,10575,26,1.20 [0.79-1.81],0.3980924037137424
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCDC80,Coiled-coil domain-containing protein 80,12105,34,0.63 [0.27-1.48],0.292611690703152
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,10345,27,1.10 [0.62-1.96],0.7421391631769448
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL11,Eotaxin,12214,33,1.81 [0.79-4.12],0.1592858061634205
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL13,C-C motif chemokine 13,12191,32,1.03 [0.66-1.62],0.8940384426541802
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL14,C-C motif chemokine 14,12080,34,0.95 [0.44-2.03],0.8870682764044215
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL15,C-C motif chemokine 15,12244,34,1.26 [0.66-2.42],0.4806926702144503
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL16,C-C motif chemokine 16,12244,34,0.94 [0.53-1.65],0.8169337605127571
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL17,C-C motif chemokine 17,12089,31,1.09 [0.77-1.54],0.6184065842426538
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL18,C-C motif chemokine 18,11937,34,1.34 [0.94-1.91],0.1058899894892073
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL19,C-C motif chemokine 19,12199,33,0.79 [0.59-1.07],0.1295837280996521
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL2,C-C motif chemokine 2,12003,33,0.96 [0.54-1.71],0.8929002189406967
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL20,C-C motif chemokine 20,12214,33,1.04 [0.75-1.44],0.8195005269894091
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL21,C-C motif chemokine 21,12159,32,1.13 [0.60-2.14],0.6959511908844411
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL22,C-C motif chemokine 22,12006,31,1.04 [0.57-1.88],0.9072576282441196
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL23,C-C motif chemokine 23,12159,32,2.25 [1.12-4.54],0.0234399077018898
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL24,C-C motif chemokine 24,12136,31,0.89 [0.60-1.31],0.5457772616240373
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL25,C-C motif chemokine 25,12214,33,2.21 [1.23-3.98],0.0083761761600864
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL26,C-C motif chemokine 26,12073,33,0.96 [0.68-1.36],0.8184757827432083
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL27,C-C motif chemokine 27,12105,34,0.86 [0.51-1.44],0.5587372263390422
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL28,C-C motif chemokine 28,12029,33,1.83 [1.18-2.83],0.0066243117678931
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL3,C-C motif chemokine 3,12073,33,1.23 [0.84-1.81],0.2829485136469394
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL4,C-C motif chemokine 4,12126,32,1.07 [0.72-1.61],0.7353578794355902
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL5,C-C motif chemokine 5,12162,34,1.14 [0.84-1.54],0.3931584908493444
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL7,C-C motif chemokine 7,12073,33,1.07 [0.65-1.76],0.7967268273441969
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL8,C-C motif chemokine 8,12171,33,0.91 [0.55-1.50],0.7007705201299312
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCN1,CCN family member 1,12017,33,0.90 [0.60-1.33],0.5863574544282721
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCN2,CCN family member 2,12086,31,1.24 [0.71-2.16],0.4448406727784599
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCN3,CCN family member 3,12224,34,0.33 [0.13-0.86],0.0229900733814562
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCN4,CCN family member 4,12192,33,1.00 [0.48-2.12],0.991954837345687
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCN5,CCN family member 5,12110,33,0.69 [0.30-1.56],0.3706149672500628
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCND2,G1/S-specific cyclin-D2,10423,26,1.12 [0.39-3.16],0.8360874010719214
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCNE1,G1/S-specific cyclin-E1,10292,27,0.90 [0.53-1.55],0.7140669524248779
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCS,Copper chaperone for superoxide dismutase,12018,33,0.59 [0.30-1.15],0.1186008022590698
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCT5,T-complex protein 1 subunit epsilon,11821,32,1.06 [0.52-2.13],0.8800213216167383
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD101,Immunoglobulin superfamily member 2,10536,26,0.68 [0.30-1.56],0.3643366876458074
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD109,CD109 antigen,12110,33,1.37 [0.54-3.47],0.5059104909702504
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD14,Monocyte differentiation antigen CD14,11873,34,1.16 [0.56-2.40],0.6981118886244071
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD160,CD160 antigen,12214,33,0.61 [0.32-1.17],0.1342717888389486
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD163,Scavenger receptor cysteine-rich type 1 protein M130,12162,34,1.40 [0.70-2.80],0.3382543880987064
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD164,Sialomucin core protein 24,12110,33,0.85 [0.25-2.85],0.7927451556651595
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD164L2,CD164 sialomucin-like 2 protein,10313,27,0.49 [0.16-1.50],0.2100815316084623
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD177,CD177 antigen,12094,33,0.97 [0.77-1.23],0.820214689306098
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD1C,T-cell surface glycoprotein CD1c,12156,33,0.23 [0.08-0.62],0.0038413018936842
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD2,T-cell surface antigen CD2,10255,26,0.65 [0.20-2.12],0.4731734604117312
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD200,OX-2 membrane glycoprotein,12073,33,0.94 [0.29-3.09],0.9243710295001006
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD200R1,Cell surface glycoprotein CD200 receptor 1,12036,32,1.40 [0.59-3.36],0.4446870508205305
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD207,C-type lectin domain family 4 member K,11821,33,1.42 [0.64-3.13],0.3854957499236586
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD209,CD209 antigen,12132,34,0.52 [0.24-1.16],0.1105903387554746
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD22,B-cell receptor CD22,12214,33,0.58 [0.27-1.23],0.1534383924525487
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD226,CD226 antigen,10292,27,1.35 [0.57-3.18],0.4908104583364523
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD244,Natural killer cell receptor 2B4,12214,33,0.84 [0.27-2.65],0.7720852150087374
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD248,Endosialin,10614,27,0.57 [0.23-1.42],0.2294317236763906
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD27,CD27 antigen,12156,33,0.66 [0.31-1.40],0.2770807624895044
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD274,Programmed cell death 1 ligand 1,12018,33,2.35 [1.18-4.70],0.0153636012832605
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD276,CD276 antigen,12102,31,0.51 [0.23-1.16],0.1074515731082053
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD28,T-cell-specific surface glycoprotein CD28,11821,32,1.50 [0.73-3.08],0.275352639401326
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD2AP,CD2-associated protein,12105,34,0.93 [0.58-1.50],0.7769575385126886
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD300A,CMRF35-like molecule 8,10385,26,0.57 [0.16-1.97],0.3728587743834486
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD300C,CMRF35-like molecule 6,12199,33,0.74 [0.30-1.83],0.5193255673591481
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD300E,CMRF35-like molecule 2,12141,33,0.71 [0.33-1.54],0.3911011590880778
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD300LF,CMRF35-like molecule 1,12192,33,1.06 [0.63-1.77],0.827285342943519
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD300LG,CMRF35-like molecule 9,12110,33,0.73 [0.32-1.64],0.4414022926304335
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD302,CD302 antigen,12045,33,1.46 [0.57-3.75],0.4328964071087507
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD33,Myeloid cell surface antigen CD33,12156,33,0.95 [0.65-1.37],0.7705802712314004
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD34,Hematopoietic progenitor cell antigen CD34,12168,33,0.91 [0.25-3.30],0.8843054524834468
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD36,Platelet glycoprotein 4,10292,27,1.43 [0.66-3.14],0.3664382995019823
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,12045,33,1.75 [0.70-4.34],0.2283737257513328
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD3D,T-cell surface glycoprotein CD3 delta chain,10232,27,1.79 [0.82-3.93],0.1466828762678074
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD3E,T-cell surface glycoprotein CD3 epsilon chain,10423,26,0.23 [0.05-0.96],0.0443064254254033
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD3G,T-cell surface glycoprotein CD3 gamma chain,10292,27,1.18 [0.86-1.61],0.305030632998049
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD4,T-cell surface glycoprotein CD4,12051,33,1.38 [0.62-3.10],0.4305334298323673
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD40,Tumor necrosis factor receptor superfamily member 5,12103,31,1.22 [0.66-2.26],0.5302978435702692
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD40LG,CD40 ligand,12214,33,0.95 [0.64-1.42],0.8130007613694004
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD46,Membrane cofactor protein,12042,34,0.93 [0.32-2.75],0.8987392980245091
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD48,CD48 antigen,12136,31,0.75 [0.26-2.22],0.6076609357218916
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD5,T-cell surface glycoprotein CD5,12171,33,0.90 [0.36-2.25],0.8239621040492252
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD55,Complement decay-accelerating factor,11694,33,0.53 [0.15-1.90],0.3282928926301948
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD58,Lymphocyte function-associated antigen 3,12091,31,0.45 [0.08-2.60],0.3753514424118475
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD59,CD59 glycoprotein,11675,33,0.93 [0.25-3.52],0.9134877801936144
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD5L,CD5 antigen-like,10556,28,0.55 [0.25-1.22],0.1405712025828891
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD6,T-cell differentiation antigen CD6,12198,33,1.14 [0.64-2.04],0.65435982889974
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD63,CD63 antigen,12003,33,1.05 [0.58-1.90],0.8705399584378227
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD69,Early activation antigen CD69,12057,34,1.12 [0.79-1.59],0.5385113685296279
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD7,T-cell antigen CD7,10264,27,0.59 [0.24-1.46],0.2543602529906617
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD70,CD70 antigen,12073,33,1.35 [0.65-2.78],0.4212189960529838
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD72,B-cell differentiation antigen CD72,10385,26,0.35 [0.14-0.87],0.0229598408955051
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD74,HLA class II histocompatibility antigen gamma chain,12199,33,0.91 [0.37-2.20],0.8268770695649708
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD79B,B-cell antigen receptor complex-associated protein beta chain,12214,33,0.99 [0.51-1.91],0.9691497499170882
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD80,T-lymphocyte activation antigen CD80,10597,27,0.45 [0.14-1.44],0.1769886974353838
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD82,CD82 antigen,10423,26,1.06 [0.45-2.49],0.9025602348956832
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD83,CD83 antigen,12073,33,0.97 [0.40-2.32],0.9374496445722889
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD84,SLAM family member 5,12073,33,1.03 [0.38-2.79],0.958233771655023
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD86,T-lymphocyte activation antigen CD86,10536,26,0.44 [0.16-1.19],0.1076977852972742
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD8A,T-cell surface glycoprotein CD8 alpha chain,12199,33,1.17 [0.64-2.12],0.6166745970419881
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD93,Complement component C1q receptor,11648,32,0.35 [0.12-0.99],0.0473366192675247
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD99,CD99 antigen,12110,33,1.64 [0.35-7.66],0.5306771545139306
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD99L2,CD99 antigen-like protein 2,12110,33,2.48 [0.72-8.57],0.1506344488599643
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDA,Cytidine deaminase,10571,27,1.31 [0.64-2.68],0.4533829408795002
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDAN1,Codanin-1,10583,26,0.66 [0.11-4.01],0.6482416646122005
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDC123,Cell division cycle protein 123 homolog,10205,26,1.44 [1.04-2.01],0.0290503679634152
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDC25A,M-phase inducer phosphatase 1,10205,26,1.43 [0.72-2.81],0.3044087032913314
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDC26,Anaphase-promoting complex subunit CDC26,10513,26,0.87 [0.50-1.53],0.6313724689592634
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDC27,Cell division cycle protein 27 homolog,11821,32,1.01 [0.60-1.70],0.9658833950931204
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDC37,Hsp90 co-chaperone Cdc37,12156,33,0.79 [0.54-1.15],0.2172632660893205
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDC42BPB,Serine/threonine-protein kinase MRCK beta,10536,26,0.95 [0.66-1.38],0.7897601577807334
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDCP1,CUB domain-containing protein 1,12018,33,1.14 [0.64-2.06],0.6534077785130019
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDH1,Cadherin-1,11729,34,0.95 [0.42-2.14],0.9088074989323512
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDH15,Cadherin-15,12178,33,0.72 [0.35-1.48],0.3772997769245563
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDH17,Cadherin-17,12105,34,1.21 [0.79-1.85],0.3866720505652544
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDH2,Cadherin-2,12105,34,0.84 [0.36-1.92],0.6761906326567402
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDH22,Cadherin-22,10423,26,0.54 [0.13-2.32],0.40729713585574
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDH23,Cadherin-23,10583,26,1.67 [0.47-5.93],0.4242147858004457
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDH3,Cadherin-3,12199,33,0.55 [0.23-1.34],0.1891358999676664
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDH4,Cadherin-4,10232,27,1.44 [0.80-2.58],0.2209892318015589
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDH5,Cadherin-5,12244,34,0.63 [0.22-1.78],0.3819569350426507
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDH6,Cadherin-6,12105,34,1.20 [0.55-2.63],0.6484655569817566
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDHR1,Cadherin-related family member 1,11813,32,1.32 [0.72-2.43],0.3708965941079283
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDHR2,Cadherin-related family member 2,12045,33,0.92 [0.61-1.37],0.6724054178840688
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDHR5,Cadherin-related family member 5,12105,34,1.27 [0.57-2.82],0.5617092932581513
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDK1,Cyclin-dependent kinase 1,10205,26,0.71 [0.25-2.01],0.5200972684272349
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,10575,26,0.63 [0.30-1.34],0.2310011241208681
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDKL5,Cyclin-dependent kinase-like 5,10232,27,1.66 [1.17-2.35],0.0044867639666654
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDKN1A,Cyclin-dependent kinase inhibitor 1,12045,33,0.92 [0.69-1.24],0.5877655212190471
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,12045,33,0.92 [0.67-1.26],0.5923030214576586
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDNF,Cerebral dopamine neurotrophic factor,12045,33,1.19 [0.48-2.94],0.7064550811582456
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,12122,31,0.30 [0.10-0.92],0.0361126641240004
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDSN,Corneodesmosin,12170,33,1.67 [0.85-3.30],0.1372032905622904
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,12135,33,1.68 [0.41-6.88],0.4692699339024022
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,10536,26,0.70 [0.44-1.12],0.140950992643677
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,10423,26,0.82 [0.41-1.61],0.5588733467223836
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,10536,26,1.07 [0.42-2.72],0.884159665785883
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,10423,26,1.24 [0.59-2.60],0.5759564693209023
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,12073,33,0.84 [0.58-1.23],0.3741705209081838
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,11821,32,1.05 [0.56-2.00],0.8719152851432992
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,11677,32,0.76 [0.48-1.23],0.2673987341206504
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,10614,27,0.64 [0.25-1.63],0.3450248432721663
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,11858,34,0.80 [0.43-1.49],0.4803888886040515
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEBPA,CCAAT/enhancer-binding protein alpha,10292,27,1.39 [0.68-2.83],0.3720683183747205
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEBPB,CCAAT/enhancer-binding protein beta,11858,34,0.82 [0.35-1.91],0.6428791719450602
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CELA2A,Chymotrypsin-like elastase family member 2A,10614,27,1.09 [0.60-1.99],0.7790786320425949
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CELA3A,Chymotrypsin-like elastase family member 3A,12222,34,0.91 [0.54-1.53],0.7208223114553577
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,10385,26,0.60 [0.16-2.16],0.4311711683960203
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEMIP2,Cell surface hyaluronidase,10292,27,1.42 [0.74-2.71],0.2935432642076521
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEND1,Cell cycle exit and neuronal differentiation protein 1,10232,27,1.46 [1.03-2.07],0.0338510875250161
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CENPF,Centromere protein F,10423,26,0.60 [0.28-1.30],0.1931294674159112
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CENPJ,Centromere protein J,10423,26,1.14 [0.71-1.81],0.5892923347104885
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEP112,Centrosomal protein of 112 kDa,10255,26,1.02 [0.42-2.49],0.9638770040928004
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEP152,Centrosomal protein of 152 kDa,10205,26,1.04 [0.44-2.48],0.92936701825887
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEP164,Centrosomal protein of 164 kDa,11854,32,0.95 [0.56-1.61],0.8606395327255686
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEP170,Centrosomal protein of 170 kDa,10345,27,1.05 [0.65-1.71],0.8336811645139184
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEP20,Centrosomal protein 20,11821,32,0.95 [0.62-1.46],0.8107144205166932
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEP290,Centrosomal protein of 290 kDa,10423,26,1.23 [0.69-2.19],0.481871356399715
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEP350,Centrosome-associated protein 350,10205,26,1.05 [0.39-2.84],0.9168404915426478
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEP43,Centrosomal protein 43,11761,34,0.96 [0.61-1.51],0.8622350510112717
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEP85,Centrosomal protein of 85 kDa,11821,32,0.93 [0.56-1.55],0.7855476346271564
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CERT,Ceramide transfer protein,11813,32,0.83 [0.50-1.39],0.4736420148664022
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CES1,Liver carboxylesterase 1,12139,34,1.12 [0.77-1.61],0.5543157902106843
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CES2,Cocaine esterase,12045,33,1.12 [0.64-1.95],0.6874795456426817
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CES3,Carboxylesterase 3,12045,33,1.04 [0.67-1.61],0.865677074093454
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CETN2,Centrin-2,11813,32,0.70 [0.42-1.17],0.1723934369086657
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CETN3,Centrin-3,10536,26,0.79 [0.47-1.31],0.3570438947214409
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CFB,Complement factor B,10421,27,0.79 [0.25-2.48],0.6856210683988269
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CFC1,Cryptic protein,11821,32,0.91 [0.44-1.90],0.8038193733918888
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CFD,Complement factor D,10621,28,0.74 [0.12-4.53],0.7474659528966431
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CFH,Complement factor H,9972,25,0.82 [0.16-4.29],0.818987035722654
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CFHR2,Complement factor H-related protein 2,10533,28,1.39 [0.69-2.81],0.3608963333756216
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CFHR4,Complement factor H-related protein 4,10602,28,0.87 [0.54-1.40],0.5652280411337203
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CFHR5,Complement factor H-related protein 5,10447,28,1.55 [0.64-3.78],0.3347234024733146
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CFI,Complement factor I,10621,28,1.72 [0.28-10.41],0.554210621573638
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CFP,Properdin,10621,28,0.52 [0.09-2.94],0.4590618366607206
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CGA,Glycoprotein hormones alpha chain,12110,33,1.68 [0.95-2.96],0.0733103709624282
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,10600,28,0.87 [0.34-2.24],0.7783609923462312
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CGN,Cingulin,10313,27,1.01 [0.43-2.40],0.9769655340703152
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CGREF1,Cell growth regulator with EF hand domain protein 1,12105,34,1.25 [0.62-2.50],0.5345595194628809
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,11821,32,0.87 [0.50-1.49],0.607710083562189
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHAD,Chondroadherin,10385,26,0.55 [0.29-1.03],0.0600103683988476
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",10583,26,1.37 [0.58-3.24],0.4705608164833249
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHCHD6,MICOS complex subunit MIC25,10539,27,1.16 [0.35-3.89],0.8050495583199273
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHEK2,Serine/threonine-protein kinase Chk2,11858,34,1.21 [0.50-2.89],0.6715523047819241
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHGA,Chromogranin-A,10614,27,1.19 [0.86-1.65],0.2978506491468942
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHGB,Secretogranin-1,12159,33,1.66 [0.85-3.24],0.1381974879788001
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHI3L1,Chitinase-3-like protein 1,11859,34,1.02 [0.69-1.48],0.9382880542126528
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHIT1,Chitotriosidase-1,12153,34,1.22 [0.92-1.63],0.1735268783973008
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHL1,Neural cell adhesion molecule L1-like protein,12145,34,0.46 [0.16-1.33],0.1511780957257755
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHM,Rab proteins geranylgeranyltransferase component A 1,10313,27,1.14 [0.63-2.05],0.6643249036219816
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHMP1A,Charged multivesicular body protein 1a,12018,33,0.88 [0.60-1.30],0.5313840619671446
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHMP6,Charged multivesicular body protein 6,10597,27,1.29 [0.67-2.50],0.4452665165803096
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHP1,Calcineurin B homologous protein 1,10232,27,0.96 [0.56-1.63],0.8751373614459586
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHRDL1,Chordin-like protein 1,12136,31,0.62 [0.22-1.73],0.3636369032909219
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHRDL2,Chordin-like protein 2,12105,34,1.13 [0.61-2.11],0.6947552300419915
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHRM1,Muscarinic acetylcholine receptor M1,10313,27,0.22 [0.06-0.77],0.0185122399430101
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CIAPIN1,Anamorsin,12156,33,0.69 [0.42-1.12],0.1319274665694555
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CILP,Cartilage intermediate layer protein 1,10614,27,1.37 [0.67-2.80],0.3833059056276445
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CINP,Cyclin-dependent kinase 2-interacting protein,10423,26,0.61 [0.21-1.77],0.3586304044050823
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CIRBP,Cold-inducible RNA-binding protein,10536,26,0.96 [0.65-1.43],0.8492849783651132
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CIT,Citron Rho-interacting kinase,10313,27,1.33 [0.66-2.66],0.4249073325094601
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CKAP4,Cytoskeleton-associated protein 4,12166,33,1.01 [0.34-3.04],0.9838476440393747
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CKB,Creatine kinase B-type,10614,27,0.86 [0.47-1.57],0.6188017616648318
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",12072,31,1.12 [0.70-1.81],0.6315942717461778
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLASP1,CLIP-associating protein 1,10205,26,1.09 [0.67-1.78],0.7319901937585295
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLC,Galectin-10,12084,34,0.75 [0.45-1.24],0.2623031115576636
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC10A,C-type lectin domain family 10 member A,12018,33,0.44 [0.19-1.02],0.0555915899178727
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC11A,C-type lectin domain family 11 member A,12089,33,1.26 [0.67-2.37],0.4771455574960639
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC12A,C-type lectin domain family 12 member A,10292,27,0.88 [0.15-5.27],0.8876284328721054
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC14A,C-type lectin domain family 14 member A,12110,33,1.02 [0.39-2.63],0.9706062895106496
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC1A,C-type lectin domain family 1 member A,11858,34,1.15 [0.47-2.80],0.7634739143397313
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC1B,C-type lectin domain family 1 member B,12199,33,1.05 [0.76-1.44],0.7648645710144535
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC2L,C-type lectin domain family 2 member L,10313,27,1.46 [0.84-2.52],0.1772455211382233
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC3B,Tetranectin,10356,26,0.33 [0.06-1.91],0.2163971422411404
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC4A,C-type lectin domain family 4 member A,12073,33,0.53 [0.23-1.20],0.1262366421665251
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC4C,C-type lectin domain family 4 member C,12073,33,0.73 [0.38-1.40],0.3467190459699684
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC4D,C-type lectin domain family 4 member D,12073,33,0.79 [0.48-1.30],0.3598598865847155
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC4G,C-type lectin domain family 4 member G,12073,33,1.52 [0.60-3.87],0.3793800918705052
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC4M,C-type lectin domain family 4 member M,10596,27,0.69 [0.32-1.46],0.3303336822889036
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC5A,C-type lectin domain family 5 member A,12073,34,0.63 [0.22-1.80],0.3858476767389023
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC6A,C-type lectin domain family 6 member A,11821,32,0.60 [0.30-1.22],0.1586207327713136
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC7A,C-type lectin domain family 7 member A,12214,33,0.96 [0.59-1.57],0.87534615976161
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLGN,Calmegin,10313,27,1.16 [0.53-2.53],0.7143642300614031
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLIC5,Chloride intracellular channel protein 5,10313,27,0.97 [0.31-3.04],0.957757445306224
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLINT1,Clathrin interactor 1,10205,26,0.75 [0.29-1.95],0.5510141153611092
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLIP2,CAP-Gly domain-containing linker protein 2,12073,33,0.86 [0.65-1.13],0.2697966367973623
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLMP,CXADR-like membrane protein,12192,33,0.71 [0.16-3.18],0.6593062115705345
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLNS1A,Methylosome subunit pICln,10313,27,1.21 [0.41-3.58],0.7298195291067018
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",11997,33,0.88 [0.63-1.22],0.4412940062165549
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLPS,Colipase,12092,33,0.81 [0.52-1.24],0.3257566354543911
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLSPN,Claspin,11792,32,0.80 [0.27-2.32],0.677685857174319
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLSTN1,Calsyntenin-1,11813,32,0.93 [0.51-1.72],0.8257260780806347
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLSTN2,Calsyntenin-2,12214,33,0.96 [0.44-2.12],0.9247883208627798
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLSTN3,Calsyntenin-3,10583,26,0.25 [0.07-0.87],0.0299073836437842
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLTA,Clathrin light chain A,11858,34,0.77 [0.38-1.54],0.4516090718498758
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLU,Clusterin,10621,28,1.42 [0.68-2.97],0.3566597980184818
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLUL1,Clusterin-like protein 1,12086,34,0.70 [0.36-1.38],0.3031491598759452
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CMC1,COX assembly mitochondrial protein homolog,10597,27,1.13 [0.76-1.68],0.5488182736510347
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CMIP,C-Maf-inducing protein,10539,27,1.12 [0.72-1.74],0.6090739844221147
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNDP1,Beta-Ala-His dipeptidase,12162,34,1.98 [0.95-4.13],0.0689026973164495
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNGB3,Cyclic nucleotide-gated cation channel beta-3,10232,27,1.35 [0.83-2.19],0.2274553071346573
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",10326,27,0.85 [0.53-1.37],0.5110642360077053
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNPY2,Protein canopy homolog 2,11858,34,1.68 [1.30-2.19],9.278623638249094e-05
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNPY4,Protein canopy homolog 4,12045,33,0.83 [0.55-1.26],0.3886169661683056
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNST,Consortin,12105,34,1.10 [0.83-1.46],0.4990464358694445
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNTF,Ciliary neurotrophic factor,10232,27,1.85 [0.65-5.29],0.2489440692106441
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNTN1,Contactin-1,12244,34,0.49 [0.18-1.34],0.1638341975195427
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNTN2,Contactin-2,12192,33,0.78 [0.39-1.57],0.4885800369642874
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNTN3,Contactin-3,12110,33,0.84 [0.34-2.03],0.6909979932843762
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNTN4,Contactin-4,12110,33,0.84 [0.23-3.08],0.7960982618111506
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNTN5,Contactin-5,12132,33,0.71 [0.31-1.61],0.4129093136709011
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNTNAP2,Contactin-associated protein-like 2,12073,33,0.92 [0.43-2.00],0.8422310343515446
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNTNAP4,Contactin-associated protein-like 4,10313,27,1.05 [0.74-1.48],0.794781656115706
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COCH,Cochlin,10597,27,1.79 [0.89-3.61],0.1047959316403122
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL15A1,Collagen alpha-1(XV) chain,10614,27,0.22 [0.06-0.86],0.0292719631910783
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL18A1,Collagen alpha-1(XVIII) chain,12156,34,1.04 [0.29-3.73],0.9526880281445146
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL1A1,Collagen alpha-1(I) chain,12244,34,0.32 [0.10-0.98],0.0463107232207595
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL24A1,Collagen alpha-1(XXIV) chain,10536,26,0.91 [0.47-1.76],0.7759641783584602
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL28A1,Collagen alpha-1(XXVIII) chain,10313,27,0.65 [0.37-1.13],0.1289396538680252
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL2A1,Collagen alpha-1(II) chain,10345,27,1.09 [0.69-1.70],0.7164930553219182
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL3A1,Collagen alpha-1(III) chain,10614,27,1.16 [0.23-5.80],0.8587050689028329
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL4A1,Collagen alpha-1(IV) chain,12105,34,0.61 [0.28-1.34],0.2178264222219033
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL4A4,Collagen alpha-4(IV) chain,10405,26,0.66 [0.41-1.07],0.0915774372972882
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL5A1,Collagen alpha-1(V) chain,10385,26,0.48 [0.18-1.31],0.1515824789226559
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL6A3,Collagen alpha-3(VI) chain,12244,34,1.00 [0.43-2.30],0.9926954265176844
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL9A1,Collagen alpha-1(IX) chain,12073,33,0.77 [0.41-1.47],0.4305235271609248
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL9A2,Collagen alpha-2(IX) chain,10423,26,1.42 [0.82-2.46],0.2050964573367545
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COLEC12,Collectin-12,12102,31,0.87 [0.26-2.92],0.8164673409656499
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COMMD1,COMM domain-containing protein 1,10345,27,1.07 [0.59-1.96],0.8148939175522476
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COMMD9,COMM domain-containing protein 9,10539,27,1.02 [0.40-2.60],0.9637810546230468
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COMP,Cartilage oligomeric matrix protein,11977,33,0.89 [0.35-2.24],0.7988132231913615
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COMT,Catechol O-methyltransferase,11739,33,0.89 [0.61-1.30],0.5584476413365379
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COPB2,Coatomer subunit beta',10255,26,1.83 [0.98-3.43],0.0596051689846461
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COPE,Coatomer subunit epsilon,11813,32,1.33 [0.80-2.21],0.274135716350809
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",10345,27,2.11 [1.27-3.51],0.0040095479632627
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CORO1A,Coronin-1A,11840,33,1.01 [0.72-1.42],0.963775843684166
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CORO6,Coronin-6,10232,27,1.07 [0.41-2.82],0.8908460174099837
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",12045,33,0.92 [0.59-1.45],0.7231770789068043
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COX6B1,Cytochrome c oxidase subunit 6B1,10597,27,1.22 [0.42-3.60],0.7146236459649338
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPA1,Carboxypeptidase A1,12244,34,0.98 [0.59-1.62],0.9388823436730672
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPA2,Carboxypeptidase A2,12161,33,0.96 [0.60-1.54],0.8721369897694009
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPA4,Carboxypeptidase A4,10178,26,0.47 [0.22-1.04],0.0637832292852117
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPB1,Carboxypeptidase B,12244,34,0.97 [0.58-1.61],0.8967528428937167
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPB2,Carboxypeptidase B2,10600,28,0.86 [0.17-4.43],0.8578820648822528
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPE,Carboxypeptidase E,12088,33,0.70 [0.34-1.46],0.3446148413423201
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPLX2,Complexin-2,10205,26,0.40 [0.10-1.51],0.1756581648259628
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPM,Carboxypeptidase M,12137,33,2.21 [0.99-4.97],0.0539814535221378
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",10292,27,3.22 [1.44-7.18],0.0043154484517369
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPPED1,Serine/threonine-protein phosphatase CPPED1,12199,33,0.60 [0.37-0.96],0.0340466409679677
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPQ,Carboxypeptidase Q,10587,27,0.72 [0.26-1.96],0.5201492029047583
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPTP,Ceramide-1-phosphate transfer protein,10255,26,0.82 [0.29-2.30],0.7011220231612134
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPVL,Probable serine carboxypeptidase CPVL,12178,33,1.00 [0.47-2.11],0.9910919496597196
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPXM1,Probable carboxypeptidase X1,12156,33,1.15 [0.75-1.76],0.5153217918719969
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPXM2,Inactive carboxypeptidase-like protein X2,10597,27,0.24 [0.05-1.06],0.0593515654820358
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CR1,Complement receptor type 1,10560,28,0.56 [0.23-1.40],0.2168799270166973
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CR2,Complement receptor type 2,12162,34,0.61 [0.32-1.15],0.1233456740000705
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,11821,32,0.87 [0.59-1.28],0.4780489447916046
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRADD,Death domain-containing protein CRADD,11997,33,0.83 [0.55-1.25],0.3685665519284365
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CREB3,Cyclic AMP-responsive element-binding protein 3,10205,26,1.18 [0.65-2.15],0.5780530673916453
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CREBZF,CREB/ATF bZIP transcription factor,10205,26,0.94 [0.22-3.99],0.9355449451776564
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CREG1,Protein CREG1,11961,33,1.78 [0.83-3.82],0.1369336707371556
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRELD1,Protein disulfide isomerase CRELD1,10385,26,0.51 [0.19-1.39],0.1882617240892918
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRELD2,Protein disulfide isomerase CRELD2,12136,31,0.81 [0.44-1.51],0.5149370930235253
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRH,Corticoliberin,11800,32,0.96 [0.67-1.40],0.8489924611351447
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRHBP,Corticotropin-releasing factor-binding protein,12102,31,0.95 [0.30-2.95],0.923737977072278
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRHR1,Corticotropin-releasing factor receptor 1,11858,34,1.15 [0.75-1.77],0.519312049505194
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRIM1,Cysteine-rich motor neuron 1 protein,12159,32,0.74 [0.15-3.58],0.7124033643344512
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRIP2,Cysteine-rich protein 2,12018,33,0.60 [0.25-1.48],0.2673046027741071
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRISP2,Cysteine-rich secretory protein 2,12192,33,0.79 [0.50-1.25],0.3168315886521441
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRISP3,Cysteine-rich secretory protein 3,10511,28,0.22 [0.08-0.59],0.0027147944346999
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRKL,Crk-like protein,12125,31,0.84 [0.63-1.13],0.2546061541367747
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRLF1,Cytokine receptor-like factor 1,12159,32,1.16 [0.33-4.08],0.8210800411976069
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRNN,Cornulin,11766,32,1.15 [0.74-1.81],0.5339555486445511
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRTAC1,Cartilage acidic protein 1,12244,34,1.02 [0.36-2.86],0.968948731246056
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRTAM,Cytotoxic and regulatory T-cell molecule,12018,33,0.96 [0.52-1.76],0.8951660167107851
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRTAP,Cartilage-associated protein,10313,27,1.15 [0.56-2.36],0.7124825442975514
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRX,Cone-rod homeobox protein,11858,34,0.98 [0.74-1.31],0.916622877606562
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRYBB1,Beta-crystallin B1,10597,27,0.91 [0.51-1.62],0.7390062983042863
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRYBB2,Beta-crystallin B2,10583,26,0.62 [0.27-1.43],0.2584266669391079
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRYGD,Gamma-crystallin D,10583,26,0.76 [0.52-1.13],0.1753873169183482
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRYM,Ketimine reductase mu-crystallin,10232,27,1.27 [0.89-1.82],0.1925372202579378
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRYZL1,Quinone oxidoreductase-like protein 1,10345,27,0.98 [0.65-1.46],0.9051933733396672
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSDE1,Cold shock domain-containing protein E1,10255,26,1.30 [1.01-1.65],0.0376262152167792
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSF1,Macrophage colony-stimulating factor 1,12159,32,0.68 [0.21-2.17],0.5155117491011023
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSF1R,Macrophage colony-stimulating factor 1 receptor,10600,28,0.66 [0.28-1.54],0.3366226590147102
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSF2,Granulocyte-macrophage colony-stimulating factor,10255,26,1.04 [0.34-3.11],0.9508063649594952
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,12018,33,1.00 [0.60-1.65],0.9878469788675766
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSF2RB,Cytokine receptor common subunit beta,10292,27,1.03 [0.44-2.42],0.9548245028206076
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSF3,Granulocyte colony-stimulating factor,11854,32,1.24 [0.68-2.25],0.4872817026539703
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSF3R,Granulocyte colony-stimulating factor receptor,10292,27,0.51 [0.14-1.92],0.3220076179274076
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSH1,Chorionic somatomammotropin hormone 1,10600,28,2.26 [0.68-7.55],0.1837721533311315
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSNK1D,Casein kinase I isoform delta,10292,27,1.31 [0.77-2.23],0.3217562133081515
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSNK2A1,Casein kinase II subunit alpha,10575,26,0.67 [0.29-1.56],0.3523418191333787
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSPG4,Chondroitin sulfate proteoglycan 4,10614,27,0.82 [0.26-2.54],0.7316899220485986
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSPG5,Chondroitin sulfate proteoglycan 5,10232,27,1.25 [0.64-2.41],0.5111624351695203
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSRP3,Cysteine and glycine-rich protein 3,10255,26,0.66 [0.41-1.08],0.0967412735414651
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CST1,Cystatin-SN,9215,20,0.86 [0.56-1.33],0.4989289958648645
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CST3,Cystatin-C,12145,34,1.37 [0.51-3.69],0.5360487715201767
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CST5,Cystatin-D,11901,33,1.27 [0.74-2.16],0.3869031007456742
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CST6,Cystatin-M,11769,32,1.47 [0.77-2.79],0.2407601379008184
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CST7,Cystatin-F,12126,32,0.99 [0.71-1.38],0.9581542048720996
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSTB,Cystatin-B,11940,32,0.97 [0.45-2.06],0.930674428199508
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTAG1A_CTAG1B,Cancer/testis antigen 1,10403,26,0.95 [0.44-2.03],0.8912720367710023
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTBS,Di-N-acetylchitobiase,10434,28,1.21 [0.30-4.90],0.7907368793964281
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTF1,Cardiotrophin-1,11858,34,0.94 [0.65-1.36],0.725455326949701
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTHRC1,Collagen triple helix repeat-containing protein 1,10614,27,0.63 [0.17-2.40],0.5013364234791495
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTLA4,Cytotoxic T-lymphocyte protein 4,10614,27,0.56 [0.16-2.01],0.3733768616477417
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTNNA1,Catenin alpha-1,10232,27,1.42 [0.69-2.92],0.3450397884077534
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTRB1,Chymotrypsinogen B,12110,33,1.20 [0.70-2.07],0.5010353541605383
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTRC,Chymotrypsin-C,12106,31,1.02 [0.62-1.66],0.9437276430322918
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTRL,Chymotrypsin-like protease CTRL-1,10583,26,0.69 [0.41-1.16],0.163157954405816
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTSB,Cathepsin B,12127,34,1.36 [0.80-2.29],0.2556894790128765
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTSC,Dipeptidyl peptidase 1,12084,32,1.27 [0.64-2.55],0.496729318774104
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTSD,Cathepsin D,11351,32,0.66 [0.29-1.53],0.3358100622924455
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTSE,Cathepsin E,10385,26,0.38 [0.18-0.83],0.0147349922923995
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTSF,Cathepsin F,12156,33,1.12 [0.52-2.42],0.7775550384104664
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTSH,Pro-cathepsin H,11825,34,0.88 [0.58-1.33],0.5326016843029643
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTSL,Cathepsin L1,12105,34,1.12 [0.33-3.83],0.8551654523212442
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTSO,Cathepsin O,12214,33,1.68 [0.65-4.33],0.2855907500681623
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTSS,Cathepsin S,9429,21,0.75 [0.12-4.58],0.7542462408706337
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTSV,Cathepsin L2,12155,33,1.37 [0.71-2.66],0.348128961910825
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTSZ,Cathepsin Z,12133,33,1.57 [0.62-4.02],0.3423712006360304
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CUZD1,CUB and zona pellucida-like domain-containing protein 1,10313,27,0.40 [0.11-1.51],0.1762280629608795
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CWC15,Spliceosome-associated protein CWC15 homolog,10470,25,1.09 [0.58-2.02],0.7965446503505449
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CX3CL1,Fractalkine,12018,33,1.19 [0.48-2.92],0.7120120465807351
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXADR,Coxsackievirus and adenovirus receptor,12073,33,1.86 [1.18-2.95],0.0077114105772312
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL1,Growth-regulated alpha protein,12090,32,1.21 [0.91-1.60],0.1891330791328039
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL10,C-X-C motif chemokine 10,12159,32,0.94 [0.59-1.50],0.7937565959985751
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL11,C-X-C motif chemokine 11,12199,33,1.15 [0.82-1.61],0.4036378875732533
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL12,Stromal cell-derived factor 1,11854,32,0.65 [0.29-1.46],0.2945415782990153
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL13,C-X-C motif chemokine 13,12199,33,1.23 [0.83-1.84],0.3050898310437343
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL14,C-X-C motif chemokine 14,11854,32,0.96 [0.57-1.64],0.8889178296111532
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL16,C-X-C motif chemokine 16,12228,34,1.72 [0.50-5.87],0.3899729760635706
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL17,C-X-C motif chemokine 17,12214,33,0.89 [0.45-1.74],0.7256335500426843
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL3,C-X-C motif chemokine 3,12103,31,1.06 [0.75-1.50],0.7484920904949092
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL5,C-X-C motif chemokine 5,12071,34,1.10 [0.85-1.43],0.461150558581498
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL6,C-X-C motif chemokine 6,12214,33,0.97 [0.65-1.44],0.8838337865212063
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL8,Interleukin-8,12004,32,1.06 [0.70-1.58],0.7947250540384051
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL9,C-X-C motif chemokine 9,12159,32,0.98 [0.62-1.54],0.9177713630404392
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CYB5A,Cytochrome b5,10205,26,1.07 [0.66-1.72],0.7920652540605394
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CYB5R2,NADH-cytochrome b5 reductase 2,10414,26,1.06 [0.55-2.06],0.857113587217505
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",10255,26,1.02 [0.66-1.57],0.9352696088044564
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CYTH3,Cytohesin-3,10205,26,0.90 [0.51-1.59],0.7238363495860234
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CYTL1,Cytokine-like protein 1,10614,27,3.42 [0.90-12.99],0.0707715882036701
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DAAM1,Disheveled-associated activator of morphogenesis 1,10385,26,1.14 [0.73-1.78],0.5646211823838615
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DAB2,Disabled homolog 2,12192,33,0.92 [0.70-1.21],0.5555524628045332
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DAG1,Dystroglycan,12159,32,0.94 [0.48-1.84],0.854697955210339
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DAND5,DAN domain family member 5,10292,27,1.26 [0.70-2.29],0.4390915365642974
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DAPK2,Death-associated protein kinase 2,10292,27,1.07 [0.56-2.03],0.8401331338019611
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,12073,33,0.94 [0.74-1.21],0.6487315164287923
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DARS1,"Aspartate--tRNA ligase, cytoplasmic",11997,33,0.73 [0.49-1.10],0.133777284736174
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DBH,Dopamine beta-hydroxylase,10574,28,1.27 [0.83-1.95],0.2639309062901429
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DBI,Acyl-CoA-binding protein,12056,33,0.92 [0.62-1.38],0.6921746546991662
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DBN1,Drebrin,10292,27,1.29 [0.63-2.63],0.493407069106178
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DBNL,Drebrin-like protein,12159,32,0.84 [0.60-1.17],0.3012629462273267
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",12156,33,1.18 [0.49-2.84],0.7077855013361306
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCC,Netrin receptor DCC,10313,27,0.41 [0.05-3.11],0.3889557579324622
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCDC2C,Doublecortin domain-containing protein 2C,10205,26,0.94 [0.50-1.76],0.8480212344424227
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCLRE1C,Protein artemis,10205,26,1.65 [0.57-4.81],0.3599717110987193
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCN,Decorin,11858,34,0.85 [0.23-3.18],0.8051421144428278
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCTD,Deoxycytidylate deaminase,10385,26,1.19 [0.79-1.80],0.399179596081236
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCTN1,Dynactin subunit 1,12192,33,0.68 [0.42-1.09],0.1080106715677956
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCTN2,Dynactin subunit 2,12045,33,0.81 [0.57-1.15],0.2421148243448055
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCTN6,Dynactin subunit 6,11813,32,1.17 [0.80-1.71],0.4203470953610602
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCTPP1,dCTP pyrophosphatase 1,12105,34,1.40 [0.54-3.65],0.486460920414946
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCUN1D1,DCN1-like protein 1,10232,27,1.11 [0.71-1.75],0.6383096011591453
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCUN1D2,DCN1-like protein 2,10205,26,1.09 [0.71-1.66],0.7042531936835632
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCXR,L-xylulose reductase,12156,33,0.72 [0.39-1.33],0.2910448795275687
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDA1,DET1- and DDB1-associated protein 1,10255,26,0.59 [0.18-1.91],0.3760721660146764
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",12045,33,0.78 [0.38-1.61],0.5027283812167702
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDC,Aromatic-L-amino-acid decarboxylase,12082,34,1.34 [0.73-2.46],0.3392272779870169
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDHD2,Phospholipase DDHD2,10575,26,0.93 [0.52-1.67],0.8116157537982174
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDI2,Protein DDI1 homolog 2,10385,26,0.63 [0.39-1.04],0.0703945021462789
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDR1,Epithelial discoidin domain-containing receptor 1,12199,33,0.31 [0.08-1.27],0.1048229102756654
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDT,D-dopachrome decarboxylase,10614,27,0.82 [0.33-2.03],0.6622046349314019
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDX1,ATP-dependent RNA helicase DDX1,10536,26,1.14 [0.58-2.23],0.7018866089964854
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDX25,ATP-dependent RNA helicase DDX25,10313,27,0.51 [0.15-1.72],0.2761900950859876
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDX39A,ATP-dependent RNA helicase DDX39A,10292,27,1.74 [0.58-5.28],0.3251870383949685
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDX4,Probable ATP-dependent RNA helicase DDX4,10292,27,1.15 [0.62-2.15],0.6522958904647569
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDX53,Probable ATP-dependent RNA helicase DDX53,10313,27,1.12 [0.40-3.10],0.8281835220287
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDX58,Antiviral innate immune response receptor RIG-I,11821,32,0.68 [0.35-1.32],0.2544226614252444
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",12073,33,0.92 [0.66-1.27],0.5961636698732313
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DEFA1_DEFA1B,Neutrophil defensin 1,11872,32,1.11 [0.65-1.91],0.6957548440442333
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DEFB103A_DEFB103B,Beta-defensin 103,10208,27,0.96 [0.38-2.45],0.9383246423927534
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DEFB104A_DEFB104B,Beta-defensin 104,10232,27,1.25 [0.72-2.15],0.4266512247915984
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DEFB116,Beta-defensin 116,10232,27,1.44 [1.08-1.93],0.0143184382039204
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DEFB118,Beta-defensin 118,10232,27,0.80 [0.36-1.78],0.5807610726217896
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DEFB4A_DEFB4B,Beta-defensin 4A,11941,33,1.03 [0.84-1.26],0.77949658183485
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DENND2B,DENN domain-containing protein 2B,10255,26,1.65 [1.09-2.49],0.018336367605571
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DENR,Density-regulated protein,10292,27,1.34 [0.75-2.40],0.3217326155626367
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DFFA,DNA fragmentation factor subunit alpha,12214,33,0.79 [0.50-1.26],0.328950089756253
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DGCR6,Protein DGCR6,10232,27,0.32 [0.09-1.06],0.0620042550177462
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DGKA,Diacylglycerol kinase alpha,10292,27,1.28 [0.66-2.48],0.460178494368081
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DGKZ,Diacylglycerol kinase zeta,11854,32,0.45 [0.17-1.19],0.107182521286158
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DHODH,Dihydroorotate dehydrogenase,10255,26,1.27 [0.67-2.41],0.4620934062720303
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DHPS,Deoxyhypusine synthase,10539,27,0.58 [0.20-1.71],0.3225571832401831
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,10583,26,0.62 [0.24-1.61],0.3251271543584346
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DIABLO,"Diablo homolog, mitochondrial",12073,34,1.05 [0.80-1.39],0.7147846163854469
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DIPK1C,Divergent protein kinase domain 1C,10313,27,0.59 [0.21-1.65],0.3143360797744626
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DIPK2B,Divergent protein kinase domain 2B,10385,26,0.25 [0.06-0.96],0.0433079304005629
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DKK1,Dickkopf-related protein 1,12199,33,1.32 [0.78-2.21],0.2983841304814296
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DKK3,Dickkopf-related protein 3,12244,34,0.61 [0.22-1.69],0.338878230815036
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DKK4,Dickkopf-related protein 4,12007,33,1.42 [0.83-2.44],0.2035084645772328
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DKKL1,Dickkopf-like protein 1,12045,33,0.89 [0.65-1.23],0.4867495303604104
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DLG4,Disks large homolog 4,10583,26,1.13 [0.67-1.91],0.646810733039654
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DLGAP5,Disks large-associated protein 5,10575,26,0.86 [0.38-1.94],0.7193166341919026
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DLK1,Protein delta homolog 1,12244,34,0.75 [0.42-1.33],0.3275128158720127
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DLL1,Delta-like protein 1,12156,33,0.75 [0.26-2.12],0.586585426187437
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DLL4,Delta-like protein 4,10345,27,0.99 [0.63-1.56],0.969095951089389
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DMD,Dystrophin,10345,27,1.10 [0.56-2.18],0.7767008836027379
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DMP1,Dentin matrix acidic phosphoprotein 1,10345,27,1.02 [0.58-1.82],0.9366344081127116
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNAJA1,DnaJ homolog subfamily A member 1,10205,26,1.14 [0.53-2.44],0.7296020141905952
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNAJA2,DnaJ homolog subfamily A member 2,12182,33,0.82 [0.57-1.19],0.292822000590644
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNAJA4,DnaJ homolog subfamily A member 4,10583,26,0.75 [0.44-1.29],0.3014573587889622
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNAJB1,DnaJ homolog subfamily B member 1,12045,33,0.81 [0.57-1.14],0.2255048822599952
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNAJB14,DnaJ homolog subfamily B member 14,10536,26,0.95 [0.52-1.73],0.8720077473883951
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNAJB2,DnaJ homolog subfamily B member 2,10385,26,0.66 [0.32-1.36],0.2556911711791562
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNAJB6,DnaJ homolog subfamily B member 6,10288,26,1.09 [0.70-1.71],0.7035014775939729
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNAJB8,DnaJ homolog subfamily B member 8,11858,34,0.85 [0.48-1.52],0.5935043838446072
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNAJC21,DnaJ homolog subfamily C member 21,10583,26,1.73 [0.72-4.15],0.2236846994715137
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNAJC6,Putative tyrosine-protein phosphatase auxilin,10345,27,1.00 [0.64-1.56],0.9989737451683306
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNAJC9,DnaJ homolog subfamily C member 9,10536,26,0.78 [0.48-1.28],0.3301982520170523
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNER,Delta and Notch-like epidermal growth factor-related receptor,12082,31,0.89 [0.24-3.28],0.8630505257689225
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNLZ,DNL-type zinc finger protein,10232,27,0.80 [0.48-1.32],0.3796788944656394
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNM1,Dynamin-1,10536,26,0.99 [0.72-1.38],0.965690942195522
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNM3,Dynamin-3,10575,26,1.18 [0.61-2.27],0.6257648214342325
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNMBP,Dynamin-binding protein,12018,33,1.01 [0.60-1.67],0.982848202310527
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNPEP,Aspartyl aminopeptidase,10583,26,1.21 [0.63-2.33],0.5699055991039685
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,12148,32,0.80 [0.44-1.45],0.4558514867034734
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DOC2B,Double C2-like domain-containing protein beta,10313,27,0.20 [0.05-0.83],0.0268866544901475
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DOCK9,Dedicator of cytokinesis protein 9,10232,27,0.94 [0.68-1.29],0.6859359201719417
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DOK1,Docking protein 1,10583,26,1.12 [0.84-1.49],0.4430604377073482
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DOK2,Docking protein 2,12105,34,1.02 [0.79-1.31],0.8728142299270222
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DPEP1,Dipeptidase 1,11997,33,1.54 [0.82-2.88],0.1782545681333645
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DPEP2,Dipeptidase 2,12045,33,0.89 [0.29-2.73],0.8344838887987145
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DPP10,Inactive dipeptidyl peptidase 10,12073,33,1.07 [0.47-2.47],0.865326245296466
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DPP4,Dipeptidyl peptidase 4,11898,33,0.72 [0.24-2.16],0.5635820778106024
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DPP6,Dipeptidyl aminopeptidase-like protein 6,12045,33,1.21 [0.49-3.00],0.686304606032381
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DPP7,Dipeptidyl peptidase 2,12008,33,0.91 [0.54-1.52],0.7067601000613688
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DPT,Dermatopontin,12244,34,0.69 [0.22-2.15],0.5225770915499848
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DPY30,Protein dpy-30 homolog,12143,33,0.77 [0.44-1.34],0.3525469840025644
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DRAXIN,Draxin,12018,33,0.61 [0.30-1.26],0.1814021492130689
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DRG2,Developmentally-regulated GTP-binding protein 2,12045,33,0.79 [0.45-1.39],0.4091279205661224
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DSC2,Desmocollin-2,11990,32,0.74 [0.29-1.88],0.5225845129031078
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DSCAM,Down syndrome cell adhesion molecule,10575,26,1.08 [0.38-3.10],0.8868979299578527
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DSG2,Desmoglein-2,12110,33,0.59 [0.19-1.88],0.3732519195372661
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DSG3,Desmoglein-3,12150,33,0.74 [0.30-1.84],0.5156077762927497
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DSG4,Desmoglein-4,12015,33,1.05 [0.58-1.92],0.8619740806402472
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DTD1,D-aminoacyl-tRNA deacylase 1,10385,26,1.28 [0.83-1.97],0.2677927214318542
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DTNB,Dystrobrevin beta,10516,27,1.13 [0.47-2.72],0.7874929488310043
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DTX2,Probable E3 ubiquitin-protein ligase DTX2,10313,27,0.96 [0.53-1.73],0.8796872520726233
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DTX3,Probable E3 ubiquitin-protein ligase DTX3,12045,33,0.83 [0.23-3.01],0.7728554520982174
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DTYMK,Thymidylate kinase,10597,27,1.06 [0.63-1.81],0.8168254151818399
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DUOX2,Dual oxidase 2,11858,34,0.69 [0.40-1.19],0.1833817772930112
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DUSP13,Dual specificity protein phosphatase 13 isoform A,10539,27,0.63 [0.23-1.70],0.3586954484193556
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DUSP29,Dual specificity phosphatase 29,10313,27,0.58 [0.26-1.25],0.1637606652027082
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DUSP3,Dual specificity protein phosphatase 3,11813,32,1.07 [0.77-1.47],0.6866385892641339
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",10536,26,1.13 [0.79-1.63],0.4932118859171434
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DXO,Decapping and exoribonuclease protein,10583,26,0.83 [0.36-1.91],0.6618469523340758
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,10539,27,0.96 [0.42-2.15],0.9136291826385734
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DYNLT1,Dynein light chain Tctex-type 1,10313,27,0.96 [0.61-1.52],0.8558505597692122
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DYNLT3,Dynein light chain Tctex-type 3,10539,27,0.87 [0.37-2.03],0.738994220148131
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,12018,33,0.89 [0.64-1.23],0.4845021980453495
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EBI3_IL27,Interleukin-27,12166,33,2.15 [0.82-5.66],0.1195754941431589
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ECE1,Endothelin-converting enzyme 1,11813,32,1.65 [0.76-3.58],0.2024380251153587
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",10597,27,1.02 [0.62-1.67],0.9363073659149888
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ECHS1,"Enoyl-CoA hydratase, mitochondrial",10345,27,1.02 [0.70-1.49],0.9046716991522143
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ECI2,Enoyl-CoA delta isomerase 2,10255,26,1.11 [0.62-1.99],0.724656327111558
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ECM1,Extracellular matrix protein 1,10325,27,0.68 [0.28-1.69],0.4103811871328534
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ECSCR,Endothelial cell-specific chemotaxis regulator,10232,27,1.41 [0.84-2.35],0.1955495671196666
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EDA2R,Tumor necrosis factor receptor superfamily member 27,12192,33,1.04 [0.46-2.37],0.9179078821530252
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EDAR,Tumor necrosis factor receptor superfamily member EDAR,12073,33,0.84 [0.60-1.18],0.3202538385408802
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EDDM3B,Epididymal secretory protein E3-beta,10539,27,0.71 [0.28-1.81],0.4742910831089604
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,10255,26,1.35 [0.62-2.93],0.4442270963064252
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EDF1,Endothelial differentiation-related factor 1,10575,26,1.14 [0.71-1.82],0.5946598918814046
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,11858,34,1.29 [0.55-3.01],0.5625522694298033
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EDN1,Endothelin-1,10345,27,2.87 [0.89-9.27],0.0777600672601115
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EDNRB,Endothelin receptor type B,10292,27,0.88 [0.36-2.16],0.7863918877694467
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EEF1D,Elongation factor 1-delta,10597,27,0.91 [0.61-1.37],0.662858129234996
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EFCAB14,EF-hand calcium-binding domain-containing protein 14,10536,26,0.54 [0.13-2.29],0.4028874904146604
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EFCAB2,Dynein regulatory complex protein 8,10423,26,1.05 [0.36-3.07],0.9317629705899926
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,12146,34,0.91 [0.34-2.40],0.8440084021068821
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EFHD1,EF-hand domain-containing protein D1,10575,26,1.16 [0.42-3.16],0.776439517915589
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EFNA1,Ephrin-A1,12095,33,1.53 [0.55-4.27],0.417690710928275
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EFNA4,Ephrin-A4,12003,33,1.52 [0.62-3.73],0.3614801839143086
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EFNB2,Ephrin-B2,10313,27,0.80 [0.38-1.68],0.5477902350583412
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EGF,Pro-epidermal growth factor,12086,31,0.96 [0.71-1.31],0.8060091760450312
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EGFL7,Epidermal growth factor-like protein 7,11821,32,1.38 [0.70-2.73],0.3503061466109647
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EGFLAM,Pikachurin,10536,26,1.39 [0.48-4.03],0.5414370387889724
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EGFR,Epidermal growth factor receptor,12244,34,1.55 [0.25-9.52],0.636062544532568
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EGLN1,Egl nine homolog 1,12073,33,0.62 [0.30-1.26],0.1826531338779837
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EHBP1,EH domain-binding protein 1,10597,27,0.94 [0.57-1.57],0.8256434602572126
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EHD3,EH domain-containing protein 3,10345,27,1.07 [0.77-1.49],0.6796201233354618
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",10583,26,1.12 [0.59-2.11],0.7285217584068087
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",10487,26,0.98 [0.69-1.40],0.9217971365507016
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,10255,26,1.21 [0.71-2.07],0.4851890014292213
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,10345,27,1.40 [0.62-3.15],0.4169240747633161
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EIF4B,Eukaryotic translation initiation factor 4B,12018,33,0.83 [0.50-1.39],0.4827075722825653
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EIF4E,Eukaryotic translation initiation factor 4E,10292,27,1.05 [0.70-1.58],0.8196558347740984
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,12105,34,0.81 [0.50-1.31],0.3850986986536652
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,12214,33,0.87 [0.64-1.19],0.3883141302151702
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,10575,26,0.86 [0.48-1.56],0.623440084283514
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EIF5,Eukaryotic translation initiation factor 5,10255,26,1.20 [0.56-2.60],0.6377746158818608
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EIF5A,Eukaryotic translation initiation factor 5A-1,11854,32,0.51 [0.16-1.66],0.2660597454347014
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ELAC1,Zinc phosphodiesterase ELAC protein 1,10575,26,0.98 [0.63-1.53],0.940172108245572
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ELAVL4,ELAV-like protein 4,10232,27,0.88 [0.55-1.41],0.5947134293221292
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ELN,Elastin,10597,27,0.78 [0.28-2.15],0.6249773996049004
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ELOA,Elongin-A,12045,33,0.49 [0.23-1.02],0.0570299640409042
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ELOB,Elongin-B,10255,26,0.84 [0.29-2.45],0.7519477697306644
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENAH,Protein enabled homolog,11854,32,0.66 [0.32-1.35],0.2559184159642591
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENDOU,Poly(U)-specific endoribonuclease,9769,25,1.32 [0.64-2.73],0.4450736439193069
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENG,Endoglin,12244,34,0.45 [0.07-2.65],0.3737292375645434
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENO1,Alpha-enolase,12092,33,0.76 [0.52-1.12],0.163802543531516
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENO2,Gamma-enolase,12199,33,0.82 [0.51-1.32],0.4145683878886017
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENO3,Beta-enolase,10345,27,1.02 [0.53-1.97],0.9451076618535664
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENOPH1,Enolase-phosphatase E1,10539,27,1.22 [0.73-2.05],0.4468678078171633
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,10255,26,0.92 [0.23-3.69],0.9017420963868747
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENPEP,Glutamyl aminopeptidase,10255,26,1.01 [0.45-2.26],0.9756584726667246
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,12244,34,1.37 [0.51-3.68],0.5320447524575074
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,12159,32,1.11 [0.49-2.53],0.7949692691946474
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,10345,27,0.71 [0.27-1.92],0.5019218996071464
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,11688,31,1.48 [1.03-2.13],0.0320599824446246
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENSA,Alpha-endosulfine,10539,27,0.71 [0.33-1.54],0.3910161866974329
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,11821,32,1.01 [0.50-2.05],0.9678199134953984
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,11858,34,1.12 [0.26-4.88],0.8815933179252554
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,11858,34,3.31 [0.99-11.12],0.0524131241102239
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENTR1,Endosome-associated-trafficking regulator 1,10345,27,0.74 [0.36-1.53],0.4206771391414369
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EP300,Histone acetyltransferase p300,10292,27,1.54 [0.72-3.30],0.2634677071597143
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPB41L5,Band 4.1-like protein 5,10313,27,1.13 [0.67-1.92],0.6478263040548439
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPCAM,Epithelial cell adhesion molecule,12101,31,1.16 [0.85-1.59],0.3392532648960301
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPGN,Epigen,10539,27,0.77 [0.29-2.07],0.6068266415489598
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPHA1,Ephrin type-A receptor 1,12148,32,1.65 [0.66-4.10],0.2824335472422593
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPHA10,Ephrin type-A receptor 10,11813,32,1.18 [0.79-1.74],0.4159598753849043
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPHA2,Ephrin type-A receptor 2,11668,31,0.93 [0.34-2.59],0.8964148717115266
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPHA4,Ephrin type-A receptor 4,10385,26,0.28 [0.08-0.94],0.0398782307176495
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPHB4,Ephrin type-B receptor 4,12244,34,0.42 [0.12-1.47],0.172541774985364
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPHB6,Ephrin type-B receptor 6,11997,33,0.97 [0.37-2.55],0.9570361284277608
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPHX2,Bifunctional epoxide hydrolase 2,11858,34,0.97 [0.59-1.58],0.9005932594176171
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPN1,Epsin-1,10423,26,0.76 [0.28-2.09],0.5969232583866579
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPO,Erythropoietin,12073,33,0.87 [0.55-1.37],0.5369514004188385
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPPK1,Epiplakin,10345,27,0.93 [0.56-1.55],0.7780049727384659
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,12169,33,1.73 [0.69-4.37],0.2454016850130466
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERBB2,Receptor tyrosine-protein kinase erbB-2,12156,33,0.80 [0.22-2.96],0.7351955798448859
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERBB3,Receptor tyrosine-protein kinase erbB-3,12078,31,2.87 [0.58-14.04],0.1941566843504412
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERBB4,Receptor tyrosine-protein kinase erbB-4,12156,33,0.77 [0.22-2.71],0.6836075286422799
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERBIN,Erbin,12045,33,0.89 [0.66-1.19],0.4215007901758053
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERC2,ERC protein 2,10313,27,1.30 [0.91-1.87],0.154709629180964
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERCC1,DNA excision repair protein ERCC-1,10205,26,1.89 [0.95-3.74],0.0682009269774148
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EREG,Proepiregulin,11997,33,0.93 [0.62-1.38],0.7059633043454423
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERI1,3'-5' exoribonuclease 1,10423,26,0.51 [0.15-1.70],0.2696157629250845
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERMAP,Erythroid membrane-associated protein,10292,27,1.10 [0.48-2.55],0.8182392497208092
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,10539,27,1.40 [0.62-3.16],0.4181338919801248
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERP29,Endoplasmic reticulum resident protein 29,10385,26,1.12 [0.81-1.54],0.4974197322130362
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERP44,Endoplasmic reticulum resident protein 44,12017,33,0.98 [0.30-3.28],0.980257642956848
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,10255,26,1.29 [0.61-2.72],0.5048436106898984
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ESAM,Endothelial cell-selective adhesion molecule,12244,34,1.09 [0.43-2.76],0.8608761103208803
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ESM1,Endothelial cell-specific molecule 1,12102,31,0.41 [0.16-1.05],0.0629913849479187
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ESPL1,Separin,10205,26,0.90 [0.45-1.81],0.7763745503181937
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ESR1,Estrogen receptor,10292,27,1.29 [0.76-2.20],0.3479813696228983
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ESYT2,Extended synaptotagmin-2,10583,26,1.13 [0.72-1.78],0.58394724251609
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EVI2B,Protein EVI2B,10205,26,1.24 [0.59-2.63],0.5692502831097064
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EVI5,Ecotropic viral integration site 5 protein homolog,10292,27,1.12 [0.74-1.69],0.5936629354718357
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EVPL,Envoplakin,10423,26,1.28 [0.51-3.25],0.5970783086143372
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EXOSC10,Exosome component 10,10255,26,1.32 [0.82-2.15],0.2561713096218778
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EXTL1,Exostosin-like 1,10255,26,0.46 [0.16-1.31],0.1466542451963179
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EZR,Ezrin,12199,33,0.61 [0.16-2.33],0.4740791275954329
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",F10,Coagulation factor X,10600,28,3.67 [1.47-9.16],0.00532600779603
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",F11,Coagulation factor XI,10465,27,0.75 [0.20-2.85],0.6731385396127644
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",F11R,Junctional adhesion molecule A,12110,33,1.19 [0.69-2.03],0.5347193325097392
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",F12,Coagulation factor XII,10621,28,0.86 [0.37-1.98],0.7206926763091266
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",F13B,Coagulation factor XIII B chain,10556,28,1.67 [0.39-7.10],0.4900762918745227
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",F2,Prothrombin,10621,28,3.36 [0.31-36.35],0.3187930340058071
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",F2R,Proteinase-activated receptor 1,12136,31,0.96 [0.55-1.69],0.8962963751655803
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",F3,Tissue factor,12122,33,2.09 [0.74-5.87],0.1628202063006566
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",F7,Coagulation factor VII,12145,34,1.23 [0.44-3.42],0.6961777373191729
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",F9,Coagulation factor IX,12136,34,1.19 [0.22-6.34],0.8396284046465345
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FABP1,"Fatty acid-binding protein, liver",12102,31,1.20 [0.87-1.65],0.2605267156512761
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FABP2,"Fatty acid-binding protein, intestinal",12105,34,1.14 [0.78-1.66],0.5029772427296886
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FABP3,"Fatty acid-binding protein, heart",10597,27,0.82 [0.38-1.77],0.6183544225914563
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FABP4,"Fatty acid-binding protein, adipocyte",12244,34,0.94 [0.51-1.73],0.8538853761445169
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FABP5,Fatty acid-binding protein 5,12154,32,0.92 [0.58-1.46],0.7251092731465971
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FABP6,Gastrotropin,11834,34,1.22 [0.76-1.97],0.4169891824272521
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FABP9,Fatty acid-binding protein 9,12073,33,0.84 [0.48-1.47],0.5505793160510407
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FADD,FAS-associated death domain protein,12105,34,0.92 [0.62-1.37],0.684689380962204
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FAM13A,Protein FAM13A,10536,26,0.82 [0.45-1.48],0.5069034828925103
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FAM171A2,Protein FAM171A2,10575,26,0.88 [0.67-1.15],0.3365401934207085
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FAM171B,Protein FAM171B,10539,27,1.36 [0.42-4.42],0.614547043979583
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FAM172A,Cotranscriptional regulator FAM172A,10345,27,0.98 [0.53-1.79],0.9402456120559134
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FAM20A,Pseudokinase FAM20A,10597,27,0.78 [0.21-2.92],0.7126393834475513
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FAM3B,Protein FAM3B,12045,33,1.56 [0.63-3.88],0.336863869965547
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FAM3C,Protein FAM3C,12082,34,1.56 [0.59-4.13],0.3699688498439989
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FAM3D,Protein FAM3D,10536,26,1.25 [0.80-1.94],0.3340800537124451
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FAP,Prolyl endopeptidase FAP,12244,34,0.47 [0.16-1.38],0.1708813657619828
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FARSA,Phenylalanine--tRNA ligase alpha subunit,10313,27,0.88 [0.49-1.58],0.6773388236135232
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FAS,Tumor necrosis factor receptor superfamily member 6,12211,34,0.66 [0.22-2.02],0.4704872931964451
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FASLG,Tumor necrosis factor ligand superfamily member 6,12214,33,0.44 [0.21-0.92],0.030126756203377
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FBLN2,Fibulin-2,10614,27,0.38 [0.12-1.24],0.1095975172690906
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FBN2,Fibrillin-2,10313,27,0.79 [0.44-1.43],0.4382691481341634
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FBP1,"Fructose-1,6-bisphosphatase 1",12105,34,0.95 [0.63-1.44],0.808484362637517
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,10597,27,0.88 [0.53-1.46],0.6281036670068119
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCAR,Immunoglobulin alpha Fc receptor,12073,33,1.47 [0.79-2.74],0.2251252550749715
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,10575,26,0.33 [0.08-1.34],0.1210231896753042
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCER2,Low affinity immunoglobulin epsilon Fc receptor,12110,33,0.83 [0.44-1.55],0.5527592578275644
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,12061,34,1.11 [0.65-1.91],0.700346059452877
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,11821,32,0.56 [0.33-0.97],0.0370404176819561
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,12125,34,0.73 [0.41-1.29],0.2779389232802282
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCN1,Ficolin-1,10574,28,1.14 [0.58-2.27],0.7005719501989147
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCN2,Ficolin-2,12056,32,1.54 [0.67-3.57],0.3132625326480575
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCRL1,Fc receptor-like protein 1,12105,34,0.65 [0.33-1.26],0.2011251365535261
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCRL2,Fc receptor-like protein 2,12156,32,0.77 [0.40-1.46],0.4160465709001
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCRL3,Fc receptor-like protein 3,11854,32,0.73 [0.41-1.28],0.272139422019549
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCRL5,Fc receptor-like protein 5,12110,33,0.92 [0.53-1.57],0.7488136663342075
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCRL6,Fc receptor-like protein 6,12073,33,0.73 [0.48-1.13],0.1607721564583597
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCRLB,Fc receptor-like B,11821,32,0.90 [0.52-1.55],0.7016279263713665
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FDX1,"Adrenodoxin, mitochondrial",10255,26,1.14 [0.66-1.98],0.642489937858312
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FDX2,"Ferredoxin-2, mitochondrial",10255,26,1.30 [0.78-2.19],0.3136264527881974
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FEN1,Flap endonuclease 1,11821,32,0.58 [0.29-1.16],0.1214949303102254
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FES,Tyrosine-protein kinase Fes/Fps,11821,32,0.60 [0.28-1.25],0.1728244277511683
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FETUB,Fetuin-B,12136,34,1.58 [0.59-4.23],0.3585338176589885
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGA,Fibrinogen alpha chain,10368,25,0.82 [0.23-2.92],0.7619659674769448
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",10575,26,0.92 [0.57-1.48],0.7219488230296895
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF12,Fibroblast growth factor 12,10292,27,1.09 [0.54-2.23],0.8052627738764386
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF16,Fibroblast growth factor 16,10292,27,1.06 [0.51-2.22],0.8692832177979374
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF19,Fibroblast growth factor 19,12159,32,1.08 [0.72-1.62],0.7087158215487399
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF2,Fibroblast growth factor 2,12073,33,0.74 [0.46-1.20],0.2245741880770556
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF20,Fibroblast growth factor 20,10292,27,1.29 [0.67-2.48],0.4412920394375494
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF21,Fibroblast growth factor 21,12166,33,1.04 [0.81-1.35],0.738959139216133
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF23,Fibroblast growth factor 23,12174,33,1.17 [0.71-1.92],0.5473870524371093
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF3,Fibroblast growth factor 3,10292,27,1.50 [0.63-3.60],0.3595127891881355
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF5,Fibroblast growth factor 5,11854,32,1.06 [0.40-2.80],0.909386438270837
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF6,Fibroblast growth factor 6,10292,27,1.16 [0.54-2.51],0.7060559582590347
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF7,Fibroblast growth factor 7,10205,26,0.81 [0.45-1.46],0.4891303442819698
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF9,Fibroblast growth factor 9,10187,26,1.71 [0.75-3.93],0.2041086980887869
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGFBP1,Fibroblast growth factor-binding protein 1,12156,33,0.90 [0.34-2.34],0.8219426384775903
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGFBP2,Fibroblast growth factor-binding protein 2,10614,27,0.73 [0.34-1.54],0.4040950587846419
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGFBP3,Fibroblast growth factor-binding protein 3,10583,26,1.21 [0.44-3.33],0.7103801784036432
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGFR2,Fibroblast growth factor receptor 2,12156,33,2.38 [0.65-8.75],0.1929322287394015
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGFR4,Fibroblast growth factor receptor 4,10385,26,1.10 [0.55-2.22],0.7840866372660977
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGL1,Fibrinogen-like protein 1,10600,28,0.81 [0.48-1.36],0.4271368248234156
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGR,Tyrosine-protein kinase Fgr,11813,32,0.48 [0.23-1.01],0.0523567480292762
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FH,"Fumarate hydratase, mitochondrial",10232,27,0.97 [0.61-1.55],0.91451921837624
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FHIP2A,FHF complex subunit HOOK interacting protein 2A,10255,26,1.17 [0.61-2.23],0.639777088899586
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FHIT,Bis(5'-adenosyl)-triphosphatase,11813,32,0.69 [0.45-1.04],0.0789944822540689
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FIS1,Mitochondrial fission 1 protein,12115,32,0.92 [0.61-1.40],0.7050076896305246
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,10575,26,0.98 [0.67-1.42],0.9056359284341864
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,12121,33,0.92 [0.69-1.21],0.5421296813245964
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,12018,33,0.71 [0.36-1.40],0.322501993842969
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,12018,33,0.99 [0.71-1.36],0.9345399838301724
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,11792,32,0.48 [0.20-1.11],0.0868379801842908
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FKBPL,FK506-binding protein-like,10536,26,0.73 [0.38-1.43],0.3598815134009816
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FLI1,Friend leukemia integration 1 transcription factor,11821,32,0.81 [0.60-1.10],0.1799312960268265
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,12018,33,0.42 [0.14-1.28],0.1270860047034833
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FLT1,Vascular endothelial growth factor receptor 1,12031,33,1.35 [0.33-5.45],0.6759476204089216
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FLT3,Receptor-type tyrosine-protein kinase FLT3,11821,32,0.20 [0.07-0.61],0.0047565333118193
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FLT3LG,Fms-related tyrosine kinase 3 ligand,12214,33,1.13 [0.45-2.85],0.8011455246351733
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FLT4,Vascular endothelial growth factor receptor 3,12156,33,2.81 [1.04-7.56],0.0410906555068715
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FMNL1,Formin-like protein 1,11813,32,0.88 [0.51-1.52],0.6594715525945045
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FMR1,Synaptic functional regulator FMR1,11821,32,1.24 [0.50-3.05],0.6400522615350897
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FN1,Fibronectin,10621,28,0.93 [0.25-3.55],0.919086303193114
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FNDC1,Fibronectin type III domain-containing protein 1,10583,26,0.37 [0.18-0.78],0.0090309886514311
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,10539,27,0.80 [0.26-2.51],0.7049222383770195
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FOLH1,Glutamate carboxypeptidase 2,10292,27,1.05 [0.73-1.51],0.8066379463031388
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FOLR1,Folate receptor alpha,12103,33,0.56 [0.18-1.69],0.3014951910233088
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FOLR2,Folate receptor beta,12199,33,0.35 [0.13-0.96],0.0413709886827911
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FOLR3,Folate receptor gamma,12117,33,0.99 [0.83-1.17],0.8920990263500275
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FOS,Proto-oncogene c-Fos,10187,26,2.13 [0.83-5.42],0.1145085117936222
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FOSB,Protein fosB,11813,32,0.55 [0.20-1.50],0.245204287866804
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FOXJ3,Forkhead box protein J3,10292,27,2.05 [1.21-3.47],0.0074877036183721
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FOXO1,Forkhead box protein O1,12073,33,0.91 [0.63-1.32],0.6179716585755113
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FOXO3,Forkhead box protein O3,11821,32,0.79 [0.55-1.12],0.1774829347950844
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FRMD4B,FERM domain-containing protein 4B,10255,26,1.03 [0.60-1.76],0.9148747218638804
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FRMD7,FERM domain-containing protein 7,10313,27,0.62 [0.21-1.82],0.3854986231305218
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FRZB,Secreted frizzled-related protein 3,11982,33,0.65 [0.20-2.06],0.462876186951967
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FSHB,Follitropin subunit beta,10345,27,1.68 [0.92-3.08],0.0934290753165587
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FST,Follistatin,12136,31,1.03 [0.55-1.93],0.9240591543844504
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FSTL1,Follistatin-related protein 1,10345,27,0.48 [0.09-2.55],0.3880103995278663
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FSTL3,Follistatin-related protein 3,12083,31,1.16 [0.45-3.01],0.7550592043460886
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FTCD,Formimidoyltransferase-cyclodeaminase,10560,26,1.10 [0.72-1.68],0.647511099123238
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FUCA1,Tissue alpha-L-fucosidase,12184,34,1.05 [0.72-1.53],0.8059571059208843
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FUOM,Fucose mutarotase,10385,26,0.63 [0.37-1.06],0.0828458019340507
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FURIN,Furin,12156,33,0.81 [0.32-2.04],0.6546504649829041
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FUS,RNA-binding protein FUS,11804,32,0.89 [0.39-2.05],0.7808762643421655
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",10398,26,1.23 [0.75-2.03],0.4117988644777549
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,12199,33,1.40 [0.74-2.65],0.2994029641389071
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FUT8,"Alpha-(1,6)-fucosyltransferase",12018,33,1.54 [0.94-2.54],0.0863462268890191
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FXN,"Frataxin, mitochondrial",12192,33,0.81 [0.53-1.23],0.3158881520172506
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FXYD5,FXYD domain-containing ion transport regulator 5,11854,32,0.77 [0.46-1.28],0.3110339076752474
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FYB1,FYN-binding protein 1,12092,33,0.99 [0.71-1.38],0.9371790795722456
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FZD10,Frizzled-10,10313,27,1.22 [0.75-2.01],0.4226050515674628
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FZD8,Frizzled-8,10232,27,1.35 [0.73-2.50],0.3327508289700244
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GABARAP,Gamma-aminobutyric acid receptor-associated protein,10539,27,1.24 [0.65-2.39],0.5134840052858108
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,10423,26,1.21 [0.74-1.97],0.4396229567725798
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,10232,27,1.11 [0.64-1.90],0.714549158903617
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GAD1,Glutamate decarboxylase 1,10205,26,1.21 [0.28-5.30],0.802778918757386
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GAD2,Glutamate decarboxylase 2,10292,27,0.95 [0.42-2.15],0.9016215685850664
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,10423,26,1.24 [0.70-2.20],0.4596620640688859
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,10345,27,1.08 [0.54-2.17],0.8215278646655007
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GAGE2A,G antigen 2A,10205,26,1.16 [0.73-1.85],0.5183783797857779
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GAL,Galanin peptides,12159,32,0.83 [0.49-1.38],0.4622124140086425
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,12045,33,0.83 [0.28-2.47],0.7424393846391457
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,12192,33,0.94 [0.29-3.04],0.9181828309509896
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,11854,32,0.91 [0.43-1.91],0.8033703763911119
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,10597,27,0.60 [0.15-2.35],0.4639311151456711
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GALNT7,N-acetylgalactosaminyltransferase 7,12045,33,1.02 [0.24-4.34],0.9805153791273143
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GAMT,Guanidinoacetate N-methyltransferase,10255,26,1.46 [0.77-2.76],0.2424904131558243
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,10157,26,0.77 [0.27-2.19],0.6293872203109961
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GART,Trifunctional purine biosynthetic protein adenosine-3,10575,26,0.96 [0.22-4.07],0.9514830877608024
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GAS2,Growth arrest-specific protein 2,10423,26,0.60 [0.23-1.55],0.2932372527607584
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GAS6,Growth arrest-specific protein 6,12170,34,0.59 [0.18-1.98],0.3950526010644604
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GASK1A,Golgi-associated kinase 1A,10255,26,2.10 [0.97-4.55],0.0611219542965321
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GAST,Gastrin,10583,26,1.08 [0.84-1.38],0.5594159648378705
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,10205,26,1.18 [0.29-4.86],0.8141650956903661
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",10345,27,1.12 [0.70-1.80],0.6388788778413426
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GBA,Lysosomal acid glucosylceramidase,10313,27,1.17 [0.60-2.30],0.6478075956800274
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GBP1,Guanylate-binding protein 1,10567,26,0.85 [0.48-1.51],0.5861253675288791
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GBP2,Guanylate-binding protein 2,11854,32,1.19 [0.71-2.00],0.5029798556473426
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GBP4,Guanylate-binding protein 4,11813,32,1.05 [0.56-1.97],0.888648597421856
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GBP6,Guanylate-binding protein 6,10255,26,1.38 [0.77-2.48],0.2840168665822515
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GC,Vitamin D-binding protein,10621,28,1.08 [0.27-4.32],0.9086797020849132
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GCC1,GRIP and coiled-coil domain-containing protein 1,10583,26,0.99 [0.70-1.40],0.9516445314583198
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GCG,Pro-glucagon,11821,32,1.07 [0.83-1.37],0.6041401968573926
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,10145,26,0.48 [0.20-1.18],0.1114752892037635
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GCLM,Glutamate--cysteine ligase regulatory subunit,10255,26,0.52 [0.18-1.47],0.2160975218389411
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",12045,33,0.86 [0.35-2.11],0.7395855862036594
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GDF15,Growth/differentiation factor 15,12244,34,1.16 [0.61-2.22],0.6536358513755913
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GDF2,Growth/differentiation factor 2,12105,34,0.81 [0.34-1.91],0.6314457098934296
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GDNF,Glial cell line-derived neurotrophic factor,11813,32,1.49 [0.72-3.06],0.2794259467702449
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GET3,ATPase GET3,10597,27,0.67 [0.30-1.47],0.3163030320232619
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GFAP,Glial fibrillary acidic protein,11798,32,0.96 [0.50-1.83],0.891794955288604
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GFER,FAD-linked sulfhydryl oxidase ALR,11821,32,0.74 [0.44-1.26],0.2687394719090092
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,11821,32,0.83 [0.60-1.16],0.2857738369627779
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GFRA1,GDNF family receptor alpha-1,12166,33,1.20 [0.42-3.42],0.7371570545238075
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GFRA2,GDNF family receptor alpha-2,12045,33,0.84 [0.20-3.64],0.8187797590815595
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GFRA3,GDNF family receptor alpha-3,11979,33,0.46 [0.15-1.40],0.1715908381826622
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GFRAL,GDNF family receptor alpha-like,10255,24,0.83 [0.44-1.58],0.5663718262671984
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GGA1,ADP-ribosylation factor-binding protein GGA1,11813,32,0.83 [0.48-1.43],0.5014829615426188
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GGACT,Gamma-glutamylaminecyclotransferase,10597,27,0.92 [0.54-1.55],0.748779654878815
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GGCT,Gamma-glutamylcyclotransferase,10570,27,0.90 [0.41-1.96],0.7905267313095252
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GGH,Gamma-glutamyl hydrolase,11920,32,0.59 [0.24-1.50],0.2695508327416236
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GGT1,Glutathione hydrolase 1 proenzyme,12095,33,1.25 [0.71-2.18],0.4407548021388614
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GGT5,Glutathione hydrolase 5 proenzyme,12018,33,1.18 [0.31-4.48],0.8047726917929731
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GH1,Somatotropin,12082,34,0.85 [0.70-1.03],0.101383853744028
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GH2,Growth hormone variant,11821,32,0.92 [0.75-1.14],0.4589972747001988
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GHR,Growth hormone receptor,10385,26,0.62 [0.17-2.29],0.4686247208176384
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GHRHR,Growth hormone-releasing hormone receptor,11813,32,0.80 [0.40-1.57],0.5081810102722026
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GHRL,Appetite-regulating hormone,12105,34,1.03 [0.71-1.48],0.8810600283549022
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GID8,Glucose-induced degradation protein 8 homolog,10575,26,1.20 [0.42-3.41],0.7319506199303802
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GIGYF2,GRB10-interacting GYF protein 2,10575,26,0.92 [0.55-1.54],0.7617357738320852
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GIMAP7,GTPase IMAP family member 7,10385,26,1.24 [0.43-3.57],0.6963916062062097
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GIMAP8,GTPase IMAP family member 8,10205,26,0.68 [0.29-1.57],0.3620117706265734
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GIP,Gastric inhibitory polypeptide,10345,27,0.82 [0.42-1.62],0.5708318525059171
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GIPC2,PDZ domain-containing protein GIPC2,10583,26,0.92 [0.26-3.25],0.8926288453683858
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GIPC3,PDZ domain-containing protein GIPC3,10536,26,0.90 [0.62-1.32],0.6032630959425909
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GIPR,Gastric inhibitory polypeptide receptor,10292,27,1.12 [0.58-2.16],0.7287851886102796
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GIT1,ARF GTPase-activating protein GIT1,10292,27,1.07 [0.73-1.57],0.7351367444286624
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GJA8,Gap junction alpha-8 protein,10205,26,1.28 [0.83-1.99],0.2694685996974788
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GKN1,Gastrokine-1,11579,32,0.71 [0.22-2.24],0.5565105093662315
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GLA,Alpha-galactosidase A,10369,26,1.41 [0.52-3.82],0.5002980499129845
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GLB1,Beta-galactosidase,12018,33,1.55 [0.76-3.16],0.2309496875081401
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GLI2,Zinc finger protein GLI2,10292,27,0.91 [0.26-3.18],0.8773197278702518
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GLO1,Lactoylglutathione lyase,11858,34,0.98 [0.58-1.64],0.928787077493602
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GLOD4,Glyoxalase domain-containing protein 4,12092,31,0.43 [0.18-1.03],0.0573830461945196
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GLP1R,Glucagon-like peptide 1 receptor,10232,27,1.34 [0.59-3.05],0.4863529202567158
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GLRX,Glutaredoxin-1,12014,34,0.88 [0.51-1.50],0.6334791199756905
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",10385,26,1.26 [0.84-1.89],0.2726616333481414
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,11813,32,1.37 [0.84-2.25],0.2101609444513603
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GLYR1,Putative oxidoreductase GLYR1,10539,27,0.52 [0.21-1.28],0.1517208732194678
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GM2A,Ganglioside GM2 activator,10330,27,1.06 [0.42-2.68],0.9018023955026356
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GMFG,Glia maturation factor gamma,10597,27,1.05 [0.63-1.76],0.8410335733714964
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GMPR,GMP reductase 1,12214,33,0.66 [0.37-1.17],0.1586790638952158
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GMPR2,GMP reductase 2,10385,26,0.90 [0.51-1.58],0.7076609773642081
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GNAS,Neuroendocrine secretory protein 55,10575,26,0.96 [0.62-1.50],0.8693432062810807
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,11821,32,1.03 [0.63-1.69],0.8979163038474705
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,10313,27,0.67 [0.26-1.72],0.4015254799864128
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GNLY,Granulysin,12110,33,0.83 [0.45-1.52],0.5492919987594995
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GNPDA1,Glucosamine-6-phosphate isomerase 1,10345,27,1.14 [0.41-3.18],0.7953733881234751
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GNPDA2,Glucosamine-6-phosphate isomerase 2,10385,26,1.18 [0.42-3.31],0.7483199708787767
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GOLGA3,Golgin subfamily A member 3,10575,26,1.00 [0.62-1.61],0.9945675674149232
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GOLM2,Protein GOLM2,12199,33,1.01 [0.26-3.93],0.9913884083729312
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,12073,33,0.95 [0.70-1.29],0.7557477367979699
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GORASP2,Golgi reassembly-stacking protein 2,10536,26,1.00 [0.45-2.26],0.993563878452899
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GOT1,"Aspartate aminotransferase, cytoplasmic",10614,27,0.59 [0.22-1.56],0.2857522805882717
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GP1BA,Platelet glycoprotein Ib alpha chain,12050,33,0.66 [0.25-1.74],0.3975555237742799
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GP1BB,Platelet glycoprotein Ib beta chain,10255,26,1.08 [0.61-1.89],0.7935932772025048
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,11710,32,1.28 [0.93-1.75],0.1267196707543525
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GP5,Platelet glycoprotein V,10385,26,1.01 [0.35-2.90],0.9840879827130464
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GP6,Platelet glycoprotein VI,12092,33,1.03 [0.73-1.47],0.8538359775916357
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPA33,Cell surface A33 antigen,12045,33,1.05 [0.84-1.30],0.6913834177489175
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPC1,Glypican-1,12192,33,0.48 [0.17-1.36],0.1678227119003822
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPC5,Glypican-5,12018,33,0.96 [0.55-1.66],0.8748904288244335
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPD1,Glycerol-3-phosphate dehydrogenase,10539,27,1.03 [0.51-2.10],0.9276531644011488
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPHA2,Glycoprotein hormone alpha-2,10536,26,0.57 [0.19-1.74],0.3243303401134987
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPI,Glucose-6-phosphate isomerase,10600,28,1.31 [0.63-2.71],0.4641405225153333
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,10536,26,0.74 [0.47-1.15],0.1769453023782752
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPKOW,G-patch domain and KOW motifs-containing protein,11813,32,0.52 [0.14-1.95],0.3299683977541104
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPNMB,Transmembrane glycoprotein NMB,11772,33,1.11 [0.37-3.35],0.8541069889679135
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPR101,Probable G-protein coupled receptor 101,10232,27,0.90 [0.46-1.75],0.74619697862003
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPR158,Probable G-protein coupled receptor 158,10575,26,1.12 [0.42-3.01],0.8188220307906439
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPR15L,Protein GPR15L,10536,26,1.57 [0.91-2.72],0.1078303419159414
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPR37,Prosaposin receptor GPR37,11858,34,1.29 [0.83-2.00],0.2557388278187822
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPRC5C,G-protein coupled receptor family C group 5 member C,10539,27,1.10 [0.60-2.03],0.7603942831165167
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GRAP2,GRB2-related adapter protein 2,12105,34,0.99 [0.78-1.26],0.9530141037808666
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,10597,27,0.96 [0.54-1.71],0.8904367462434783
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GRIK2,"Glutamate receptor ionotropic, kainate 2",10575,26,0.73 [0.28-1.95],0.5340559714096875
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",10232,27,1.20 [0.72-1.99],0.4782323457077253
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GRK5,G protein-coupled receptor kinase 5,11858,34,0.87 [0.45-1.68],0.6691056043043776
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GRN,Progranulin,12061,33,1.76 [0.51-6.13],0.3743183070136063
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GRP,Gastrin-releasing peptide,10345,27,1.31 [0.71-2.40],0.3838361052559264
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GRPEL1,"GrpE protein homolog 1, mitochondrial",12045,33,1.02 [0.62-1.68],0.9444199794369093
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GRSF1,G-rich sequence factor 1,10150,26,1.22 [0.78-1.91],0.3770618562379323
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GSAP,Gamma-secretase-activating protein,11821,32,0.60 [0.33-1.10],0.1016378204929337
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GSN,Gelsolin,10570,28,0.56 [0.17-1.89],0.3548668689117847
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GSR,"Glutathione reductase, mitochondrial",10536,28,3.04 [0.68-13.60],0.1455105199684258
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GSTA1,Glutathione S-transferase A1,12084,34,0.94 [0.65-1.37],0.7618248042175925
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GSTA3,Glutathione S-transferase A3,11821,32,1.19 [0.82-1.74],0.3612659747410603
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GSTM4,Glutathione S-transferase Mu 4,10255,26,1.12 [0.71-1.76],0.618223215234952
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GSTP1,Glutathione S-transferase P,11737,32,0.77 [0.47-1.27],0.3063189978200631
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GSTT2B,Glutathione S-transferase theta-2B,10583,26,1.18 [0.99-1.39],0.0610184373746793
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,10423,26,0.96 [0.56-1.65],0.8818506391518472
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GTPBP2,GTP-binding protein 2,10313,27,1.02 [0.64-1.62],0.9402540877773612
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GUCA2A,Guanylin,12056,33,2.37 [1.07-5.27],0.0335769519297323
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GUCY2C,Heat-stable enterotoxin receptor,10423,26,1.08 [0.71-1.64],0.7216623579655659
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GUK1,Guanylate kinase,10255,26,0.77 [0.24-2.40],0.6478053853703618
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GUSB,Beta-glucuronidase,12167,34,1.40 [0.88-2.23],0.1573345052342829
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GYS1,"Glycogen [starch] synthase, muscle",11858,34,1.04 [0.74-1.44],0.8363370192798971
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GZMA,Granzyme A,12214,33,0.83 [0.35-1.98],0.672377638124133
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GZMB,Granzyme B,12073,33,0.57 [0.32-0.99],0.0466036924731984
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GZMH,Granzyme H,11858,34,1.05 [0.71-1.56],0.7897026044716337
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",H2AP,Huntingtin-interacting protein M,10205,26,1.30 [0.80-2.11],0.2960942341788549
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",10255,26,1.04 [0.61-1.76],0.8937324779843732
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",12145,33,0.75 [0.49-1.15],0.1872266573723602
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HAO1,Hydroxyacid oxidase 1,12192,33,1.15 [0.92-1.43],0.2212994693785118
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HARS1,"Histidine--tRNA ligase, cytoplasmic",12110,33,0.87 [0.58-1.30],0.4920453022089244
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HAVCR1,Hepatitis A virus cellular receptor 1,12171,33,1.48 [0.95-2.30],0.0846426932652649
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HAVCR2,Hepatitis A virus cellular receptor 2,12110,33,0.70 [0.29-1.70],0.4282351914574684
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HBEGF,Proheparin-binding EGF-like growth factor,12145,33,1.21 [0.79-1.84],0.3795056444775452
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HBQ1,Hemoglobin subunit theta-1,12192,33,0.78 [0.46-1.33],0.3578509903748252
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HBZ,Hemoglobin subunit zeta,10597,27,0.87 [0.60-1.24],0.4348526122073651
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HCG22,Protein PBMUCL2,10255,26,0.67 [0.24-1.85],0.4405749809344331
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HCLS1,Hematopoietic lineage cell-specific protein,12214,33,0.82 [0.48-1.42],0.4819800666445341
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HDAC8,Histone deacetylase 8,10292,27,1.24 [0.74-2.07],0.4165946357941222
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HDAC9,Histone deacetylase 9,10232,27,1.18 [0.74-1.89],0.4780372215044131
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HDDC2,5'-deoxynucleotidase HDDC2,10536,26,0.93 [0.39-2.22],0.8730602396830817
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HDGF,Hepatoma-derived growth factor,12175,33,0.77 [0.55-1.08],0.1252421412004175
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HDGFL2,Hepatoma-derived growth factor-related protein 2,10583,26,0.90 [0.49-1.67],0.7477407312336264
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HEBP1,Heme-binding protein 1,11858,34,0.94 [0.53-1.65],0.8281291780555371
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HEG1,Protein HEG homolog 1,10385,26,0.78 [0.19-3.17],0.7274824839844076
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HEPACAM2,HEPACAM family member 2,10583,26,1.02 [0.41-2.56],0.961188134889768
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HEPH,Hephaestin,10597,27,0.56 [0.13-2.36],0.4312787347102905
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HEXIM1,Protein HEXIM1,12073,33,0.92 [0.62-1.35],0.6538766400101181
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HGF,Hepatocyte growth factor,12214,33,0.73 [0.29-1.79],0.4848269285855412
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HGFAC,Hepatocyte growth factor activator,10492,27,0.59 [0.31-1.11],0.1015343541364694
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,11821,32,0.74 [0.48-1.13],0.1644280314489021
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HHEX,Hematopoietically-expressed homeobox protein HHEX,10583,26,1.04 [0.63-1.72],0.8796082192470065
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HIF1A,Hypoxia-inducible factor 1-alpha,10292,27,1.51 [1.13-2.02],0.0052033167647645
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HIP1,Huntingtin-interacting protein 1,10255,26,1.41 [0.58-3.40],0.4462799626187835
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HIP1R,Huntingtin-interacting protein 1-related protein,10558,25,0.76 [0.28-2.06],0.5837935301695794
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HJV,Hemojuvelin,10575,26,1.65 [1.03-2.65],0.037009509384222
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HK2,Hexokinase-2,11858,34,0.76 [0.25-2.32],0.6323821630973765
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",10575,26,0.65 [0.21-1.99],0.4467001830589983
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",12043,33,1.18 [0.52-2.66],0.6915411287491708
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",12073,33,1.92 [0.76-4.84],0.1680507892721486
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HMBS,Porphobilinogen deaminase,12192,33,0.76 [0.39-1.48],0.4188626032254435
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HMCN2,Hemicentin-2,10368,26,0.58 [0.32-1.08],0.0862867019355655
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",10345,27,0.78 [0.35-1.73],0.5345445962623134
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",10255,26,1.21 [0.54-2.74],0.6440600604874027
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HMMR,Hyaluronan mediated motility receptor,10183,26,1.63 [1.04-2.54],0.0313861329675571
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HMOX1,Heme oxygenase 1,11963,33,1.88 [1.08-3.28],0.0259005606897695
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HMOX2,Heme oxygenase 2,11813,32,0.79 [0.37-1.69],0.5494770674943554
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HNF1A,Hepatocyte nuclear factor 1-alpha,10313,27,1.05 [0.64-1.72],0.8417018867063218
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HNMT,Histamine N-methyltransferase,11964,33,0.66 [0.35-1.24],0.1946653007274074
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,11827,34,0.94 [0.62-1.41],0.7519487216232628
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,10575,26,0.70 [0.29-1.69],0.4235010691614475
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HPCAL1,Hippocalcin-like protein 1,12214,33,0.92 [0.61-1.40],0.7050833433141013
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HPGDS,Hematopoietic prostaglandin D synthase,11821,32,0.74 [0.32-1.74],0.4897397307682406
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HPSE,Heparanase,10464,27,1.12 [0.75-1.68],0.5887163910283377
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HRAS,GTPase Hras,10394,26,0.69 [0.38-1.28],0.2379380294030351
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,10345,27,1.87 [1.09-3.21],0.0225578486064679
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HRG,Histidine-rich glycoprotein,10556,28,0.81 [0.26-2.58],0.7244304376724997
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HS1BP3,HCLS1-binding protein 3,10345,27,1.08 [0.71-1.64],0.7310728060746732
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,12045,33,1.94 [0.90-4.17],0.0910309237798357
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,12192,33,1.93 [0.91-4.10],0.0864936794101361
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,10292,27,1.00 [0.31-3.23],0.9970894141152412
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HSBP1,Heat shock factor-binding protein 1,10345,27,1.01 [0.68-1.49],0.9740576296253852
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,12073,33,1.48 [0.68-3.22],0.318212991039024
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,10583,26,1.16 [0.64-2.08],0.626348068979597
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HSD17B3,Testosterone 17-beta-dehydrogenase 3,10255,26,0.99 [0.46-2.14],0.9873544293150456
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,10345,27,0.79 [0.36-1.77],0.5721392646559448
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HSP90B1,Endoplasmin,11755,32,0.99 [0.62-1.56],0.9525604446980614
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HSPA1A,Heat shock 70 kDa protein 1A,12148,32,0.76 [0.48-1.20],0.2413315341808114
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HSPA2,Heat shock-related 70 kDa protein 2,10539,27,0.53 [0.15-1.85],0.316952201607481
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HSPB1,Heat shock protein beta-1,11914,34,1.13 [0.71-1.81],0.6039163781802326
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HSPB6,Heat shock protein beta-6,12192,33,1.20 [0.53-2.72],0.6605472891420152
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,12026,34,0.86 [0.27-2.77],0.8019594623006817
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HTR1A,5-hydroxytryptamine receptor 1A,10232,27,0.83 [0.47-1.49],0.53718012437912
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HTR1B,5-hydroxytryptamine receptor 1B,10232,27,1.44 [0.82-2.50],0.2026156316340186
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HTRA2,"Serine protease HTRA2, mitochondrial",12156,33,0.96 [0.58-1.59],0.8733028394819782
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HYAL1,Hyaluronidase-1,12044,33,1.75 [0.48-6.45],0.3981179637815627
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HYOU1,Hypoxia up-regulated protein 1,12244,34,1.38 [0.36-5.30],0.6423490163606448
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ICA1,Islet cell autoantigen 1,11854,32,0.98 [0.65-1.47],0.9095183043893832
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ICAM1,Intercellular adhesion molecule 1,12053,33,0.78 [0.26-2.31],0.6474289914955156
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ICAM2,Intercellular adhesion molecule 2,12244,34,1.28 [0.49-3.33],0.6091122019790445
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ICAM3,Intercellular adhesion molecule 3,12244,34,0.46 [0.14-1.53],0.2058544401322115
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ICAM4,Intercellular adhesion molecule 4,12073,33,0.89 [0.49-1.59],0.6835381677761041
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ICAM5,Intercellular adhesion molecule 5,12105,34,0.77 [0.40-1.50],0.4477861221797716
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ICOSLG,ICOS ligand,12045,33,1.54 [0.32-7.44],0.5916051536114693
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ID4,DNA-binding protein inhibitor ID-4,10423,26,1.23 [0.61-2.51],0.5633201870383693
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IDI2,Isopentenyl-diphosphate delta-isomerase 2,11813,32,1.10 [0.57-2.11],0.7755397445352272
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IDO1,"Indoleamine 2,3-dioxygenase 1",10345,27,0.61 [0.33-1.11],0.1024916103001397
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IDS,Iduronate 2-sulfatase,12214,33,,
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IDUA,Alpha-L-iduronidase,12192,33,1.08 [0.55-2.11],0.8233369931963525
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,10269,25,0.48 [0.17-1.30],0.1487222286639297
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,10423,26,1.44 [0.82-2.53],0.2018379797424433
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,10423,26,1.13 [0.42-3.00],0.8130029402391097
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFNAR1,Interferon alpha/beta receptor 1,10536,26,0.32 [0.07-1.54],0.1551138361770905
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFNG,Interferon gamma,11854,32,1.06 [0.80-1.40],0.6799755065659183
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFNGR1,Interferon gamma receptor 1,12159,32,0.66 [0.14-3.01],0.5881616315677582
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFNGR2,Interferon gamma receptor 2,12018,33,0.85 [0.46-1.56],0.5946091881537047
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFNL1,Interferon lambda-1,11813,32,0.97 [0.48-1.94],0.9276079555637732
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFNL2,Interferon lambda-2,10232,27,1.36 [0.90-2.03],0.1407627532172265
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFNLR1,Interferon lambda receptor 1,12073,33,0.99 [0.43-2.29],0.990093585332902
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFNW1,Interferon omega-1,10255,26,0.79 [0.24-2.62],0.6966758273413898
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFT20,Intraflagellar transport protein 20 homolog,10313,27,0.99 [0.42-2.38],0.989449968345023
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGBP1,Immunoglobulin-binding protein 1,10575,26,0.80 [0.43-1.48],0.4767739730695944
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,10232,27,1.27 [0.70-2.31],0.4244523327219811
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,10614,27,0.28 [0.08-1.07],0.0624808826150159
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGF1R,Insulin-like growth factor 1 receptor,12045,33,1.24 [0.29-5.36],0.7720113579443453
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,10255,26,1.73 [1.03-2.90],0.0366064567541514
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGF2R,Cation-independent mannose-6-phosphate receptor,12110,33,2.26 [0.60-8.54],0.2288608073337477
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGFBP1,Insulin-like growth factor-binding protein 1,12222,34,0.91 [0.70-1.18],0.4828923423180702
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGFBP2,Insulin-like growth factor-binding protein 2,12230,34,0.88 [0.55-1.41],0.5860125353200177
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGFBP3,Insulin-like growth factor-binding protein 3,12162,34,1.89 [0.62-5.76],0.2599782509873677
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGFBP4,Insulin-like growth factor-binding protein 4,11950,33,1.24 [0.65-2.39],0.5114135437737077
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGFBP6,Insulin-like growth factor-binding protein 6,12055,34,1.44 [0.57-3.66],0.4456625890305927
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGFBP7,Insulin-like growth factor-binding protein 7,12244,34,1.02 [0.38-2.76],0.9627734272473684
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGFBPL1,Insulin-like growth factor-binding protein-like 1,12105,34,1.08 [0.45-2.62],0.8577601158752608
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGFL4,Insulin growth factor-like family member 4,10292,27,1.12 [0.73-1.71],0.6111872660425448
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGHMBP2,DNA-binding protein SMUBP-2,10255,26,1.10 [0.56-2.15],0.7773333442226111
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGLC2,Immunoglobulin lambda constant 2,10594,28,0.22 [0.03-1.72],0.1491347867647227
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGLON5,IgLON family member 5,10205,26,0.64 [0.32-1.27],0.201829474886012
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGSF21,Immunoglobulin superfamily member 21,10345,27,1.00 [0.39-2.56],0.999764699992454
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGSF3,Immunoglobulin superfamily member 3,12045,33,1.10 [0.46-2.62],0.8290633017165467
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGSF8,Immunoglobulin superfamily member 8,12105,34,1.77 [0.68-4.64],0.2422310983200581
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGSF9,Protein turtle homolog A,10597,27,1.03 [0.66-1.61],0.88512410040213
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IKBKG,NF-kappa-B essential modulator,12073,33,0.91 [0.65-1.29],0.6049223575354807
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IKZF2,Zinc finger protein Helios,11821,32,0.85 [0.54-1.33],0.4768087082569339
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL10,Interleukin-10,11854,32,1.30 [1.02-1.66],0.037366041779377
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL10RA,Interleukin-10 receptor subunit alpha,11854,32,0.70 [0.34-1.45],0.3375064072133026
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL10RB,Interleukin-10 receptor subunit beta,12159,32,1.08 [0.38-3.13],0.8811245201241734
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL11,Interleukin-11,11854,32,1.08 [0.70-1.68],0.7154838383548682
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL12A_IL12B,Interleukin-12,12045,33,0.93 [0.64-1.36],0.7065813534770804
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL12B,Interleukin-12 subunit beta,12214,33,0.86 [0.50-1.47],0.5723011315236465
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL12RB1,Interleukin-12 receptor subunit beta-1,11854,32,1.50 [0.72-3.10],0.2745957209045704
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL12RB2,Interleukin-12 receptor subunit beta-2,10292,27,1.09 [0.45-2.62],0.8538960932027765
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL13,Interleukin-13,11854,32,1.17 [0.68-2.02],0.5595707078702793
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL13RA1,Interleukin-13 receptor subunit alpha-1,11967,33,1.17 [0.26-5.20],0.8408359662972071
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL13RA2,Interleukin-13 receptor subunit alpha-2,10232,27,1.04 [0.28-3.86],0.9503355306164384
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL15,Interleukin-15,12073,33,3.61 [1.84-7.10],0.0001883502075329
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL15RA,Interleukin-15 receptor subunit alpha,11854,32,0.98 [0.40-2.36],0.9589809397982628
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL16,Pro-interleukin-16,12214,33,0.85 [0.39-1.85],0.688818760508484
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL17A,Interleukin-17A,11839,32,1.31 [0.72-2.37],0.3758216972593251
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL17C,Interleukin-17C,11854,32,1.13 [0.76-1.69],0.5491700990282267
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL17D,Interleukin-17D,11854,32,0.61 [0.20-1.88],0.3875826752725673
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL17F,Interleukin-17F,11854,32,1.08 [0.74-1.57],0.7000518278359982
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL17RA,Interleukin-17 receptor A,12110,33,1.29 [0.63-2.64],0.4794991413710721
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL17RB,Interleukin-17 receptor B,11930,31,1.00 [0.55-1.83],0.9999952486995212
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL18,Interleukin-18,12068,31,0.96 [0.49-1.87],0.9006164027993769
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL18BP,Interleukin-18-binding protein,12162,34,0.58 [0.21-1.62],0.3000361172168104
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL18R1,Interleukin-18 receptor 1,12214,33,2.35 [0.98-5.63],0.054213989516448
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL18RAP,Interleukin-18 receptor accessory protein,11949,33,1.03 [0.87-1.22],0.7084766308435095
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL19,Interleukin-19,11804,34,0.89 [0.57-1.40],0.622803182569587
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL1A,Interleukin-1 alpha,11854,32,0.93 [0.50-1.73],0.8218766489839857
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL1B,Interleukin-1 beta,11799,31,1.02 [0.58-1.80],0.9421702040893408
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL1R1,Interleukin-1 receptor type 1,12095,33,2.71 [0.73-10.06],0.1360104221526811
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL1R2,Interleukin-1 receptor type 2,12085,31,1.93 [0.38-9.94],0.4309792033519628
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL1RAP,Interleukin-1 receptor accessory protein,12110,33,1.75 [0.90-3.42],0.101438664232933
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL1RL1,Interleukin-1 receptor-like 1,12211,34,1.50 [0.77-2.94],0.2313709383291132
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL1RL2,Interleukin-1 receptor-like 2,11854,32,1.33 [0.58-3.06],0.4997439282394343
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL1RN,Interleukin-1 receptor antagonist protein,12091,32,1.18 [0.71-1.95],0.5267905121017664
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL2,Interleukin-2,11854,32,1.98 [0.73-5.34],0.1781507707056087
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL20,Interleukin-20,11854,32,1.35 [0.88-2.07],0.1633864025193291
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL20RA,Interleukin-20 receptor subunit alpha,11854,32,0.40 [0.15-1.06],0.0667466782606867
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL20RB,Interleukin-20 receptor subunit beta,10292,27,0.79 [0.32-1.98],0.6163640707533561
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL21R,Interleukin-21 receptor,10292,27,0.78 [0.34-1.79],0.5538249528001017
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL22,Interleukin-22,10539,27,0.95 [0.55-1.64],0.8619779912447165
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL22RA1,Interleukin-22 receptor subunit alpha-1,11854,32,1.32 [0.74-2.34],0.3457066907216222
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL24,Interleukin-24,11854,32,0.89 [0.46-1.74],0.7313343647818327
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL25,Interleukin-25,10170,26,1.13 [0.38-3.38],0.8213769076828455
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL2RA,Interleukin-2 receptor subunit alpha,11999,33,0.68 [0.31-1.48],0.3317747630527827
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL2RB,Interleukin-2 receptor subunit beta,11854,32,0.77 [0.31-1.91],0.5675995328866223
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL2RG,Cytokine receptor common subunit gamma,10539,27,1.35 [0.68-2.68],0.3864097695202506
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL3,Interleukin-3,10205,26,0.65 [0.39-1.09],0.1010069595370364
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL31,Interleukin-31,10292,27,1.29 [0.78-2.13],0.3169379660123772
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL31RA,Interleukin-31 receptor subunit alpha,10245,27,1.66 [0.68-4.06],0.2642616451134052
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL32,Interleukin-32,12073,33,1.31 [0.67-2.56],0.4227560132778482
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL33,Interleukin-33,11854,32,0.91 [0.40-2.06],0.8287876029996204
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL34,Interleukin-34,11797,32,0.82 [0.35-1.94],0.6487607994047858
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL36A,Interleukin-36 alpha,10292,27,0.64 [0.27-1.49],0.2993845381736181
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL36G,Interleukin-36 gamma,10242,27,0.90 [0.49-1.63],0.71901185859612
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL3RA,Interleukin-3 receptor subunit alpha,11854,32,1.95 [0.85-4.48],0.1162720597367828
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL4,Interleukin-4,11854,32,0.91 [0.68-1.24],0.5648368343475134
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL4R,Interleukin-4 receptor subunit alpha,12073,33,1.18 [0.52-2.66],0.6918268287138859
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL5,Interleukin-5,11854,32,1.17 [0.98-1.39],0.08485770661708
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL5RA,Interleukin-5 receptor subunit alpha,12073,33,0.95 [0.55-1.67],0.870294122088897
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL6,Interleukin-6,12045,33,0.84 [0.53-1.34],0.4693329810729608
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL6R,Interleukin-6 receptor subunit alpha,12036,33,0.73 [0.29-1.82],0.496985162171776
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL6ST,Interleukin-6 receptor subunit beta,12105,34,1.03 [0.17-6.19],0.9707908759458992
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL7,Interleukin-7,12073,33,1.14 [0.71-1.82],0.5958780898786152
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL7R,Interleukin-7 receptor subunit alpha,12110,33,1.03 [0.58-1.83],0.923342949121593
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL9,Interleukin-9,10423,26,1.62 [1.11-2.35],0.0119898719285756
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,11793,32,0.70 [0.38-1.27],0.2427506783266235
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IMMT,MICOS complex subunit MIC60,10539,27,0.76 [0.31-1.88],0.549521987204844
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IMPA1,Inositol monophosphatase 1,12018,33,0.75 [0.44-1.27],0.2877491601406803
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IMPACT,Protein IMPACT,10583,26,0.75 [0.39-1.47],0.4058193225727949
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IMPG1,Interphotoreceptor matrix proteoglycan 1,10232,27,1.02 [0.29-3.58],0.9691309676456484
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ING1,Inhibitor of growth protein 1,11792,32,0.87 [0.42-1.84],0.7241191497151274
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",INHBB,Inhibin beta B chain,10385,26,0.45 [0.22-0.95],0.0372003241199676
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",INHBC,Inhibin beta C chain,12110,33,1.39 [0.66-2.92],0.3805470885231503
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",INPP1,Inositol polyphosphate 1-phosphatase,12045,33,0.80 [0.44-1.45],0.4623810654390481
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",10345,27,0.81 [0.41-1.59],0.5307201239353799
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",10575,26,0.58 [0.21-1.65],0.3094184437308231
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",12045,33,1.02 [0.74-1.41],0.9162397894384288
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",INSL3,Insulin-like 3,10583,26,1.43 [0.68-3.04],0.3464004782167249
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",INSL4,Early placenta insulin-like peptide,10539,27,1.50 [0.87-2.58],0.1424576489297317
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",INSL5,Insulin-like peptide INSL5,10536,26,0.64 [0.40-1.02],0.0632300650532747
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",INSR,Insulin receptor,10292,27,1.92 [0.22-16.74],0.5554435838643139
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IPCEF1,Interactor protein for cytohesin exchange factors 1,12003,33,0.80 [0.57-1.13],0.2048127580710143
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IQGAP2,Ras GTPase-activating-like protein IQGAP2,12045,33,0.92 [0.52-1.63],0.7846581526622958
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",11858,34,1.04 [0.74-1.46],0.8415755656198958
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IRAK1,Interleukin-1 receptor-associated kinase 1,11854,32,0.86 [0.53-1.40],0.5511927019197276
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IRAK4,Interleukin-1 receptor-associated kinase 4,12073,33,0.91 [0.68-1.21],0.5162186593245461
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,11658,32,1.01 [0.43-2.39],0.9832878796255576
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ISM1,Isthmin-1,12073,33,0.70 [0.32-1.53],0.3688563593524806
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ISM2,Isthmin-2,10614,27,0.97 [0.41-2.29],0.9437735215648848
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IST1,IST1 homolog,10456,26,0.93 [0.64-1.36],0.7239617575825134
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGA11,Integrin alpha-11,12073,33,0.61 [0.25-1.48],0.2724940817176018
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGA2,Integrin alpha-2,10385,26,0.63 [0.21-1.84],0.395893558897222
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGA5,Integrin alpha-5,12110,33,1.22 [0.36-4.12],0.7526190651191187
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGA6,Integrin alpha-6,12073,33,0.67 [0.35-1.27],0.2202950528383582
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGAL,Integrin alpha-L,10292,27,1.00 [0.43-2.33],0.9976103864039532
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGAM,Integrin alpha-M,12110,33,1.62 [0.62-4.21],0.325312209511331
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGAV,Integrin alpha-V,12192,33,1.91 [0.27-13.56],0.5160598631119785
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGAX,Integrin alpha-X,10423,26,1.08 [0.55-2.11],0.8252438579044418
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGB1,Integrin beta-1,12102,34,0.80 [0.19-3.42],0.7609707043837205
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGB1BP1,Integrin beta-1-binding protein 1,11821,32,1.40 [0.69-2.86],0.3543565730877517
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGB1BP2,Integrin beta-1-binding protein 2,11858,34,1.02 [0.77-1.35],0.8815762924877625
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGB2,Integrin beta-2,12031,34,1.92 [0.68-5.46],0.2189886530752968
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGB5,Integrin beta-5,12156,33,0.89 [0.39-2.05],0.7845085564933489
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGB6,Integrin beta-6,11854,32,1.88 [0.66-5.39],0.2392834059889708
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGB7,Integrin beta-7,12192,33,1.01 [0.52-1.98],0.972394186827008
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGBL1,Integrin beta-like protein 1,10614,27,0.44 [0.15-1.32],0.1419569376173148
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,10621,28,0.94 [0.14-6.37],0.9517570065245988
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,12162,34,0.49 [0.23-1.02],0.0580358424862918
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,10621,28,0.93 [0.24-3.65],0.9226784930064164
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,10539,27,1.84 [1.14-2.95],0.0118169652880492
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITM2A,Integral membrane protein 2A,12073,33,0.91 [0.54-1.54],0.7376544035787822
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITPA,Inosine triphosphate pyrophosphatase,10255,26,1.07 [0.61-1.88],0.8023172210323517
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",10345,27,1.15 [0.72-1.83],0.5662373750099885
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",10232,27,0.59 [0.21-1.68],0.3275972245863568
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",11813,32,1.29 [0.74-2.24],0.3704640320179874
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IZUMO1,Izumo sperm-egg fusion protein 1,10205,26,1.13 [0.56-2.28],0.7312683454235841
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",JAM2,Junctional adhesion molecule B,12199,33,0.42 [0.12-1.40],0.1570218137410737
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",JAM3,Junctional adhesion molecule C,10385,26,1.41 [0.70-2.83],0.3369262877384781
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",JCHAIN,Immunoglobulin J chain,11854,32,1.34 [0.83-2.16],0.2264698653629476
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,10205,26,1.73 [1.21-2.49],0.0029199702970704
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",JPT2,Jupiter microtubule associated homolog 2,10536,26,0.89 [0.57-1.37],0.5864528083306229
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",JUN,Transcription factor AP-1,11854,32,0.99 [0.52-1.87],0.9652520811062216
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,12045,33,0.84 [0.44-1.61],0.5992652195199855
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KAZN,Kazrin,10536,26,1.03 [0.71-1.48],0.8774194666152014
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KCNC4,Potassium voltage-gated channel subfamily C member 4,10232,27,1.08 [0.59-2.00],0.7969397036719651
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KCNH2,Potassium voltage-gated channel subfamily H member 2,10313,27,0.62 [0.29-1.32],0.2145216498126948
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KCNIP4,Kv channel-interacting protein 4,11813,32,1.11 [0.64-1.93],0.7018868802157934
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KCTD5,BTB/POZ domain-containing protein KCTD5,10386,25,0.80 [0.31-2.06],0.6437296982024996
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KDM3A,Lysine-specific demethylase 3A,10292,27,0.99 [0.63-1.55],0.9724515390842746
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KDR,Vascular endothelial growth factor receptor 2,12156,33,2.52 [0.69-9.23],0.1619536466247754
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KEL,Kell blood group glycoprotein,11813,32,0.50 [0.21-1.19],0.1158646332243642
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KHDC3L,KH domain-containing protein 3,10205,26,0.83 [0.43-1.63],0.5926639895161805
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KHK,Ketohexokinase,10345,27,1.62 [0.91-2.88],0.0977191042102259
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIAA0319,Dyslexia-associated protein KIAA0319,10583,26,0.81 [0.23-2.91],0.751969744785127
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIAA1549,UPF0606 protein KIAA1549,10423,26,1.02 [0.60-1.73],0.9376463945179913
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIAA1549L,UPF0606 protein KIAA1549L,10423,26,0.90 [0.25-3.26],0.8753778294964196
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIAA2013,Uncharacterized protein KIAA2013,10539,27,1.16 [0.64-2.09],0.6273399756951863
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIF1C,Kinesin-like protein KIF1C,10255,26,1.22 [0.50-3.00],0.6623991198078343
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIF20B,Kinesin-like protein KIF20B,10232,27,0.91 [0.55-1.52],0.7276657310956645
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIF22,Kinesin-like protein KIF22,10255,26,0.94 [0.69-1.28],0.6978968602036397
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIFBP,KIF-binding protein,12045,33,0.91 [0.63-1.31],0.6111071185131685
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,10539,27,0.90 [0.59-1.36],0.613630158511856
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,11821,32,1.02 [0.69-1.52],0.9177348436894868
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,10536,26,0.68 [0.51-0.91],0.0089102566318258
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,11821,32,0.70 [0.54-0.91],0.0077267221138086
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,10205,26,0.58 [0.27-1.24],0.157756937492852
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIRREL1,Kin of IRRE-like protein 1,10232,27,0.90 [0.45-1.80],0.7654291570298913
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIRREL2,Kin of IRRE-like protein 2,11813,32,0.56 [0.25-1.27],0.1630272377523413
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIT,Mast/stem cell growth factor receptor Kit,12136,34,0.14 [0.05-0.36],4.437823458019681e-05
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KITLG,Kit ligand,12105,34,0.80 [0.36-1.75],0.5701927762081183
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLB,Beta-klotho,11813,32,0.83 [0.54-1.29],0.4191334003652285
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLF4,Krueppel-like factor 4,10232,27,1.16 [0.46-2.94],0.7569852154102522
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLHL41,Kelch-like protein 41,10575,26,0.85 [0.36-2.00],0.7061436045766178
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK1,Kallikrein-1,11985,33,0.88 [0.68-1.14],0.331812989488004
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK10,Kallikrein-10,12111,33,1.15 [0.54-2.42],0.7170146116074896
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK11,Kallikrein-11,12046,33,0.78 [0.28-2.18],0.6299058482864359
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK12,Kallikrein-12,11821,32,0.88 [0.71-1.09],0.2351490191884976
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK13,Kallikrein-13,11834,33,1.34 [0.70-2.57],0.377448741113652
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK14,Kallikrein-14,12192,33,0.65 [0.34-1.27],0.2079075952321494
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK15,Kallikrein-15,10518,27,1.11 [0.55-2.25],0.7777549265306867
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK3,Prostate-specific antigen,10614,27,1.19 [0.66-2.17],0.5606992910174569
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK4,Kallikrein-4,12192,33,0.62 [0.35-1.10],0.0991394550685098
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK6,Kallikrein-6,12132,33,1.09 [0.41-2.94],0.8590350361550041
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK7,Kallikrein-7,10121,26,0.61 [0.22-1.67],0.3379584718959276
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK8,Kallikrein-8,11704,33,1.17 [0.50-2.73],0.7119907445968399
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLKB1,Plasma kallikrein,10399,26,3.07 [0.67-14.14],0.1498305016885079
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLRB1,Killer cell lectin-like receptor subfamily B member 1,12214,33,0.46 [0.20-1.04],0.0620264444352837
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,10232,27,1.47 [1.05-2.06],0.0244202253839841
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLRD1,Natural killer cells antigen CD94,12214,33,0.67 [0.34-1.32],0.2457794836324851
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLRF1,Killer cell lectin-like receptor subfamily F member 1,10292,27,0.21 [0.07-0.60],0.0032918156419518
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLRK1,NKG2-D type II integral membrane protein,10583,26,0.56 [0.27-1.17],0.1240727368201128
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KRT14,"Keratin, type I cytoskeletal 14",11430,30,0.91 [0.27-3.07],0.8824078228347019
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KRT17,"Keratin, type I cytoskeletal 17",10255,26,1.15 [0.41-3.25],0.7943356280132474
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KRT18,"Keratin, type I cytoskeletal 18",12045,33,0.96 [0.65-1.41],0.8218070293156788
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KRT19,"Keratin, type I cytoskeletal 19",12051,33,0.84 [0.53-1.34],0.4614378737495456
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KRT5,"Keratin, type II cytoskeletal 5",11813,32,0.78 [0.40-1.54],0.4806790743584305
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KRT6C,"Keratin, type II cytoskeletal 6C",10255,26,1.05 [0.41-2.71],0.9187249134253505
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KRT8,"Keratin, type II cytoskeletal 8",10232,27,0.87 [0.47-1.59],0.6486742107731596
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KYAT1,Kynurenine--oxoglutarate transaminase 1,12089,34,0.85 [0.49-1.46],0.5453139256460626
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KYNU,Kynureninase,12214,33,1.03 [0.52-2.04],0.92427776113746
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",L1CAM,Neural cell adhesion molecule L1,12156,33,1.03 [0.35-3.00],0.9592294395258392
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,10597,27,1.18 [0.79-1.75],0.425863109625195
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LACRT,Extracellular glycoprotein lacritin,10515,27,1.05 [0.55-2.03],0.8773562446086343
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LACTB2,Endoribonuclease LACTB2,12105,34,0.94 [0.59-1.49],0.7891024163778334
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAG3,Lymphocyte activation gene 3 protein,12045,33,1.05 [0.50-2.21],0.8954863459556291
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,12102,31,0.95 [0.41-2.18],0.895035499375191
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,12018,33,1.18 [0.86-1.62],0.3178752815666557
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAMA1,Laminin subunit alpha-1,10255,26,0.72 [0.30-1.77],0.4759859445346138
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAMA4,Laminin subunit alpha-4,12159,32,1.05 [0.40-2.74],0.920237352990746
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAMB1,Laminin subunit beta-1,10345,27,1.16 [0.33-4.04],0.8142406620467046
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAMP1,Lysosome-associated membrane glycoprotein 1,10296,27,1.67 [0.84-3.32],0.1457069404577704
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAMP2,Lysosome-associated membrane glycoprotein 2,11739,30,3.40 [0.57-20.21],0.1775806207997672
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAMP3,Lysosome-associated membrane glycoprotein 3,12198,33,0.80 [0.45-1.40],0.432608878361386
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAMTOR5,Ragulator complex protein LAMTOR5,10539,27,0.69 [0.25-1.92],0.4796139067228513
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAP3,Cytosol aminopeptidase,11854,32,1.07 [0.56-2.06],0.8349935772271195
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LARP1,La-related protein 1,10539,27,0.87 [0.45-1.66],0.6625397792166103
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAT,Linker for activation of T-cells family member 1,12214,33,0.95 [0.64-1.42],0.8097793961305577
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAT2,Linker for activation of T-cells family member 2,12045,33,0.88 [0.68-1.13],0.3152883194584094
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LATS1,Serine/threonine-protein kinase LATS1,10292,27,1.21 [0.78-1.87],0.4006060812847049
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAYN,Layilin,11997,33,1.12 [0.49-2.60],0.7854993112992928
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LBP,Lipopolysaccharide-binding protein,12162,34,1.11 [0.66-1.88],0.6825346859094454
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LBR,Delta(14)-sterol reductase LBR,12199,33,0.81 [0.49-1.33],0.3975376586218132
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LCAT,Phosphatidylcholine-sterol acyltransferase,10600,28,2.76 [0.50-15.25],0.2431231835341574
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LCN15,Lipocalin-15,10575,26,1.20 [0.72-2.02],0.4822254088822808
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LCN2,Neutrophil gelatinase-associated lipocalin,11778,33,0.76 [0.33-1.72],0.5059391607956458
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LCP1,Plastin-2,10614,27,0.94 [0.43-2.08],0.8824170722265072
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LDLR,Low-density lipoprotein receptor,12121,34,1.16 [0.65-2.07],0.6227666935569307
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LDLRAP1,Low density lipoprotein receptor adapter protein 1,10575,26,1.05 [0.71-1.55],0.8070132129414871
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LECT2,Leukocyte cell-derived chemotaxin-2,10597,27,1.15 [0.67-1.98],0.6224560402181081
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LEFTY2,Left-right determination factor 2,12166,33,1.08 [0.57-2.06],0.8126519238429468
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LEG1,Protein LEG1 homolog,10025,24,0.63 [0.34-1.16],0.1370940485004976
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LELP1,Late cornified envelope-like proline-rich protein 1,10232,27,0.79 [0.44-1.42],0.4278065561430811
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LEO1,RNA polymerase-associated protein LEO1,10575,26,0.80 [0.21-3.01],0.7374857039655962
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LEP,Leptin,12105,34,1.12 [0.69-1.84],0.6447412996254729
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LEPR,Leptin receptor,12105,34,1.51 [0.61-3.77],0.3759879383905985
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LETM1,Mitochondrial proton/calcium exchanger protein,10575,26,1.22 [0.62-2.40],0.5653880638049805
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LGALS1,Galectin-1,12105,34,1.20 [0.50-2.84],0.683704503022688
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LGALS3,Galectin-3,12121,34,0.52 [0.19-1.43],0.206069814480553
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LGALS3BP,Galectin-3-binding protein,10621,28,0.57 [0.15-2.11],0.4006633661059869
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LGALS4,Galectin-4,12102,31,1.59 [0.93-2.71],0.0876365480951647
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LGALS7_LGALS7B,Galectin-7,12044,33,0.97 [0.45-2.10],0.9454375491771724
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LGALS8,Galectin-8,12199,33,0.93 [0.56-1.56],0.783669103011954
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LGALS9,Galectin-9,12103,31,1.07 [0.40-2.84],0.8911846826800799
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LGMN,Legumain,12159,32,1.73 [0.75-3.97],0.1967286816425962
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LHB,Lutropin subunit beta,11821,32,1.08 [0.75-1.55],0.671598188808508
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,12124,32,1.04 [0.62-1.74],0.8772260475796817
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LIF,Leukemia inhibitory factor,11813,32,0.71 [0.35-1.45],0.3472941167101375
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LIFR,Leukemia inhibitory factor receptor,12073,33,1.14 [0.32-3.99],0.8420580917251426
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,12110,33,1.03 [0.43-2.47],0.9433072388825916
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,10614,27,1.13 [0.80-1.60],0.4789489986187614
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,10255,26,0.86 [0.38-1.91],0.7027589210908083
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,12082,34,0.79 [0.30-2.04],0.6208316821348018
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,10597,27,1.15 [0.69-1.91],0.5873570092901952
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,12244,34,1.27 [0.42-3.83],0.6745328261108696
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,12197,34,1.33 [0.55-3.23],0.5336695202504094
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,11854,32,1.33 [0.68-2.62],0.4072864696862128
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,12244,34,1.10 [0.71-1.70],0.6733292436109415
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LIPF,Gastric triacylglycerol lipase,10345,27,0.54 [0.29-1.00],0.0500610840073991
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LMNB1,Lamin-B1,10515,26,1.18 [0.68-2.04],0.5641196013839331
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LMNB2,Lamin-B2,10583,26,0.79 [0.20-3.17],0.7401596418301815
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LMOD1,Leiomodin-1,10575,26,1.46 [0.68-3.17],0.3319618821887421
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LMOD2,Leiomodin-2,10232,27,1.19 [0.72-1.98],0.4912268560013018
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LONP1,"Lon protease homolog, mitochondrial",10345,27,1.04 [0.68-1.60],0.8505503486559923
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LPA,Apolipoprotein(a),10368,25,1.13 [0.91-1.41],0.2721576244022181
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LPCAT2,Lysophosphatidylcholine acyltransferase 2,12045,33,0.96 [0.44-2.10],0.917114357167192
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LPL,Lipoprotein lipase,12105,34,1.59 [0.79-3.20],0.1904694728297631
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LPO,Lactoperoxidase,11724,33,0.78 [0.47-1.30],0.346854773776872
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LPP,Lipoma-preferred partner,10255,26,0.91 [0.50-1.63],0.7397693958677775
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,10255,26,0.72 [0.39-1.31],0.2803913261709924
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,10313,27,0.56 [0.20-1.58],0.2701437050866269
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRG1,Leucine-rich alpha-2-glycoprotein,10621,28,0.40 [0.11-1.48],0.1684941515813112
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,12145,33,1.17 [0.48-2.86],0.7351719918306404
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,10250,27,1.35 [0.44-4.16],0.6051905368503607
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRP1,Prolow-density lipoprotein receptor-related protein 1,12045,33,1.02 [0.32-3.27],0.9772916960428036
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRP11,Low-density lipoprotein receptor-related protein 11,12105,34,1.05 [0.46-2.41],0.9089921420368012
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRP2,Low-density lipoprotein receptor-related protein 2,10313,27,0.39 [0.12-1.25],0.1110703644373099
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRP2BP,LRP2-binding protein,10313,27,0.72 [0.41-1.29],0.2750829864898355
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,12199,33,0.84 [0.46-1.52],0.5598499262233092
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRRC25,Leucine-rich repeat-containing protein 25,12045,33,0.87 [0.39-1.94],0.7280814056016369
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRRC37A2,Leucine-rich repeat-containing protein 37A2,10536,26,0.99 [0.41-2.41],0.98732608176623
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRRC38,Leucine-rich repeat-containing protein 38,10313,27,1.46 [0.79-2.71],0.223501145974035
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRRC59,Leucine-rich repeat-containing protein 59,10597,27,1.12 [0.54-2.33],0.7681100125230766
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,10539,27,0.96 [0.44-2.11],0.9259031664057172
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRRN1,Leucine-rich repeat neuronal protein 1,11854,32,0.76 [0.34-1.70],0.5029210038224767
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,10313,27,1.34 [0.64-2.84],0.4403009249686012
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,10575,26,1.09 [0.28-4.24],0.8963329915108806
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LSM1,U6 snRNA-associated Sm-like protein LSm1,11821,32,0.71 [0.36-1.38],0.308908408214662
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LSM8,U6 snRNA-associated Sm-like protein LSm8,10423,26,1.04 [0.70-1.54],0.8585769805672141
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LSP1,Lymphocyte-specific protein 1,12073,33,0.61 [0.27-1.39],0.2414858009249614
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LTA,Lymphotoxin-alpha,12073,33,0.77 [0.36-1.66],0.4996801851990676
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LTA4H,Leukotriene A-4 hydrolase,12192,33,0.62 [0.34-1.13],0.1171996309889191
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LTB,Lymphotoxin-beta,10539,27,0.60 [0.18-2.02],0.4067990733448013
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LTBP2,Latent-transforming growth factor beta-binding protein 2,12244,34,0.72 [0.27-1.89],0.4991756324395668
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LTBP3,Latent-transforming growth factor beta-binding protein 3,11821,32,0.69 [0.35-1.36],0.2792654627729319
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LTBR,Tumor necrosis factor receptor superfamily member 3,12058,31,0.67 [0.21-2.12],0.4979004284182609
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LTO1,Protein LTO1 homolog,11854,32,1.27 [0.69-2.35],0.4412673471829127
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LUZP2,Leucine zipper protein 2,10539,27,1.16 [0.54-2.46],0.7080614801863951
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LXN,Latexin,11969,33,0.99 [0.62-1.58],0.9695956540260378
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LY6D,Lymphocyte antigen 6D,12058,32,1.91 [1.02-3.60],0.0446032393967348
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LY75,Lymphocyte antigen 75,12073,33,0.81 [0.37-1.79],0.5990228603683633
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LY9,T-lymphocyte surface antigen Ly-9,11964,32,1.78 [0.65-4.89],0.2602204707570282
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LY96,Lymphocyte antigen 96,12018,33,1.26 [0.53-2.98],0.5962365214554519
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LYAR,Cell growth-regulating nucleolar protein,11821,32,0.63 [0.30-1.34],0.2306212116758761
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LYN,Tyrosine-protein kinase Lyn,12045,33,0.85 [0.59-1.22],0.3836116482321472
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LYPD1,Ly6/PLAUR domain-containing protein 1,11813,32,0.69 [0.33-1.43],0.3184445673265609
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LYPD3,Ly6/PLAUR domain-containing protein 3,12050,33,0.91 [0.36-2.27],0.8339665521423223
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LYPD8,Ly6/PLAUR domain-containing protein 8,11821,32,0.91 [0.48-1.73],0.7711582981549248
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LYPLA2,Acyl-protein thioesterase 2,10232,27,0.98 [0.69-1.40],0.9283142413605996
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,10313,27,0.96 [0.67-1.37],0.8202274544699879
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,10621,28,2.27 [0.38-13.70],0.3717927319861536
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LYZL2,Lysozyme-like protein 2,10205,26,1.24 [0.46-3.34],0.6711565291180872
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LZTFL1,Leucine zipper transcription factor-like protein 1,10385,26,1.11 [0.66-1.88],0.6904759000977424
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",M6PR,Cation-dependent mannose-6-phosphate receptor,10345,27,1.53 [0.76-3.09],0.2334013850837646
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,11974,33,0.63 [0.29-1.38],0.2504592849836971
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAEA,E3 ubiquitin-protein transferase MAEA,11821,32,0.53 [0.21-1.34],0.1826767385376787
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAG,Myelin-associated glycoprotein,10313,27,1.10 [0.50-2.42],0.8220600421060076
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAGEA3,Melanoma-associated antigen 3,10423,26,1.05 [0.66-1.68],0.8222870247629248
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAGED1,Melanoma-associated antigen D1,11821,32,0.65 [0.31-1.33],0.2370534985169878
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAMDC2,MAM domain-containing protein 2,10597,27,0.66 [0.23-1.87],0.4295762018361703
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAMDC4,Apical endosomal glycoprotein,10539,27,1.23 [0.65-2.34],0.5241414525222252
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",10345,27,0.59 [0.14-2.54],0.4772164505157725
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAN2B2,Epididymis-specific alpha-mannosidase,10597,27,1.47 [0.78-2.74],0.2301365912562911
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",10205,26,0.76 [0.36-1.62],0.477097654502991
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MANF,Mesencephalic astrocyte-derived neurotrophic factor,12159,32,0.97 [0.75-1.25],0.79305307520831
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MANSC1,MANSC domain-containing protein 1,12156,33,0.47 [0.15-1.47],0.1936187861400682
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MANSC4,MANSC domain-containing protein 4,10255,26,1.22 [0.73-2.06],0.4483868603758508
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,10232,27,0.96 [0.28-3.25],0.948000384832682
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,10255,26,0.92 [0.49-1.73],0.800247429933811
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAP2,Microtubule-associated protein 2,10583,26,1.33 [0.66-2.69],0.4226609635563604
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,10536,26,0.74 [0.40-1.36],0.3301052125481879
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,12073,33,0.88 [0.65-1.19],0.3990947040951764
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,11821,32,0.88 [0.63-1.24],0.4661818122487915
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,11997,33,0.92 [0.70-1.22],0.5633680258760211
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAPK13,Mitogen-activated protein kinase 13,10205,26,1.15 [0.51-2.57],0.7346259093023901
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAPK9,Mitogen-activated protein kinase 9,12073,33,0.76 [0.37-1.55],0.4506305247680592
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAPKAPK2,MAP kinase-activated protein kinase 2,10423,26,1.08 [0.65-1.80],0.7743463351855622
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAPRE3,Microtubule-associated protein RP/EB family member 3,10205,26,1.13 [0.91-1.41],0.2541087350728254
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAPT,Microtubule-associated protein tau,11813,32,1.08 [0.60-1.95],0.7895715509351586
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MARCO,Macrophage receptor MARCO,12105,34,2.00 [0.65-6.16],0.2282880714519728
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MARS1,"Methionine--tRNA ligase, cytoplasmic",10369,26,1.14 [0.73-1.77],0.5666405860224785
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MASP1,Mannan-binding lectin serine protease 1,11997,33,1.05 [0.28-3.93],0.9398550270898186
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MATN2,Matrilin-2,12122,31,0.62 [0.21-1.83],0.3874191522264331
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MATN3,Matrilin-3,12003,33,1.74 [0.68-4.42],0.2471551122215004
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAVS,Mitochondrial antiviral-signaling protein,11821,32,0.97 [0.68-1.37],0.8448749405818308
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAX,Protein max,11813,32,0.90 [0.66-1.22],0.4974662005316925
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MB,Myoglobin,12244,34,0.70 [0.37-1.35],0.2904224009310914
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MBL2,Mannose-binding protein C,10466,26,0.77 [0.54-1.09],0.1380950784515599
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MCAM,Cell surface glycoprotein MUC18,12162,34,0.80 [0.32-1.98],0.628260746793263
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",10575,26,0.92 [0.36-2.33],0.853620813183699
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MCEMP1,Mast cell-expressed membrane protein 1,10292,27,1.12 [0.76-1.65],0.5600097028316073
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MCFD2,Multiple coagulation factor deficiency protein 2,12045,34,1.07 [0.53-2.16],0.8539241194708017
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MCTS1,Malignant T-cell-amplified sequence 1,10536,26,1.02 [0.24-4.38],0.9767642319105404
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,12018,33,1.23 [0.78-1.93],0.3820175201107435
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MDH1,"Malate dehydrogenase, cytoplasmic",10537,28,0.91 [0.37-2.26],0.841533588291201
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MDK,Midkine,12126,33,1.41 [0.90-2.21],0.1364871424399598
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MDM1,Nuclear protein MDM1,10313,27,1.22 [0.37-3.98],0.7440487379000014
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",10345,27,1.09 [0.73-1.63],0.6751029302285447
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MED18,Mediator of RNA polymerase II transcription subunit 18,11821,32,0.94 [0.62-1.43],0.7773903467904932
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MED21,Mediator of RNA polymerase II transcription subunit 21,10255,26,1.29 [0.72-2.30],0.3985192988666319
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MEGF10,Multiple epidermal growth factor-like domains protein 10,12102,31,0.74 [0.30-1.78],0.4965742463563812
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MEGF11,Multiple epidermal growth factor-like domains protein 11,10255,26,1.00 [0.32-3.14],0.998723170061114
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MEGF9,Multiple epidermal growth factor-like domains protein 9,12211,34,3.28 [0.76-14.18],0.1112862151500305
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MELTF,Melanotransferrin,10597,27,0.64 [0.19-2.21],0.4831860550085806
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MENT,Protein MENT,10385,26,0.96 [0.18-5.17],0.9574278560816908
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MEP1A,Meprin A subunit alpha,10536,26,1.33 [0.81-2.18],0.2668545011850028
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MEP1B,Meprin A subunit beta,12105,34,1.00 [0.77-1.28],0.9759887050214184
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MEPE,Matrix extracellular phosphoglycoprotein,12102,31,0.61 [0.21-1.74],0.3552892668210923
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MERTK,Tyrosine-protein kinase Mer,12214,33,1.51 [0.47-4.90],0.4897913404989795
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MESD,LRP chaperone MESD,12110,33,0.96 [0.75-1.24],0.7827053662488044
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MET,Hepatocyte growth factor receptor,12125,34,0.72 [0.16-3.19],0.667174808507633
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",METAP1,Methionine aminopeptidase 1,11813,32,0.39 [0.12-1.24],0.1113876993251088
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",12073,33,0.86 [0.59-1.26],0.4338049558681016
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",METAP2,Methionine aminopeptidase 2,12166,33,0.76 [0.45-1.26],0.2853751465714145
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MFAP3,Microfibril-associated glycoprotein 3,11858,34,1.52 [0.97-2.39],0.0652603286264659
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MFAP3L,Microfibrillar-associated protein 3-like,10313,27,0.30 [0.10-0.88],0.0287219002015167
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MFAP4,Microfibril-associated glycoprotein 4,10385,26,0.52 [0.16-1.70],0.2825413973121727
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MFAP5,Microfibrillar-associated protein 5,12244,34,0.78 [0.37-1.63],0.5069770515164439
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MFGE8,Lactadherin,12110,33,0.91 [0.44-1.87],0.7898500627536857
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MGLL,Monoglyceride lipase,12136,31,0.92 [0.64-1.31],0.6288503909097701
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MGMT,Methylated-DNA--protein-cysteine methyltransferase,12073,33,0.95 [0.74-1.21],0.6755474574903939
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MIA,Melanoma-derived growth regulatory protein,12156,33,1.82 [0.86-3.87],0.1174841627751599
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MICALL2,MICAL-like protein 2,10313,27,1.00 [0.57-1.74],0.9983689593389624
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,12073,33,1.03 [0.83-1.27],0.8051088201799538
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MIF,Macrophage migration inhibitory factor,12095,33,0.83 [0.54-1.30],0.41881880119351
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MILR1,Allergin-1,11854,32,0.70 [0.37-1.33],0.2744348813885048
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,10539,27,1.05 [0.74-1.48],0.7923679442384168
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MINK1,Misshapen-like kinase 1,10583,26,0.93 [0.63-1.39],0.7291822700251295
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MITD1,MIT domain-containing protein 1,12018,33,0.90 [0.65-1.23],0.4914364734587675
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MKI67,Proliferation marker protein Ki-67,10292,27,1.14 [0.48-2.74],0.7659765380481842
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MLLT1,Protein ENL,10205,26,1.38 [0.93-2.04],0.1076059912209199
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MLN,Promotilin,12073,33,1.33 [0.94-1.88],0.1110875809518314
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MME,Neprilysin,12045,33,1.06 [0.74-1.51],0.7610591072883064
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MMP1,Interstitial collagenase,11625,29,1.14 [0.79-1.66],0.4849708471321166
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MMP10,Stromelysin-2,12072,31,1.02 [0.59-1.75],0.9527589684486328
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MMP12,Macrophage metalloelastase,12087,33,0.82 [0.46-1.45],0.494047130746629
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MMP13,Collagenase 3,11813,32,0.62 [0.24-1.59],0.3245029975937888
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MMP15,Matrix metalloproteinase-15,10597,27,1.34 [0.82-2.20],0.2358717455027996
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MMP3,Stromelysin-1,12110,33,1.73 [1.05-2.85],0.0319128818101411
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MMP7,Matrilysin,11838,33,1.44 [0.74-2.79],0.2793606603488265
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MMP8,Neutrophil collagenase,12173,33,0.95 [0.62-1.44],0.7910277316302987
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MMP9,Matrix metalloproteinase-9,12084,33,0.72 [0.43-1.20],0.210058805336764
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",10255,26,1.21 [0.59-2.48],0.5948600667831931
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MN1,Transcriptional activator MN1,10313,27,1.08 [0.58-2.00],0.8076968128645052
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MNAT1,CDK-activating kinase assembly factor MAT1,10423,26,0.51 [0.18-1.43],0.199464585762869
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MNDA,Myeloid cell nuclear differentiation antigen,12084,34,0.92 [0.67-1.27],0.6300193885514694
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MOCS2,Molybdopterin synthase catalytic subunit,10385,26,1.37 [0.80-2.37],0.2541011569298783
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MOG,Myelin-oligodendrocyte glycoprotein,12192,33,2.12 [0.87-5.16],0.0960487733512563
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MORC3,MORC family CW-type zinc finger protein 3,10583,26,0.51 [0.10-2.54],0.4095582256867132
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MORF4L1,Mortality factor 4-like protein 1,10423,26,0.99 [0.41-2.41],0.9822898660060444
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MORF4L2,Mortality factor 4-like protein 2,10205,26,1.11 [0.42-2.93],0.8385042535633189
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MORN4,MORN repeat-containing protein 4,10205,26,0.75 [0.40-1.39],0.3616860215051652
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MPHOSPH8,M-phase phosphoprotein 8,11858,34,1.02 [0.68-1.53],0.9378944954424896
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MPI,Mannose-6-phosphate isomerase,12045,33,0.88 [0.61-1.27],0.4877273941862091
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,12136,31,0.99 [0.65-1.51],0.980164418958783
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MPO,Myeloperoxidase,12110,33,0.53 [0.27-1.02],0.0589911823744524
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MPRIP,Myosin phosphatase Rho-interacting protein,10514,27,1.85 [1.03-3.31],0.0391759801067037
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MRC1,Macrophage mannose receptor 1,10600,28,1.25 [0.38-4.12],0.7133208834788671
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MRI1,Methylthioribose-1-phosphate isomerase,10313,27,1.01 [0.58-1.74],0.9848812156122512
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MRPL24,"39S ribosomal protein L24, mitochondrial",10255,26,1.29 [0.55-3.05],0.5583939473540998
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MRPL28,"39S ribosomal protein L28, mitochondrial",10575,26,1.22 [0.57-2.63],0.6100739553910793
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MRPL46,"39S ribosomal protein L46, mitochondrial",11813,32,1.87 [0.79-4.42],0.152834813453411
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MRPL52,"39S ribosomal protein L52, mitochondrial",10183,26,1.60 [0.53-4.78],0.4013478966869027
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",10575,26,1.11 [0.69-1.79],0.6571561665355415
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MRPS16,"28S ribosomal protein S16, mitochondrial",10292,27,1.74 [0.75-4.03],0.1945666658746835
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MSLN,Mesothelin,12020,33,0.65 [0.37-1.12],0.1214022913671495
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MSLNL,Mesothelin-like protein,10313,27,0.97 [0.36-2.59],0.9450988050718726
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MSMB,Beta-microseminoprotein,12053,34,0.79 [0.53-1.18],0.2564791679305154
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MSR1,Macrophage scavenger receptor types I and II,12199,33,1.63 [0.83-3.19],0.1533324584363697
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MSRA,Mitochondrial peptide methionine sulfoxide reductase,12156,33,0.87 [0.57-1.33],0.5119982105719995
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MST1,Hepatocyte growth factor-like protein,10433,27,1.76 [0.71-4.34],0.2213605216876314
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MSTN,Growth/differentiation factor 8,11858,34,1.17 [0.65-2.12],0.5944011569674752
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MTDH,Protein LYRIC,10292,27,1.11 [0.74-1.66],0.6252633601110207
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",10583,26,0.75 [0.16-3.41],0.7060147555715236
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,10423,26,1.21 [0.86-1.69],0.2699544985150698
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MTIF3,"Translation initiation factor IF-3, mitochondrial",10536,26,1.06 [0.69-1.63],0.7896680782264536
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MTPN,Myotrophin,11858,34,0.89 [0.34-2.29],0.8051948464207662
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MTR,Methionine synthase,10255,26,1.10 [0.65-1.86],0.712264937285932
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MTSS1,Protein MTSS 1,10536,26,1.03 [0.74-1.45],0.8511331668432023
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MTSS2,Protein MTSS 2,10539,27,1.01 [0.69-1.48],0.9462013141790035
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MTUS1,Microtubule-associated tumor suppressor 1,10423,26,0.78 [0.38-1.64],0.5183527975559206
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MUC13,Mucin-13,11813,32,1.35 [0.74-2.44],0.3246444040241146
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MUC16,Mucin-16,12045,33,1.01 [0.86-1.18],0.950992879163008
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MUC2,Mucin-2,10614,27,0.86 [0.57-1.29],0.4646734912294582
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MUCL3,Mucin-like protein 3,10205,26,0.80 [0.29-2.16],0.6545791220905467
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MVK,Mevalonate kinase,11854,32,0.87 [0.58-1.32],0.5138945075652248
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MXRA8,Matrix remodeling-associated protein 8,10385,26,0.39 [0.12-1.26],0.1156784883687798
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYBPC1,"Myosin-binding protein C, slow-type",10597,27,1.08 [0.62-1.86],0.7918630002011489
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYBPC2,"Myosin-binding protein C, fast-type",10345,27,0.86 [0.51-1.44],0.5569285751377706
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,10575,26,0.97 [0.55-1.71],0.904277790237306
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYDGF,Myeloid-derived growth factor,10597,27,1.17 [0.81-1.69],0.3955430418339092
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYH4,Myosin-4,10255,26,1.05 [0.49-2.22],0.9051234447291708
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYH7B,Myosin-7B,10205,26,1.24 [0.60-2.57],0.5614674476850869
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYH9,Myosin-9,10614,27,1.21 [0.87-1.68],0.2592459880369031
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",10255,26,0.79 [0.27-2.29],0.6613703786448467
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYL3,Myosin light chain 3,10345,27,1.08 [0.64-1.84],0.7705565429143136
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYL4,Myosin light chain 4,10345,27,0.72 [0.32-1.59],0.4148448361473623
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYL6B,Myosin light chain 6B,10313,27,0.91 [0.57-1.43],0.6681014681316908
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",10313,27,0.37 [0.10-1.31],0.1216076935569925
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYO6,Unconventional myosin-VI,10575,26,1.38 [0.60-3.21],0.4515106652201541
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYO9B,Unconventional myosin-IXb,11854,32,1.12 [0.71-1.77],0.6261374040113177
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYOC,Myocilin,12110,33,1.12 [0.56-2.24],0.7465487774314503
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYOM1,Myomesin-1,10232,27,0.33 [0.10-1.06],0.0627614140485974
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYOM2,Myomesin-2,10255,26,0.81 [0.33-1.97],0.6380653375853258
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYOM3,Myomesin-3,10385,26,1.04 [0.69-1.59],0.8445908095331722
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MZB1,Marginal zone B- and B1-cell-specific protein,12145,32,1.16 [0.66-2.05],0.596681325614584
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MZT1,Mitotic-spindle organizing protein 1,11821,32,1.03 [0.56-1.90],0.9221062309708016
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NAA10,N-alpha-acetyltransferase 10,10255,26,1.20 [0.58-2.49],0.6310243848354006
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NAA80,N-alpha-acetyltransferase 80,10313,27,1.05 [0.77-1.44],0.7589983974301855
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NAAA,N-acylethanolamine-hydrolyzing acid amidase,11963,33,0.88 [0.52-1.50],0.6446970161112984
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NACC1,Nucleus accumbens-associated protein 1,10539,27,0.89 [0.44-1.80],0.7362556172051273
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NADK,NAD kinase,12105,34,1.24 [0.78-1.97],0.3575799027388054
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NAGA,Alpha-N-acetylgalactosaminidase,10264,27,1.02 [0.51-2.04],0.957546565489621
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NAGK,N-acetyl-D-glucosamine kinase,10326,27,0.92 [0.47-1.80],0.8095935979419165
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,10385,26,0.44 [0.09-2.22],0.321984732581964
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NAMPT,Nicotinamide phosphoribosyltransferase,11821,32,0.73 [0.36-1.48],0.3820226395528893
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NAP1L4,Nucleosome assembly protein 1-like 4,10513,26,0.54 [0.25-1.21],0.1341840516296328
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NAPRT,Nicotinate phosphoribosyltransferase,10583,26,1.15 [0.39-3.43],0.8021046060135669
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NARS1,"Asparagine--tRNA ligase, cytoplasmic",10575,26,1.10 [0.49-2.45],0.8152282324190347
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NBL1,Neuroblastoma suppressor of tumorigenicity 1,12156,33,0.78 [0.25-2.48],0.679266811910441
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NBN,Nibrin,11854,32,0.77 [0.37-1.60],0.4897533950892275
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NCAM1,Neural cell adhesion molecule 1,12162,34,0.48 [0.16-1.45],0.1929413967633096
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NCAM2,Neural cell adhesion molecule 2,12110,33,0.76 [0.24-2.45],0.6505560410133542
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NCAN,Neurocan core protein,12199,33,1.16 [0.51-2.61],0.7266150464810165
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NCF2,Neutrophil cytosol factor 2,12059,33,0.65 [0.42-1.01],0.0556810938218771
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NCK2,Cytoplasmic protein NCK2,12159,32,0.91 [0.68-1.22],0.5285658096657269
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NCLN,Nicalin,11854,32,0.93 [0.47-1.86],0.8383772570136748
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NCR1,Natural cytotoxicity triggering receptor 1,12055,33,0.30 [0.14-0.64],0.0018344160680798
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,10536,26,0.86 [0.28-2.68],0.7985656805389366
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NCS1,Neuronal calcium sensor 1,12192,33,1.97 [0.68-5.72],0.2106327103817595
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NDRG1,Protein NDRG1,11813,32,0.89 [0.53-1.52],0.679814820070046
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,10539,27,0.71 [0.34-1.51],0.379186265665985
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,10276,27,2.63 [1.05-6.61],0.0394890507421118
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,10536,26,1.04 [0.68-1.58],0.8646996861896147
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",11821,32,1.02 [0.68-1.54],0.9104204002148016
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NEB,Nebulin,10255,26,0.51 [0.14-1.86],0.3043726569653905
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NECAP2,Adaptin ear-binding coat-associated protein 2,10255,26,0.75 [0.40-1.40],0.3636849372361814
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NECTIN1,Nectin-1,10292,27,1.82 [0.79-4.19],0.1561200915173419
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NECTIN2,Nectin-2,12082,34,1.86 [0.73-4.70],0.1905592496430304
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NECTIN4,Nectin-4,12156,33,0.93 [0.35-2.48],0.87867834288755
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,10292,27,1.00 [0.47-2.13],0.999105789977028
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NEDD9,Enhancer of filamentation 1,10292,27,1.34 [0.51-3.55],0.550725233141039
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NEFL,Neurofilament light polypeptide,11774,32,1.21 [0.60-2.45],0.5903477783605473
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NEK7,Serine/threonine-protein kinase Nek7,10423,26,0.82 [0.45-1.49],0.513262284354506
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NELL1,Protein kinase C-binding protein NELL1,12156,33,1.08 [0.54-2.20],0.8214233429336828
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NELL2,Protein kinase C-binding protein NELL2,12159,32,0.99 [0.33-2.98],0.9924785421503268
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NENF,Neudesin,10539,27,1.06 [0.78-1.44],0.7152325280620262
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NEO1,Neogenin,10575,26,1.40 [0.31-6.30],0.662205140617125
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NEXN,Nexilin,10600,28,1.21 [0.72-2.01],0.4714401578297356
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFASC,Neurofascin,12214,33,1.16 [0.39-3.42],0.7941913650865093
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFAT5,Nuclear factor of activated T-cells 5,10292,27,1.05 [0.69-1.59],0.8340149942326779
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",12073,33,0.98 [0.71-1.37],0.9148465290886748
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",11854,32,1.44 [0.97-2.16],0.0738086827252437
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFE2,Transcription factor NF-E2 45 kDa subunit,10345,27,1.03 [0.62-1.70],0.914152632240675
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFIC,Nuclear factor 1 C-type,10575,26,1.01 [0.45-2.30],0.9758700911256482
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFKB1,Nuclear factor NF-kappa-B p105 subunit,10255,26,0.86 [0.51-1.47],0.5851067021677719
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFKB2,Nuclear factor NF-kappa-B p100 subunit,10423,26,0.51 [0.16-1.63],0.2570603498682721
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFKBIE,NF-kappa-B inhibitor epsilon,11821,32,0.55 [0.27-1.12],0.0976279102762978
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",10536,26,1.06 [0.73-1.53],0.7583814569045778
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFX1,Transcriptional repressor NF-X1,10255,26,0.64 [0.35-1.19],0.1631047672504226
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFYA,Nuclear transcription factor Y subunit alpha,10255,26,0.44 [0.12-1.67],0.2296361137370328
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NGF,Beta-nerve growth factor,12018,33,3.46 [0.25-48.04],0.3545227061567081
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NGFR,Tumor necrosis factor receptor superfamily member 16,10597,27,0.36 [0.08-1.56],0.1737903965239999
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NGRN,Neugrin,10583,26,0.51 [0.07-3.52],0.4907097335392081
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NHLRC3,NHL repeat-containing protein 3,10130,26,2.19 [0.64-7.49],0.2095725419904265
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NID1,Nidogen-1,12113,34,1.08 [0.51-2.26],0.847873419140027
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NID2,Nidogen-2,12110,33,1.08 [0.72-1.61],0.7135916890512009
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NINJ1,Ninjurin-1,11821,32,0.70 [0.33-1.51],0.3670782848210597
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NIT1,Deaminated glutathione amidase,10345,27,1.00 [0.46-2.15],0.9995484139551192
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NIT2,Omega-amidase NIT2,10554,27,0.91 [0.55-1.49],0.7049485437728693
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NLGN1,Neuroligin-1,10313,27,0.99 [0.58-1.71],0.9792262151510248
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NLGN2,Neuroligin-2,10232,27,1.18 [0.62-2.25],0.6118023167775568
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NME1,Nucleoside diphosphate kinase A,10292,27,2.13 [0.54-8.39],0.2785638846494809
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NME3,Nucleoside diphosphate kinase 3,12122,31,0.96 [0.24-3.88],0.9585816643003466
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NMI,N-myc-interactor,10505,27,1.02 [0.61-1.71],0.9418362849508992
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,12018,33,0.57 [0.34-0.97],0.03626659957697
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NMRK2,Nicotinamide riboside kinase 2,10205,26,1.21 [0.57-2.56],0.6137223483100813
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,10575,26,1.27 [0.83-1.95],0.2695789455975473
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NOMO1,Nodal modulator 1,12110,33,1.11 [0.30-4.11],0.8761590075800285
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NOP56,Nucleolar protein 56,10255,26,0.96 [0.66-1.39],0.8120316411330766
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NOS1,"Nitric oxide synthase, brain",11813,32,0.77 [0.40-1.49],0.4378418845342029
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NOS2,"Nitric oxide synthase, inducible",10255,26,1.70 [0.83-3.46],0.1435048207861224
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NOS3,"Nitric oxide synthase, endothelial",11813,32,1.32 [0.81-2.16],0.2710065030331242
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NOTCH1,Neurogenic locus notch homolog protein 1,12244,34,0.63 [0.09-4.46],0.644488236193262
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NOTCH2,Neurogenic locus notch homolog protein 2,10614,27,0.14 [0.02-1.01],0.0510317761892227
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NOTCH3,Neurogenic locus notch homolog protein 3,12244,34,0.80 [0.33-1.93],0.6152237494697245
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPC2,NPC intracellular cholesterol transporter 2,10420,27,0.96 [0.31-2.97],0.9374313194559704
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPDC1,Neural proliferation differentiation and control protein 1,12105,34,1.58 [0.69-3.65],0.2812105886669644
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPHS1,Nephrin,10292,27,0.89 [0.29-2.78],0.8438523600996108
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPHS2,Podocin,10292,27,0.93 [0.64-1.36],0.6994118804493337
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPL,N-acetylneuraminate lyase,10597,27,0.92 [0.41-2.07],0.8393534455590257
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPPB,Natriuretic peptides B,11858,34,1.17 [0.92-1.48],0.2043118576480346
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPPC,C-type natriuretic peptide,12073,33,1.43 [0.76-2.67],0.2642656013026151
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPR1,Atrial natriuretic peptide receptor 1,10255,26,1.61 [0.77-3.38],0.2074395777734002
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPTN,Neuroplastin,11821,32,0.83 [0.52-1.33],0.441476845083568
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPTX1,Neuronal pentraxin-1,12110,33,0.55 [0.24-1.24],0.1493404360600111
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPTX2,Neuronal pentraxin-2,10614,27,2.47 [0.83-7.35],0.1034783737908409
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPTXR,Neuronal pentraxin receptor,12105,34,1.00 [0.41-2.44],0.9951496490001835
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPY,Pro-neuropeptide Y,12192,33,1.17 [0.73-1.87],0.5201631982236099
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NRCAM,Neuronal cell adhesion molecule,12105,34,1.11 [0.39-3.16],0.8495741597601587
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NRGN,Neurogranin,10600,28,1.25 [0.84-1.85],0.275926885865781
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NRN1,Neuritin,10575,26,1.03 [0.36-2.97],0.9563520020484676
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NRP1,Neuropilin-1,12178,34,0.43 [0.15-1.28],0.1291604290923472
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NRP2,Neuropilin-2,12110,33,1.05 [0.36-3.06],0.9216767357016816
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NRTN,Neurturin,11854,32,1.00 [0.53-1.86],0.994558700769905
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NRXN3,Neurexin-3,10313,27,1.00 [0.35-2.84],0.9965853483282496
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NSFL1C,NSFL1 cofactor p47,12199,33,0.65 [0.41-1.04],0.074187659402035
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",10597,27,1.04 [0.63-1.72],0.8689214872616903
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NT5C1A,Cytosolic 5'-nucleotidase 1A,10583,26,1.31 [0.46-3.78],0.6127275416016258
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NT5C3A,Cytosolic 5'-nucleotidase 3A,12060,33,0.78 [0.56-1.09],0.149588766179933
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NT5E,5'-nucleotidase,12156,33,1.05 [0.63-1.76],0.8406004413293344
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NTF3,Neurotrophin-3,12073,33,0.79 [0.33-1.88],0.5929511291363418
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NTF4,Neurotrophin-4,11821,32,0.98 [0.43-2.26],0.960970486899144
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NTRK2,BDNF/NT-3 growth factors receptor,12105,34,0.64 [0.19-2.12],0.4683962249161459
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NTRK3,NT-3 growth factor receptor,12199,33,0.79 [0.19-3.21],0.7414994235853919
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NTproBNP,N-terminal prohormone of brain natriuretic peptide,12105,34,1.37 [1.07-1.76],0.0131094350921603
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NUB1,NEDD8 ultimate buster 1,12073,33,0.92 [0.63-1.34],0.6687463055022578
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,10539,27,1.17 [0.84-1.64],0.3529114145257501
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NUCB2,Nucleobindin-2,12171,33,1.19 [0.52-2.70],0.684746013816803
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NUDC,Nuclear migration protein nudC,12214,33,0.91 [0.56-1.48],0.6957012357103772
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,10345,27,0.45 [0.07-2.87],0.3943184646145642
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,10255,26,0.90 [0.40-2.04],0.8085245358236463
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NUDT16,U8 snoRNA-decapping enzyme,10517,26,0.95 [0.61-1.47],0.8123550694302379
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],12045,33,0.76 [0.43-1.35],0.3484849414606846
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NUDT5,ADP-sugar pyrophosphatase,12110,33,0.65 [0.34-1.22],0.1801949016671373
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NUMB,Protein numb homolog,10292,27,1.07 [0.68-1.68],0.78243198527741
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NUP50,Nuclear pore complex protein Nup50,10255,26,0.47 [0.10-2.12],0.3236967135526258
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NXPE4,NXPE family member 4,10255,26,0.60 [0.15-2.35],0.4645760918655345
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NXPH1,Neurexophilin-1,11813,32,1.25 [0.60-2.59],0.5559796282041192
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NXPH3,Neurexophilin-3,10292,27,1.41 [0.41-4.92],0.5863581172884147
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OBP2B,Odorant-binding protein 2b,11986,33,1.32 [0.80-2.20],0.2808043893717433
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OCLN,Occludin,10575,26,1.20 [0.53-2.68],0.6615921643772316
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ODAM,Odontogenic ameloblast-associated protein,11797,32,1.04 [0.62-1.76],0.8712515004008496
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OFD1,Oral-facial-digital syndrome 1 protein,10423,26,1.36 [0.90-2.05],0.1455629652312972
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OGA,Protein O-GlcNAcase,10536,26,0.90 [0.52-1.56],0.7149090044465074
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OGFR,Opioid growth factor receptor,12045,33,0.92 [0.36-2.33],0.8532206892088736
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OGN,Mimecan,12110,33,0.84 [0.40-1.78],0.647269081789503
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,10423,26,1.13 [0.65-1.95],0.6633666229237232
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OLFM4,Olfactomedin-4,9998,23,0.94 [0.68-1.31],0.7079870160953445
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OLR1,Oxidized low-density lipoprotein receptor 1,11997,34,0.56 [0.31-1.02],0.0572662430360245
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OMD,Osteomodulin,12159,32,0.60 [0.32-1.14],0.1189324250713426
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OMG,Oligodendrocyte-myelin glycoprotein,12045,33,1.12 [0.70-1.81],0.6300703954939867
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OMP,Olfactory marker protein,10232,27,0.98 [0.46-2.09],0.9498770755453252
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OPHN1,Oligophrenin-1,10583,26,0.95 [0.67-1.35],0.7686640776530319
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OPLAH,5-oxoprolinase,10345,27,1.15 [0.67-1.98],0.6116033798542855
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OPTC,Opticin,12045,33,1.36 [0.78-2.37],0.2747993355503716
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ORM1,Alpha-1-acid glycoprotein 1,10585,28,1.65 [0.29-9.54],0.5730622131413563
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OSBPL2,Oxysterol-binding protein-related protein 2,10583,26,0.74 [0.24-2.26],0.5912803913085172
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OSCAR,Osteoclast-associated immunoglobulin-like receptor,12122,31,0.63 [0.25-1.58],0.3251809468241752
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OSM,Oncostatin-M,12025,33,0.69 [0.44-1.06],0.0884398882045659
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OSMR,Oncostatin-M-specific receptor subunit beta,12178,34,0.60 [0.13-2.65],0.4983458876745785
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OSTN,Osteocrin,10313,27,0.54 [0.17-1.69],0.2869546568631108
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OTOA,Otoancorin,10232,27,0.76 [0.33-1.75],0.5207314638105227
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OTUD6B,Deubiquitinase OTUD6B,10536,26,0.78 [0.40-1.50],0.4491790835886667
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OTUD7B,OTU domain-containing protein 7B,10575,26,1.10 [0.61-1.99],0.7565807431886213
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",10345,27,1.45 [0.86-2.45],0.1614240898425504
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OXT,Oxytocin-neurophysin 1,12199,33,1.26 [1.01-1.57],0.0414066092281114
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",P4HB,Protein disulfide-isomerase,12057,33,1.10 [0.49-2.46],0.8150035770605153
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PACS2,Phosphofurin acidic cluster sorting protein 2,10255,26,0.97 [0.52-1.82],0.9333939182114824
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PADI2,Protein-arginine deiminase type-2,11854,32,0.92 [0.49-1.72],0.7848676180299127
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PADI4,Protein-arginine deiminase type-4,11797,32,0.57 [0.33-1.00],0.0504034403946891
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PAEP,Glycodelin,12018,33,1.27 [0.90-1.80],0.1680421973765694
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,10575,26,1.05 [0.77-1.43],0.7523371950883287
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",10423,26,0.79 [0.35-1.78],0.5649836156809906
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,11858,34,0.75 [0.42-1.33],0.3219766985486296
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PAGR1,PAXIP1-associated glutamate-rich protein 1,10345,27,0.61 [0.23-1.60],0.3178484008658978
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,10187,26,1.35 [0.69-2.62],0.3812062426730646
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PAK4,Serine/threonine-protein kinase PAK 4,11813,32,0.87 [0.51-1.51],0.6317551872683236
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PALLD,Palladin,10292,27,0.96 [0.37-2.52],0.9395961130892176
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PALM,Paralemmin-1,10475,26,0.99 [0.29-3.37],0.9876612856663916
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PALM2,Paralemmin-2,10583,26,1.52 [0.60-3.86],0.381228514782888
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PALM3,Paralemmin-3,10255,26,1.30 [0.91-1.88],0.1531942741666483
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PAM,Peptidyl-glycine alpha-amidating monooxygenase,12179,34,1.30 [0.42-4.01],0.6476420475685556
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PAMR1,Inactive serine protease PAMR1,12110,33,1.10 [0.35-3.44],0.8643526413535896
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PAPPA,Pappalysin-1,11854,32,0.97 [0.48-1.94],0.92508226649092
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PARD3,Partitioning defective 3 homolog,10423,26,0.92 [0.53-1.60],0.769293911467282
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PARK7,Parkinson disease protein 7,12110,33,0.61 [0.34-1.10],0.102806824709125
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PARP1,Poly [ADP-ribose] polymerase 1,12073,33,0.48 [0.22-1.05],0.0678553744039458
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PAXX,Protein PAXX,10385,26,1.00 [0.43-2.31],0.9941658871189106
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PBK,Lymphokine-activated killer T-cell-originated protein kinase,10205,26,1.30 [0.37-4.56],0.68425237990371
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PBLD,Phenazine biosynthesis-like domain-containing protein,11813,32,1.08 [0.59-1.98],0.8101820558245811
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,10536,26,0.78 [0.20-3.01],0.7200907157323502
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCARE,Photoreceptor cilium actin regulator,10232,27,1.27 [0.93-1.74],0.1275062145749223
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,10371,26,0.96 [0.42-2.17],0.9169880407335032
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCBP2,Poly(rC)-binding protein 2,10575,26,0.92 [0.54-1.57],0.7695452874763632
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCDH1,Protocadherin-1,12175,33,0.70 [0.16-3.16],0.646149014898791
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCDH12,Protocadherin-12,10575,26,0.81 [0.19-3.40],0.77186544376635
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCDH17,Protocadherin-17,12105,34,0.56 [0.23-1.39],0.2122716666971548
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCDH7,Protocadherin-7,10536,26,1.10 [0.42-2.89],0.8442525648729635
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCDH9,Protocadherin-9,10536,26,0.69 [0.24-2.01],0.4971885405024348
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCDHB15,Protocadherin beta-15,10539,27,0.48 [0.18-1.27],0.1395190881590014
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCNA,Proliferating cell nuclear antigen,10205,26,1.23 [0.77-1.95],0.3937704591527941
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCSK7,Proprotein convertase subtilisin/kexin type 7,10539,27,0.97 [0.44-2.16],0.9471833954555294
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCSK9,Proprotein convertase subtilisin/kexin type 9,12244,34,2.80 [1.34-5.84],0.0060012094226686
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCYT2,Ethanolamine-phosphate cytidylyltransferase,10536,26,0.93 [0.57-1.54],0.7909403143647891
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDAP1,28 kDa heat- and acid-stable phosphoprotein,10597,27,1.13 [0.77-1.64],0.5406427632948928
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDCD1,Programmed cell death protein 1,12173,33,0.84 [0.42-1.72],0.6406621884788224
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDCD1LG2,Programmed cell death 1 ligand 2,12045,33,0.83 [0.31-2.22],0.7052721986488351
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDCD5,Programmed cell death protein 5,12199,33,0.66 [0.39-1.14],0.1379285091098544
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDCD6,Programmed cell death protein 6,12105,34,1.31 [0.76-2.26],0.3384773528106876
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDCL2,Phosducin-like protein 2,10205,26,1.14 [0.64-2.04],0.6633405076368996
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",10205,26,0.76 [0.32-1.79],0.531391533175072
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",10255,26,1.06 [0.60-1.90],0.8328280743268175
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",10385,26,1.13 [0.78-1.64],0.5250525331030149
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDGFA,Platelet-derived growth factor subunit A,12244,34,1.30 [0.85-1.98],0.224618963729072
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDGFB,Platelet-derived growth factor subunit B,12159,32,1.14 [0.79-1.64],0.4977935999618404
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDGFC,Platelet-derived growth factor C,11821,32,1.18 [0.43-3.26],0.7532032728448643
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDGFRA,Platelet-derived growth factor receptor alpha,12105,34,0.52 [0.18-1.53],0.2343645464948078
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDGFRB,Platelet-derived growth factor receptor beta,12244,34,0.81 [0.34-1.93],0.632559126687936
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDIA2,Protein disulfide-isomerase A2,10205,26,1.29 [0.64-2.60],0.4710098854166246
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDIA3,Protein disulfide-isomerase A3,10385,26,1.54 [0.38-6.23],0.5436892975090732
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDIA4,Protein disulfide-isomerase A4,10614,27,0.97 [0.52-1.80],0.9279521561977296
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDIA5,Protein disulfide-isomerase A5,10205,26,1.04 [0.56-1.94],0.9064357236585726
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDLIM5,PDZ and LIM domain protein 5,10575,26,1.04 [0.75-1.44],0.8043000299475326
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDLIM7,PDZ and LIM domain protein 7,12159,32,0.95 [0.74-1.22],0.6762368210395655
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",11821,32,0.50 [0.22-1.16],0.1076977639976986
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDRG1,p53 and DNA damage-regulated protein 1,10313,27,0.95 [0.45-1.99],0.8883163915464154
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,10205,26,0.87 [0.40-1.90],0.7360198568911582
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDZD2,PDZ domain-containing protein 2,10255,26,1.49 [0.91-2.44],0.1115916470810704
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,10292,27,1.37 [0.64-2.94],0.4208258084030994
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PEAR1,Platelet endothelial aggregation receptor 1,12244,34,1.74 [0.45-6.68],0.418245650666969
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PEBP1,Phosphatidylethanolamine-binding protein 1,12110,33,0.71 [0.41-1.23],0.2171646169794968
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PECAM1,Platelet endothelial cell adhesion molecule,12110,33,1.64 [0.62-4.38],0.3200812992344908
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PECR,Peroxisomal trans-2-enoyl-CoA reductase,10345,27,0.76 [0.18-3.18],0.7078454738909781
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PENK,Proenkephalin-A,10385,26,0.62 [0.19-2.06],0.4330900424397629
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PEPD,Xaa-Pro dipeptidase,10600,28,2.67 [0.71-9.97],0.1451919950654694
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PER3,Period circadian protein homolog 3,10292,27,1.31 [0.99-1.73],0.0603337487776276
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PF4,Platelet factor 4,10542,28,1.23 [0.86-1.74],0.2545690900263028
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PFDN2,Prefoldin subunit 2,11813,32,0.91 [0.51-1.65],0.7666687548973918
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PFDN4,Prefoldin subunit 4,10205,26,1.38 [0.79-2.39],0.2549449440712666
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PFDN6,Prefoldin subunit 6,10313,27,1.04 [0.61-1.77],0.887942998725782
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",12017,33,0.92 [0.62-1.38],0.6992246718935753
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PGA4,Pepsin A-4,10600,28,0.67 [0.45-1.01],0.0584427562867335
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",10597,27,0.85 [0.43-1.69],0.6400985858920989
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PGF,Placenta growth factor,12214,33,1.58 [0.50-4.97],0.4309275201010608
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PGLYRP1,Peptidoglycan recognition protein 1,12197,34,0.72 [0.34-1.51],0.3869187267753742
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,10487,27,1.53 [0.46-5.14],0.4915081104442879
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PGLYRP4,Peptidoglycan recognition protein 4,10255,26,0.61 [0.27-1.40],0.2457256394449234
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PGM2,Phosphoglucomutase-2,10313,27,0.62 [0.26-1.48],0.2833289768619852
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PGR,Progesterone receptor,10292,27,0.74 [0.40-1.37],0.3391795266306944
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PHACTR2,Phosphatase and actin regulator 2,10575,26,1.01 [0.73-1.41],0.947741473663143
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PHLDB1,Pleckstrin homology-like domain family B member 1,10536,26,0.75 [0.36-1.55],0.4330507905154563
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PHLDB2,Pleckstrin homology-like domain family B member 2,10205,26,1.26 [0.95-1.66],0.106983022410832
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,12018,33,0.97 [0.35-2.72],0.959284312266007
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,10385,26,0.72 [0.29-1.75],0.4650859550976252
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PI16,Peptidase inhibitor 16,10600,28,0.32 [0.08-1.27],0.1048660000533231
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PI3,Elafin,11947,34,1.26 [0.76-2.07],0.3699193040977402
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",10575,26,1.02 [0.63-1.66],0.9321276058970712
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PIGR,Polymeric immunoglobulin receptor,11948,33,1.32 [0.58-2.98],0.5045668325867126
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,12073,33,0.52 [0.30-0.89],0.0164888406747777
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,12110,33,0.88 [0.29-2.72],0.8250270208824688
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,10292,27,1.62 [1.02-2.57],0.0401624406604426
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PILRA,Paired immunoglobulin-like type 2 receptor alpha,12110,33,1.35 [0.65-2.82],0.4173403136468422
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PILRB,Paired immunoglobulin-like type 2 receptor beta,12105,34,1.38 [0.79-2.41],0.252947851344799
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,10385,26,1.53 [0.84-2.77],0.1626986914404823
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PITHD1,PITH domain-containing protein 1,10187,26,1.15 [0.78-1.68],0.4813770001237205
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PKD1,Polycystin-1,10597,27,0.68 [0.16-2.80],0.591109018075795
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PKD2,Polycystin-2,10255,26,1.00 [0.52-1.93],0.9974933131489276
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PKLR,Pyruvate kinase PKLR,12125,31,0.69 [0.41-1.14],0.1443544246151348
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PKN3,Serine/threonine-protein kinase N3,10423,26,0.94 [0.56-1.58],0.8269357723432403
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLA2G10,Group 10 secretory phospholipase A2,12018,33,1.09 [0.65-1.83],0.7372336670483515
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLA2G15,Phospholipase A2 group XV,12156,33,1.61 [0.52-4.97],0.4072874364549415
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLA2G1B,Phospholipase A2,12226,34,0.73 [0.38-1.40],0.342435288266554
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLA2G2A,"Phospholipase A2, membrane associated",12053,34,1.27 [0.83-1.96],0.2723056933964156
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLA2G4A,Cytosolic phospholipase A2,12159,32,0.92 [0.65-1.32],0.6693052823129548
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLA2G7,Platelet-activating factor acetylhydrolase,12110,33,0.94 [0.37-2.40],0.8976480435672276
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLAT,Tissue-type plasminogen activator,12211,34,1.09 [0.60-2.00],0.7785240172067833
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLAU,Urokinase-type plasminogen activator,12110,33,1.17 [0.44-3.10],0.7469419023229414
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLAUR,Urokinase plasminogen activator surface receptor,12026,31,0.56 [0.18-1.81],0.3350363249297887
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLB1,"Phospholipase B1, membrane-associated",10583,26,1.35 [0.70-2.58],0.3676120482147962
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",10292,27,1.51 [0.83-2.73],0.1737085986878421
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",10583,26,1.08 [0.73-1.58],0.7110875735104416
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLEKHO1,Pleckstrin homology domain-containing family O member 1,10583,26,0.96 [0.56-1.67],0.8926999478876401
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLG,Plasminogen,10351,26,1.90 [0.33-11.09],0.4747641345383488
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLIN1,Perilipin-1,11813,32,1.26 [0.55-2.89],0.5870790025095936
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLIN3,Perilipin-3,12105,34,0.90 [0.44-1.84],0.7643911490752837
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLPBP,Pyridoxal phosphate homeostasis protein,12105,34,0.84 [0.53-1.32],0.4429686886605414
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLSCR3,Phospholipid scramblase 3,10563,26,1.05 [0.56-1.97],0.887707147534802
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLTP,Phospholipid transfer protein,12209,34,0.51 [0.23-1.16],0.1070084947581628
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLXDC1,Plexin domain-containing protein 1,11821,32,0.97 [0.36-2.56],0.944424752242385
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLXDC2,Plexin domain-containing protein 2,10583,26,1.27 [0.38-4.27],0.7008944089447818
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLXNA4,Plexin-A4,12073,33,1.04 [0.71-1.51],0.8476267338810719
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLXNB2,Plexin-B2,12186,34,1.96 [0.57-6.72],0.2847595424864254
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLXNB3,Plexin-B3,12070,34,1.11 [0.58-2.10],0.7583607393913139
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,12034,34,1.05 [0.88-1.26],0.5673871321263912
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PMCH,Pro-MCH,10255,26,0.87 [0.51-1.49],0.6125851022882163
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PMM2,Phosphomannomutase 2,10255,26,1.10 [0.59-2.06],0.7558902283296192
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PMS1,PMS1 protein homolog 1,10313,27,0.94 [0.44-2.02],0.8707016234994447
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PMVK,Phosphomevalonate kinase,11791,32,0.97 [0.74-1.29],0.8530016154570813
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PNLIP,Pancreatic triacylglycerol lipase,10600,28,0.92 [0.52-1.63],0.7712455343478068
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PNLIPRP1,Inactive pancreatic lipase-related protein 1,10583,26,1.13 [0.71-1.82],0.600561656119604
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PNLIPRP2,Pancreatic lipase-related protein 2,12102,31,0.97 [0.88-1.08],0.5752617966957074
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PNMA1,Paraneoplastic antigen Ma1,10345,27,0.91 [0.46-1.80],0.7897453258147753
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PNMA2,Paraneoplastic antigen Ma2,10232,27,1.26 [0.59-2.70],0.5571327968072739
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",11854,32,0.74 [0.51-1.07],0.1068472737639555
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PODXL,Podocalyxin,12045,33,5.59 [0.76-41.35],0.0916241768322656
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PODXL2,Podocalyxin-like protein 2,12156,33,1.45 [0.48-4.32],0.5071998472685965
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",POF1B,Protein POF1B,10292,27,1.26 [0.63-2.53],0.5152797136407561
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",POLR2A,DNA-directed RNA polymerase II subunit RPB1,10292,27,2.09 [0.96-4.55],0.0647846849713416
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",12045,33,0.74 [0.26-2.10],0.5781662056688612
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",POMC,Pro-opiomelanocortin,10345,27,0.82 [0.47-1.43],0.4870104622374391
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PON1,Serum paraoxonase/arylesterase 1,10600,28,2.30 [0.52-10.24],0.2736160721973926
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PON2,Serum paraoxonase/arylesterase 2,11858,34,1.71 [0.75-3.94],0.2040764455770598
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PON3,Serum paraoxonase/lactonase 3,12159,32,1.15 [0.37-3.57],0.8063131830863096
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",POSTN,Periostin,10614,27,0.69 [0.25-1.92],0.4828171623520609
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPBP,Platelet basic protein,10550,28,1.37 [0.89-2.11],0.1558678893086593
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPCDC,Phosphopantothenoylcysteine decarboxylase,12199,33,0.61 [0.31-1.22],0.1617102762785095
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPIB,Peptidyl-prolyl cis-trans isomerase B,12123,34,1.03 [0.74-1.43],0.8612650261341014
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPIE,Peptidyl-prolyl cis-trans isomerase E,10423,26,0.90 [0.47-1.72],0.7493939440368339
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",10614,27,1.10 [0.63-1.91],0.746225886603135
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPL,Periplakin,10292,27,0.99 [0.32-3.04],0.9909583207370304
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPM1A,Protein phosphatase 1A,11821,32,0.69 [0.23-2.09],0.516548860293598
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPM1B,Protein phosphatase 1B,10292,27,1.26 [0.78-2.02],0.3478624694214767
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPM1F,Protein phosphatase 1F,10597,27,0.91 [0.45-1.85],0.793915719085188
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPME1,Protein phosphatase methylesterase 1,12045,33,0.69 [0.42-1.13],0.1390399088959661
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,10539,27,1.02 [0.65-1.60],0.9285580529924546
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,12156,33,1.03 [0.75-1.41],0.8735654546821033
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,10423,26,1.29 [0.87-1.93],0.2083715591371295
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,10575,26,1.10 [0.70-1.73],0.6703130018404799
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,10575,26,1.71 [0.86-3.39],0.126447472522009
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPP1R2,Protein phosphatase inhibitor 2,12105,34,0.95 [0.65-1.40],0.8138299297748324
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPP1R9B,Neurabin-2,12214,33,0.85 [0.62-1.19],0.3481941939651833
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,10536,26,0.97 [0.70-1.35],0.8694237799391419
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPP3R1,Calcineurin subunit B type 1,12018,33,1.05 [0.50-2.22],0.8928184262408141
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPT1,Palmitoyl-protein thioesterase 1,10313,27,0.77 [0.40-1.48],0.433431131233455
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPY,Pancreatic prohormone,12111,33,1.11 [0.83-1.49],0.4652469849650604
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PQBP1,Polyglutamine-binding protein 1,11821,32,1.08 [0.64-1.83],0.7714329999579772
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRAME,Melanoma antigen preferentially expressed in tumors,10205,26,0.85 [0.20-3.67],0.8308654589450664
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRAP1,Proline-rich acidic protein 1,10614,27,0.81 [0.34-1.93],0.6348305257798971
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRC1,Protein regulator of cytokinesis 1,10539,27,1.09 [0.55-2.13],0.8111057933074878
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRCP,Lysosomal Pro-X carboxypeptidase,12182,34,0.80 [0.30-2.16],0.666140506615828
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRDX1,Peroxiredoxin-1,11781,32,0.94 [0.64-1.36],0.7281827884159399
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRDX2,Peroxiredoxin-2,10422,27,0.76 [0.42-1.40],0.3821308192286596
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",11854,32,0.85 [0.54-1.33],0.474501270597769
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRDX5,"Peroxiredoxin-5, mitochondrial",12214,33,0.85 [0.55-1.30],0.4457661674733799
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRDX6,Peroxiredoxin-6,12192,33,0.67 [0.39-1.14],0.137889543695143
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PREB,Prolactin regulatory element-binding protein,11854,32,1.59 [0.67-3.75],0.2908948935826236
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRELP,Prolargin,12102,31,1.17 [0.30-4.62],0.8235430357557039
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRG2,Bone marrow proteoglycan,10614,27,0.39 [0.19-0.81],0.0118920301058032
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRG3,Proteoglycan 3,10614,27,0.61 [0.31-1.19],0.1485795684767465
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,11854,32,0.76 [0.40-1.45],0.4108565209521846
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,10313,27,0.90 [0.26-3.11],0.8640799048563614
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,12105,34,1.00 [0.70-1.42],0.9794781655538388
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,10565,26,0.90 [0.57-1.42],0.6478719431577638
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRKCQ,Protein kinase C theta type,11854,32,0.76 [0.34-1.71],0.5077413379558847
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRKD2,Serine/threonine-protein kinase D2,10255,26,0.83 [0.33-2.08],0.6855411629260226
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRKG1,cGMP-dependent protein kinase 1,10385,26,1.09 [0.80-1.47],0.5836943063532934
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,11821,32,0.86 [0.52-1.40],0.5309768993538283
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRL,Prolactin,12199,33,0.92 [0.60-1.41],0.6985412349436064
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRND,Prion-like protein doppel,10583,26,0.66 [0.33-1.33],0.2457215643715269
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PROC,Vitamin K-dependent protein C,12136,34,1.71 [0.50-5.88],0.3958328709540049
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PROCR,Endothelial protein C receptor,10255,26,1.49 [0.77-2.86],0.2325732556151053
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PROK1,Prokineticin-1,12073,33,1.16 [0.70-1.93],0.5603049284723225
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PROS1,Vitamin K-dependent protein S,10621,28,2.73 [0.90-8.32],0.0767825133910906
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRR4,Proline-rich protein 4,10297,26,0.60 [0.33-1.10],0.0980262681413361
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRR5,Proline-rich protein 5,10292,27,1.23 [0.61-2.46],0.5597379638781841
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRRT3,Proline-rich transmembrane protein 3,10345,27,0.88 [0.35-2.24],0.7915237541822648
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRSS2,Trypsin-2,12162,34,1.14 [0.65-1.99],0.6459909640348114
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRSS22,Brain-specific serine protease 4,10292,27,0.83 [0.27-2.54],0.7482005849569406
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRSS27,Serine protease 27,12073,34,0.50 [0.23-1.09],0.0805482240798518
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRSS53,Serine protease 53,10583,26,0.97 [0.35-2.67],0.9585012876027426
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRSS8,Prostasin,12065,32,1.17 [0.57-2.43],0.6645932922422413
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,11813,32,0.95 [0.72-1.25],0.7175827688631531
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRTG,Protogenin,12192,33,0.93 [0.27-3.21],0.913420556554831
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRTN3,Myeloblastin,11793,34,1.09 [0.60-1.99],0.7656196477706745
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRUNE2,Protein prune homolog 2,10423,26,0.27 [0.06-1.27],0.0961306325386055
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSAP,Prosaposin,10503,27,1.02 [0.28-3.76],0.9704776019761732
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSAPL1,Proactivator polypeptide-like 1,10536,26,1.18 [0.57-2.45],0.6532560628224808
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSCA,Prostate stem cell antigen,10536,26,0.88 [0.77-1.00],0.0488014606299203
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSG1,Pregnancy-specific beta-1-glycoprotein 1,12018,33,0.76 [0.62-0.92],0.0060579041824139
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSIP1,PC4 and SFRS1-interacting protein,12073,33,0.62 [0.34-1.14],0.1228906031751713
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSMA1,Proteasome subunit alpha type-1,11821,32,1.39 [0.80-2.44],0.2467427678270716
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSMC3,26S proteasome regulatory subunit 6A,10205,26,1.37 [0.43-4.37],0.5898191076376593
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSMD1,26S proteasome non-ATPase regulatory subunit 1,10575,26,0.70 [0.32-1.58],0.394035822657486
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSMD5,26S proteasome non-ATPase regulatory subunit 5,10313,27,0.55 [0.21-1.39],0.2043171553743868
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSMD9,26S proteasome non-ATPase regulatory subunit 9,12045,33,0.70 [0.38-1.28],0.2444201553357681
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSME1,Proteasome activator complex subunit 1,12000,33,0.41 [0.18-0.95],0.0376307044539717
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSME2,Proteasome activator complex subunit 2,11959,33,0.87 [0.38-2.01],0.7474709529329953
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSMG3,Proteasome assembly chaperone 3,12073,33,0.79 [0.43-1.44],0.4422102441877932
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSMG4,Proteasome assembly chaperone 4,10292,27,0.85 [0.43-1.66],0.6349425698256342
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSPN,Persephin,12073,33,1.23 [0.91-1.68],0.1829714566136125
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSRC1,Proline/serine-rich coiled-coil protein 1,11821,32,0.65 [0.35-1.22],0.1828819158947419
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,10019,25,1.11 [0.76-1.61],0.5988733677140134
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",11813,32,0.63 [0.22-1.77],0.3780173875768936
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTGDS,Prostaglandin-H2 D-isomerase,12011,33,1.12 [0.42-3.01],0.817397866004689
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTGES2,Prostaglandin E synthase 2,10204,26,1.25 [0.63-2.46],0.5221490811148202
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTGR1,Prostaglandin reductase 1,10597,27,1.14 [0.74-1.76],0.5564225474017221
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTH,Parathyroid hormone,10313,27,1.17 [0.76-1.81],0.4807212509150478
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,12073,33,1.26 [0.69-2.30],0.4434731896826679
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTK7,Inactive tyrosine-protein kinase 7,11813,32,0.85 [0.37-1.97],0.701423957341391
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTN,Pleiotrophin,11858,34,1.16 [0.63-2.13],0.635925579413466
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTP4A3,Protein tyrosine phosphatase type IVA 3,10292,27,1.13 [0.59-2.18],0.7054456059551287
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,12018,33,1.11 [0.76-1.64],0.5872764550369367
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,12136,31,0.85 [0.61-1.19],0.345306329497845
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,10274,27,0.85 [0.28-2.57],0.775238070921973
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPRB,Receptor-type tyrosine-protein phosphatase beta,10597,27,1.34 [0.38-4.71],0.6507594539067882
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPRC,Receptor-type tyrosine-protein phosphatase C,10614,27,0.18 [0.03-0.97],0.0463610528742486
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPRF,Receptor-type tyrosine-protein phosphatase F,12244,34,0.89 [0.31-2.52],0.8271405097222568
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPRH,Receptor-type tyrosine-protein phosphatase H,10536,26,0.37 [0.16-0.85],0.018539827865679
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,10536,26,1.09 [0.20-5.92],0.9229133316169216
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPRM,Receptor-type tyrosine-protein phosphatase mu,12060,33,1.23 [0.35-4.32],0.7417285234538861
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,11986,33,1.20 [0.48-3.00],0.6943163212187531
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPRR,Receptor-type tyrosine-protein phosphatase R,10583,26,1.06 [0.39-2.90],0.911943060433828
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPRS,Receptor-type tyrosine-protein phosphatase S,12244,34,0.41 [0.12-1.40],0.1548197491067076
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,10597,27,0.52 [0.17-1.61],0.2573880539292024
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,10385,26,0.94 [0.50-1.75],0.8457254837475106
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTS,6-pyruvoyl tetrahydrobiopterin synthase,11759,32,0.60 [0.32-1.12],0.1082539785846929
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTTG1,Securin,10423,26,1.02 [0.42-2.50],0.9568382321372148
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTX3,Pentraxin-related protein PTX3,12073,33,0.71 [0.40-1.25],0.2320898865328839
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PVALB,Parvalbumin alpha,12121,33,0.99 [0.75-1.30],0.9287401600619628
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PVR,Poliovirus receptor,12199,33,1.73 [0.81-3.70],0.1597877198178144
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PXDNL,Peroxidasin-like protein,10539,27,0.98 [0.51-1.92],0.964046168087196
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PXN,Paxillin,11813,32,0.57 [0.28-1.14],0.1088466885593905
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PYDC1,Pyrin domain-containing protein 1,10345,27,1.93 [1.22-3.06],0.0047435733887806
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PYY,Peptide YY,10255,26,0.94 [0.63-1.39],0.7430013648463858
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PZP,Pregnancy zone protein,10621,28,0.77 [0.42-1.41],0.4022589515968107
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",QDPR,Dihydropteridine reductase,12043,34,0.77 [0.38-1.56],0.4616232483157323
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",QPCT,Glutaminyl-peptide cyclotransferase,12133,34,0.27 [0.09-0.78],0.0153241699130528
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",QSOX1,Sulfhydryl oxidase 1,10413,27,1.26 [0.67-2.35],0.476722109746367
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAB10,Ras-related protein Rab-10,10597,27,1.14 [0.59-2.23],0.6927953688105619
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAB11FIP3,Rab11 family-interacting protein 3,10597,27,0.99 [0.70-1.39],0.9419804167919388
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAB27B,Ras-related protein Rab-27B,10597,27,1.20 [0.75-1.93],0.4455214938449956
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAB2B,Ras-related protein Rab-2B,10539,27,1.34 [0.75-2.38],0.3250593148879158
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAB33A,Ras-related protein Rab-33A,10255,26,0.81 [0.44-1.48],0.493280124397091
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAB37,Ras-related protein Rab-37,11854,32,0.85 [0.55-1.32],0.4759522222720249
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAB39B,Ras-related protein Rab-39B,10255,26,1.23 [0.92-1.64],0.1621767703893828
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,10232,27,1.03 [0.53-1.97],0.9373446862629908
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAB44,Ras-related protein Rab-44,10539,27,0.46 [0.14-1.51],0.2010792338613283
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAB6A,Ras-related protein Rab-6A,12073,33,0.57 [0.30-1.10],0.0929154099712269
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAB6B,Ras-related protein Rab-6B,11813,32,0.69 [0.32-1.45],0.32361425088861
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RABEP1,Rab GTPase-binding effector protein 1,10385,26,1.02 [0.63-1.66],0.9301260230052332
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RABEPK,Rab9 effector protein with kelch motifs,11821,32,0.55 [0.27-1.09],0.0877043387989056
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RABGAP1L,Rab GTPase-activating protein 1-like,11854,32,0.67 [0.38-1.18],0.1661880177780735
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAC3,Ras-related C3 botulinum toxin substrate 3,10313,27,1.22 [0.81-1.83],0.3448434988618799
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAD23B,UV excision repair protein RAD23 homolog B,11821,32,0.60 [0.29-1.24],0.1660506855689797
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAD51,DNA repair protein RAD51 homolog 1,10423,26,0.97 [0.47-2.00],0.936890192770475
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RALB,Ras-related protein Ral-B,10292,27,1.68 [0.54-5.21],0.3724137502247479
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RALY,RNA-binding protein Raly,10539,27,0.55 [0.21-1.48],0.2398168665905923
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RANBP1,Ran-specific GTPase-activating protein,10345,27,0.64 [0.31-1.30],0.2163356830578464
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RANBP2,E3 SUMO-protein ligase RanBP2,10232,27,1.18 [0.42-3.33],0.7586369906178846
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RANGAP1,Ran GTPase-activating protein 1,11821,32,0.61 [0.27-1.37],0.2316299672003944
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAP1A,Ras-related protein Rap-1A,10292,27,1.20 [0.78-1.84],0.4057849305150065
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAPGEF2,Rap guanine nucleotide exchange factor 2,10423,26,0.98 [0.47-2.03],0.9483752421687174
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RARRES1,Retinoic acid receptor responder protein 1,11821,32,0.89 [0.33-2.44],0.8251429769441189
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RARRES2,Retinoic acid receptor responder protein 2,12178,34,1.06 [0.56-2.01],0.8531078143064851
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RASA1,Ras GTPase-activating protein 1,11813,32,1.28 [0.53-3.09],0.5811201147941605
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,10205,26,0.46 [0.26-0.83],0.0095384591359991
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RASSF2,Ras association domain-containing protein 2,11821,32,0.86 [0.47-1.58],0.6265994161585219
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RBFOX3,RNA binding protein fox-1 homolog 3,10575,26,1.14 [0.47-2.75],0.7739323823479163
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RBKS,Ribokinase,11834,33,0.70 [0.42-1.16],0.1669130496046983
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RBM17,Splicing factor 45,10575,26,0.93 [0.57-1.54],0.7919009234863893
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RBM19,Probable RNA-binding protein 19,10255,26,1.17 [0.57-2.38],0.6675551907458626
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RBM25,RNA-binding protein 25,10205,26,0.86 [0.37-2.00],0.7250462742057757
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RBP1,Retinol-binding protein 1,10313,27,1.05 [0.61-1.79],0.871266021584581
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RBP2,Retinol-binding protein 2,12045,33,1.34 [0.91-1.97],0.1391654241578656
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RBP5,Retinol-binding protein 5,12045,33,1.52 [0.94-2.47],0.0885565361591452
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RBP7,Retinoid-binding protein 7,10536,26,0.70 [0.34-1.44],0.3283490814917048
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RBPMS,RNA-binding protein with multiple splicing,10292,27,1.18 [0.75-1.86],0.4735291533564353
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RBPMS2,RNA-binding protein with multiple splicing 2,10345,27,1.12 [0.78-1.60],0.5353953303801442
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RCC1,Regulator of chromosome condensation,10539,27,0.84 [0.38-1.88],0.6714906488251857
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RCOR1,REST corepressor 1,11858,34,1.18 [0.71-1.99],0.5219654534166556
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,10345,27,0.66 [0.11-3.97],0.6518986665517894
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",REEP4,Receptor expression-enhancing protein 4,10575,26,1.05 [0.57-1.92],0.8774413706820821
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",REG1A,Lithostathine-1-alpha,12027,33,1.43 [0.85-2.39],0.1779124590277878
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",REG1B,Lithostathine-1-beta,12244,34,1.27 [0.79-2.03],0.3268871603342254
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",REG3A,Regenerating islet-derived protein 3-alpha,12244,34,1.41 [0.92-2.16],0.1144691971263588
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",REG3G,Regenerating islet-derived protein 3-gamma,10539,27,0.73 [0.28-1.90],0.5160436054922315
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",REG4,Regenerating islet-derived protein 4,12122,31,1.66 [0.94-2.91],0.0787021944416627
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RELB,Transcription factor RelB,10292,27,0.94 [0.44-1.98],0.8654739227581878
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RELT,Tumor necrosis factor receptor superfamily member 19L,12110,33,1.90 [0.72-5.03],0.1952452430560732
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",REN,Renin,12105,34,1.39 [1.00-1.93],0.0494930534992466
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",REPS1,RalBP1-associated Eps domain-containing protein 1,10292,27,1.26 [0.53-3.03],0.6014198608031063
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",REST,RE1-silencing transcription factor,10205,26,1.56 [0.67-3.65],0.3048809409804679
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,12045,33,0.79 [0.37-1.70],0.5491484262833324
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RETN,Resistin,12086,34,0.79 [0.38-1.64],0.5287552607735793
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",REXO2,"Oligoribonuclease, mitochondrial",10255,26,0.93 [0.42-2.06],0.8674406197286344
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RFC4,Replication factor C subunit 4,10539,27,1.39 [0.25-7.61],0.7040743682217476
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RGCC,Regulator of cell cycle RGCC,10575,26,1.13 [0.69-1.87],0.6263150416230046
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,10423,26,0.92 [0.48-1.77],0.8006741160858803
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RGMA,Repulsive guidance molecule A,12199,33,1.71 [0.64-4.58],0.2847895769625355
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RGMB,RGM domain family member B,12199,33,0.69 [0.21-2.23],0.5347923976759121
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RGS10,Regulator of G-protein signaling 10,10575,26,0.94 [0.50-1.77],0.8434979665714714
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RGS8,Regulator of G-protein signaling 8,11854,32,1.15 [0.76-1.75],0.5026193423574581
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RHOC,Rho-related GTP-binding protein RhoC,11944,33,0.92 [0.71-1.19],0.5142023125218578
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RICTOR,Rapamycin-insensitive companion of mTOR,10292,27,1.54 [1.01-2.35],0.0425464525531592
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,10385,26,0.58 [0.25-1.32],0.1939090059311584
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RILP,Rab-interacting lysosomal protein,12145,33,0.64 [0.38-1.08],0.0948756726754346
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RILPL2,RILP-like protein 2,10597,27,1.08 [0.74-1.58],0.6906599052048503
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,10255,26,1.17 [0.74-1.83],0.505300593376734
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RLN1,Prorelaxin H1,10575,26,0.76 [0.26-2.21],0.614213700886962
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RLN2,Prorelaxin H2,10361,26,0.89 [0.40-2.02],0.7895937066055326
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNASE1,Ribonuclease pancreatic,10600,28,0.88 [0.21-3.60],0.8580627161596176
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNASE10,Inactive ribonuclease-like protein 10,10345,27,1.19 [0.60-2.39],0.6147473460821271
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNASE3,Eosinophil cationic protein,12052,34,0.81 [0.60-1.11],0.188399323089336
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNASE4,Ribonuclease 4,10234,27,1.41 [0.40-4.91],0.5922457773714276
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNASE6,Ribonuclease K6,10518,28,0.92 [0.29-2.95],0.8855853442478353
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNASEH2A,Ribonuclease H2 subunit A,10575,26,0.94 [0.41-2.14],0.8833192519669817
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNASET2,Ribonuclease T2,12196,34,2.22 [0.94-5.27],0.070436179427136
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNF149,E3 ubiquitin-protein ligase RNF149,10345,27,0.60 [0.18-1.98],0.3972369439397407
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNF168,E3 ubiquitin-protein ligase RNF168,10292,27,1.26 [0.55-2.89],0.5839234618252764
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNF31,E3 ubiquitin-protein ligase RNF31,10292,27,1.51 [0.69-3.30],0.3046023835207004
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNF4,E3 ubiquitin-protein ligase RNF4,10423,26,1.40 [0.95-2.07],0.0880186382315625
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNF41,E3 ubiquitin-protein ligase NRDP1,11821,32,0.68 [0.41-1.12],0.1284529503646204
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNF43,E3 ubiquitin-protein ligase RNF43,10423,26,1.04 [0.55-1.95],0.90764053874164
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNF5,E3 ubiquitin-protein ligase RNF5,10345,27,1.03 [0.61-1.73],0.9088350989594188
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ROBO1,Roundabout homolog 1,12122,31,0.96 [0.26-3.52],0.9543585448253122
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ROBO2,Roundabout homolog 2,12199,33,0.56 [0.15-2.08],0.3861785644034382
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ROBO4,Roundabout homolog 4,10345,27,1.13 [0.14-8.88],0.908128564130604
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,12105,34,0.63 [0.25-1.63],0.3444428976576803
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RP2,Protein XRP2,12045,33,0.53 [0.24-1.19],0.1247457458135328
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RPA2,Replication protein A 32 kDa subunit,10292,27,1.89 [0.85-4.20],0.1191517421449914
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RPE,Ribulose-phosphate 3-epimerase,10423,26,0.92 [0.52-1.62],0.7771751423976557
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RPGR,X-linked retinitis pigmentosa GTPase regulator,10313,27,0.51 [0.18-1.47],0.2141085080227037
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RPL14,60S ribosomal protein L14,10345,27,0.77 [0.27-2.19],0.6254034682294073
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RPS10,40S ribosomal protein S10,10255,26,1.26 [0.58-2.72],0.5583205448621803
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RRAS,Ras-related protein R-Ras,10313,27,1.06 [0.80-1.40],0.6929753901537901
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RRM2,Ribonucleoside-diphosphate reductase subunit M2,11821,32,0.79 [0.39-1.59],0.5111052913826288
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,11821,32,0.73 [0.45-1.19],0.2048271171194178
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RRP15,RRP15-like protein,10232,27,1.08 [0.73-1.59],0.6998169141544928
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RSPO1,R-spondin-1,12018,33,1.07 [0.44-2.61],0.8800585411166278
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RSPO3,R-spondin-3,12192,33,1.72 [0.66-4.48],0.2674764156472797
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RTBDN,Retbindin,12045,33,2.20 [0.86-5.63],0.1010773379147893
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RTKN2,Rhotekin-2,10255,26,1.44 [0.92-2.27],0.1119491129501904
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",10575,26,0.95 [0.63-1.43],0.7905634948362597
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RTN4R,Reticulon-4 receptor,12192,33,1.33 [0.57-3.10],0.514300576304899
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RUVBL1,RuvB-like 1,11821,32,0.88 [0.64-1.22],0.445437696982271
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RWDD1,RWD domain-containing protein 1,12199,33,0.76 [0.47-1.23],0.2588714014404657
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RYR1,Ryanodine receptor 1,10255,26,1.20 [0.49-2.94],0.6978318063953014
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",S100A11,Protein S100-A11,12013,33,0.81 [0.39-1.70],0.5813903066557518
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",S100A12,Protein S100-A12,11929,33,1.03 [0.69-1.54],0.8954982382425194
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",S100A13,Protein S100-A13,10292,27,0.78 [0.26-2.32],0.6574875645189544
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",S100A14,Protein S100-A14,10575,26,1.10 [0.57-2.14],0.7798556409827584
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",S100A16,Protein S100-A16,11797,32,0.89 [0.52-1.53],0.6811378388693221
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",S100A3,Protein S100-A3,10539,27,0.93 [0.39-2.23],0.8779498565412742
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",S100A4,Protein S100-A4,12156,33,0.65 [0.39-1.09],0.1041275717757897
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",S100G,Protein S100-G,10575,26,1.06 [0.47-2.39],0.88048509476907
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",S100P,Protein S100-P,11858,34,1.15 [0.69-1.90],0.5941039936849509
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SAA4,Serum amyloid A-4 protein,10621,28,1.37 [0.66-2.84],0.4020847011730781
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SAFB2,Scaffold attachment factor B2,10575,26,0.86 [0.20-3.62],0.8360745625272125
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SAG,S-arrestin,10232,27,1.28 [0.70-2.34],0.4304041061000638
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SAMD9L,Sterile alpha motif domain-containing protein 9-like,12073,33,0.83 [0.53-1.30],0.4163334089638096
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SAP18,Histone deacetylase complex subunit SAP18,10423,26,0.84 [0.46-1.51],0.5545925271965111
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SARG,Specifically androgen-regulated gene protein,10548,27,1.04 [0.74-1.46],0.8211742860393495
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SART1,U4/U6.U5 tri-snRNP-associated protein 1,10255,26,0.42 [0.09-1.86],0.2512739484830747
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SAT1,Diamine acetyltransferase 1,10255,26,0.89 [0.39-2.00],0.7705564473853708
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SAT2,Thialysine N-epsilon-acetyltransferase,10423,26,0.87 [0.48-1.60],0.6598324697174147
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SATB1,DNA-binding protein SATB1,10575,26,0.23 [0.04-1.35],0.1028431820632747
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SBSN,Suprabasin,10594,27,1.00 [0.34-2.99],0.9959520503597524
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCAMP3,Secretory carrier-associated membrane protein 3,12045,33,0.89 [0.62-1.29],0.550560825890706
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCARA5,Scavenger receptor class A member 5,12199,33,1.25 [0.44-3.53],0.6724682074571549
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCARB1,Scavenger receptor class B member 1,11813,32,0.79 [0.41-1.51],0.4778556626005291
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCARB2,Lysosome membrane protein 2,11803,32,1.53 [0.64-3.69],0.3395153046444479
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCARF1,Scavenger receptor class F member 1,12244,34,1.08 [0.53-2.21],0.8343794477373374
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCARF2,Scavenger receptor class F member 2,12199,33,0.96 [0.34-2.70],0.9457173481283112
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCG2,Secretogranin-2,12124,33,1.81 [0.73-4.46],0.1971980644521793
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCG3,Secretogranin-3,12122,31,0.95 [0.38-2.38],0.9076901023997406
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCGB1A1,Uteroglobin,12109,32,1.12 [0.65-1.91],0.6868084585732357
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCGB2A2,Mammaglobin-A,10255,26,0.82 [0.22-3.09],0.764128043798342
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCGB3A1,Secretoglobin family 3A member 1,10385,26,0.98 [0.24-3.98],0.9808352953453656
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCGB3A2,Secretoglobin family 3A member 2,12136,31,0.92 [0.63-1.35],0.6774497305573786
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCGN,Secretagogin,11854,32,0.73 [0.35-1.50],0.3872588915774001
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCIN,Adseverin,10232,27,1.17 [0.74-1.86],0.4985953486127705
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCLY,Selenocysteine lyase,12145,33,1.28 [0.70-2.33],0.4188065212462447
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCN2A,Sodium channel protein type 2 subunit alpha,10232,27,0.95 [0.42-2.14],0.8980398794404337
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCN2B,Sodium channel subunit beta-2,10313,27,0.16 [0.04-0.74],0.0182507658831292
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCN3A,Sodium channel protein type 3 subunit alpha,10313,27,1.09 [0.41-2.95],0.8587248267160523
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCN3B,Sodium channel subunit beta-3,10232,27,1.18 [0.59-2.36],0.6322422510168265
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCN4B,Sodium channel subunit beta-4,10345,27,0.63 [0.26-1.52],0.3066656447687209
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCP2,Non-specific lipid-transfer protein,11821,32,0.69 [0.40-1.20],0.1880893512775838
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCPEP1,Retinoid-inducible serine carboxypeptidase,10299,27,0.80 [0.36-1.77],0.5803567881187959
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCRG1,Scrapie-responsive protein 1,10597,27,0.46 [0.12-1.77],0.2584281351514357
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCRIB,Protein scribble homolog,10345,27,0.82 [0.51-1.31],0.3991768138064953
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCRN1,Secernin-1,12073,33,0.66 [0.36-1.21],0.1791342563369072
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCT,Secretin,10313,27,1.09 [0.51-2.34],0.816758246202814
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SDC1,Syndecan-1,12105,34,0.73 [0.33-1.64],0.4503518659516345
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SDC4,Syndecan-4,12105,34,1.14 [0.59-2.22],0.7008081281821474
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SDCCAG8,Serologically defined colon cancer antigen 8,10539,27,0.99 [0.71-1.37],0.9404685247829362
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SDHB,Succinate dehydrogenase,10536,26,1.31 [0.83-2.08],0.2490849914301864
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SDK2,Protein sidekick-2,10385,26,0.65 [0.23-1.86],0.4252900225461385
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEC31A,Protein transport protein Sec31A,10345,27,1.09 [0.67-1.77],0.7241452539578315
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEL1L,Protein sel-1 homolog 1,10345,27,1.74 [0.99-3.07],0.0552765828299326
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SELE,E-selectin,12244,34,1.07 [0.59-1.94],0.8180659925957722
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SELENOP,Selenoprotein P,10621,28,1.49 [0.34-6.49],0.5987557403915318
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SELL,L-selectin,10621,28,0.41 [0.09-1.78],0.2347575638957982
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SELP,P-selectin,12162,34,1.15 [0.68-1.94],0.59867205913541
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SELPLG,P-selectin glycoprotein ligand 1,12073,33,1.70 [0.52-5.56],0.3807226774391123
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEMA3F,Semaphorin-3F,12105,34,1.10 [0.35-3.47],0.8737565342732476
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEMA3G,Semaphorin-3G,10385,26,0.89 [0.37-2.12],0.7851574192419117
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEMA4C,Semaphorin-4C,12045,33,0.68 [0.19-2.36],0.5381476400580978
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEMA4D,Semaphorin-4D,12199,33,1.03 [0.37-2.89],0.9497684951488066
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEMA6C,Semaphorin-6C,10292,27,1.30 [0.33-5.18],0.7057358736102708
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEMA7A,Semaphorin-7A,12211,34,0.71 [0.23-2.22],0.5532020076515092
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEPTIN3,Neuronal-specific septin-3,10575,26,0.95 [0.56-1.61],0.8431600462271681
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEPTIN7,Septin-7,10423,26,0.80 [0.35-1.87],0.6128294447473521
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEPTIN8,Septin-8,10569,26,1.04 [0.33-3.28],0.9404911098835924
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEPTIN9,Septin-9,12045,33,0.88 [0.29-2.67],0.819053062538171
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINA1,Alpha-1-antitrypsin,10409,27,,
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINA11,Serpin A11,12244,34,1.22 [0.58-2.57],0.6086540980737383
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINA12,Serpin A12,11727,32,1.26 [1.01-1.58],0.0372060166369525
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINA3,Alpha-1-antichymotrypsin,10568,28,2.96 [0.34-25.63],0.324505637620002
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINA4,Kallistatin,10426,27,4.10 [1.01-16.74],0.0491651565985734
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINA5,Plasma serine protease inhibitor,10467,27,0.46 [0.13-1.70],0.2474477983396265
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINA6,Corticosteroid-binding globulin,10621,28,9.87 [1.38-70.75],0.0227583259944883
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINA7,Thyroxine-binding globulin,10621,28,0.24 [0.04-1.61],0.1419876549588127
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINA9,Serpin A9,11983,33,1.19 [0.79-1.79],0.4094194767175756
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINB1,Leukocyte elastase inhibitor,12069,33,0.83 [0.58-1.18],0.2986712343552119
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINB5,Serpin B5,11858,34,1.38 [0.74-2.57],0.3116048517217055
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINB6,Serpin B6,12163,33,0.81 [0.48-1.39],0.4464023172821112
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINB8,Serpin B8,12214,33,0.69 [0.37-1.28],0.2363035374365469
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINB9,Serpin B9,12018,33,0.92 [0.36-2.36],0.8685803244922985
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINC1,Antithrombin-III,10600,28,4.97 [0.51-48.71],0.1685857777010654
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPIND1,Heparin cofactor 2,10600,28,2.08 [0.56-7.72],0.2748099472299296
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINE1,Plasminogen activator inhibitor 1,12244,34,1.21 [0.76-1.92],0.4134035307214637
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINE2,Glia-derived nexin,10597,27,1.21 [0.70-2.09],0.4876112463354412
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINF1,Pigment epithelium-derived factor,10459,27,1.04 [0.27-4.10],0.9517794645173592
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINF2,Alpha-2-antiplasmin,10421,27,2.27 [0.17-30.96],0.5391332366268893
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPING1,Plasma protease C1 inhibitor,10600,28,8.59 [1.38-53.49],0.0211364894127217
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINH1,Serpin H1,10423,26,0.90 [0.67-1.21],0.4924951125487522
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINI1,Neuroserpin,10369,26,0.19 [0.05-0.69],0.0115174529846826
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINI2,Serpin I2,10536,26,1.01 [0.52-1.99],0.9658100304637226
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,11813,32,1.01 [0.62-1.64],0.9747190180996524
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SETMAR,Histone-lysine N-methyltransferase SETMAR,11981,33,0.84 [0.29-2.46],0.7565316723400906
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEZ6,Seizure protein 6 homolog,10313,27,0.20 [0.06-0.71],0.0127935450485653
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEZ6L,Seizure 6-like protein,12156,33,1.46 [0.49-4.34],0.493921392485332
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEZ6L2,Seizure 6-like protein 2,12045,33,0.63 [0.16-2.49],0.5082780073257072
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SF3B4,Splicing factor 3B subunit 4,12045,33,0.71 [0.46-1.10],0.1217474895549213
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SFRP1,Secreted frizzled-related protein 1,11992,33,1.00 [0.49-2.04],0.9908585486293868
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SFRP4,Secreted frizzled-related protein 4,10385,26,0.34 [0.15-0.81],0.0144705980512785
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SFTPA1,Pulmonary surfactant-associated protein A1,11821,32,0.99 [0.58-1.69],0.9683631765472714
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SFTPA2,Pulmonary surfactant-associated protein A2,11821,32,0.76 [0.41-1.41],0.3851020933473764
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SFTPD,Pulmonary surfactant-associated protein D,12105,34,1.06 [0.68-1.66],0.8014107288147552
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SGSH,N-sulphoglucosamine sulphohydrolase,10390,27,1.26 [0.68-2.31],0.4600075429612539
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SH2B3,SH2B adapter protein 3,11821,32,0.89 [0.64-1.23],0.4772714623899904
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SH2D1A,SH2 domain-containing protein 1A,12073,33,0.86 [0.47-1.59],0.6338343215861157
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,10232,27,1.01 [0.55-1.88],0.9720704038533082
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SH3BP1,SH3 domain-binding protein 1,10536,26,1.06 [0.49-2.29],0.8735675019036718
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SH3GL3,Endophilin-A3,10370,26,1.21 [0.78-1.88],0.4027006777802039
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SH3GLB2,Endophilin-B2,10583,26,0.73 [0.41-1.30],0.2868345067869384
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SHBG,Sex hormone-binding globulin,10600,28,0.91 [0.47-1.77],0.7846062217391849
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SHC1,SHC-transforming protein 1,10205,26,nan [nan-nan],
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SHD,SH2 domain-containing adapter protein D,10227,26,0.68 [0.36-1.31],0.2490296214842476
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SHH,Sonic hedgehog protein,10292,27,1.24 [0.62-2.49],0.5354173505744082
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SHISA5,Protein shisa-5,10614,27,1.03 [0.27-3.88],0.969754581020184
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SHMT1,"Serine hydroxymethyltransferase, cytosolic",12136,31,0.87 [0.60-1.25],0.4418186507342858
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SHPK,Sedoheptulokinase,10423,26,0.57 [0.18-1.80],0.3365397250429808
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIAE,Sialate O-acetylesterase,12137,33,0.76 [0.39-1.49],0.4266291767537231
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIGLEC1,Sialoadhesin,12159,32,1.57 [0.79-3.14],0.198888925685737
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIGLEC10,Sialic acid-binding Ig-like lectin 10,12073,33,0.67 [0.27-1.71],0.4049131425556186
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIGLEC15,Sialic acid-binding Ig-like lectin 15,11813,32,1.20 [0.88-1.65],0.2494930885896633
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIGLEC5,Sialic acid-binding Ig-like lectin 5,12110,33,0.87 [0.70-1.07],0.1904294074592258
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIGLEC6,Sialic acid-binding Ig-like lectin 6,12192,33,0.46 [0.19-1.13],0.0917626201322373
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIGLEC7,Sialic acid-binding Ig-like lectin 7,12105,34,0.90 [0.29-2.75],0.853618477990854
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIGLEC8,Sialic acid-binding Ig-like lectin 8,10345,27,0.98 [0.43-2.24],0.9694890766521992
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIGLEC9,Sialic acid-binding Ig-like lectin 9,12171,33,0.80 [0.28-2.27],0.6778445763118295
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIL1,Nucleotide exchange factor SIL1,10345,27,0.45 [0.08-2.46],0.3581514980274988
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,12137,34,1.15 [0.66-1.98],0.6216099109987618
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIRPB1,Signal-regulatory protein beta-1,12091,31,0.84 [0.42-1.68],0.6205699342753009
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIRT1,NAD-dependent protein deacetylase sirtuin-1,10292,27,1.13 [0.75-1.69],0.5690950460980093
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIRT2,NAD-dependent protein deacetylase sirtuin-2,12045,33,0.86 [0.61-1.22],0.4085519118686183
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",11813,32,0.84 [0.44-1.61],0.6053415232434494
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIT1,Signaling threshold-regulating transmembrane adapter 1,11854,32,0.67 [0.38-1.19],0.172450259307244
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SKAP1,Src kinase-associated phosphoprotein 1,11997,33,0.75 [0.49-1.15],0.1887206671568212
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SKAP2,Src kinase-associated phosphoprotein 2,12159,32,1.00 [0.75-1.35],0.979785665130978
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SKIV2L,Helicase SKI2W,10255,26,1.27 [0.55-2.96],0.5780079294435677
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLA2,Src-like-adapter 2,10575,26,0.94 [0.66-1.36],0.7574145205118887
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLAMF1,Signaling lymphocytic activation molecule,11854,32,1.11 [0.65-1.90],0.6966712777652561
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLAMF6,SLAM family member 6,11821,32,0.72 [0.31-1.70],0.4573556823298879
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLAMF7,SLAM family member 7,12073,33,1.09 [0.65-1.83],0.7536246028969691
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLAMF8,SLAM family member 8,11821,32,1.02 [0.57-1.82],0.9494110575021528
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC12A2,Solute carrier family 12 member 2,10255,26,0.70 [0.15-3.23],0.6437404737408051
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC13A1,Solute carrier family 13 member 1,10539,27,0.92 [0.47-1.80],0.8091225538367597
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC16A1,Monocarboxylate transporter 1,11813,32,0.80 [0.44-1.47],0.4745066118132318
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC1A4,Neutral amino acid transporter A,10313,27,0.45 [0.16-1.21],0.1141168276078766
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC27A4,Long-chain fatty acid transport protein 4,11813,32,0.96 [0.57-1.61],0.8782887821935226
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC28A1,Sodium/nucleoside cotransporter 1,10205,26,nan [nan-nan],
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC34A3,Sodium-dependent phosphate transport protein 2C,10205,26,1.16 [0.60-2.24],0.6682220890705632
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC39A14,Zinc transporter ZIP14,11813,32,1.29 [0.55-3.01],0.5546445928595036
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC39A5,Zinc transporter ZIP5,12073,33,1.31 [0.86-1.98],0.2028501109669371
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC44A4,Choline transporter-like protein 4,10313,27,0.85 [0.45-1.58],0.6010252572499253
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC4A1,Band 3 anion transport protein,10614,27,0.67 [0.30-1.50],0.3303887730742038
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC51B,Organic solute transporter subunit beta,10255,26,1.52 [1.06-2.18],0.021699077098694
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,10385,26,1.12 [0.72-1.75],0.622544928102796
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,10536,26,1.16 [0.61-2.22],0.6493190722069272
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",10205,26,0.78 [0.37-1.68],0.5299519776630479
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLIT2,Slit homolog 2 protein,11813,32,0.79 [0.41-1.54],0.4970046939982299
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLITRK1,SLIT and NTRK-like protein 1,10292,27,0.76 [0.24-2.44],0.64058751082148
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLITRK2,SLIT and NTRK-like protein 2,12192,33,0.65 [0.29-1.42],0.2777299772514355
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLITRK6,SLIT and NTRK-like protein 6,11858,34,0.75 [0.31-1.82],0.5279420650806728
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLK,STE20-like serine/threonine-protein kinase,10423,26,0.83 [0.46-1.50],0.5419091542738622
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLMAP,Sarcolemmal membrane-associated protein,10536,26,1.10 [0.70-1.72],0.6830085672063386
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLURP1,Secreted Ly-6/uPAR-related protein 1,10533,27,0.99 [0.37-2.67],0.9842809159271352
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMAD1,Mothers against decapentaplegic homolog 1,11821,32,0.86 [0.57-1.27],0.4414353606744751
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMAD2,Mothers against decapentaplegic homolog 2,10539,27,0.95 [0.55-1.64],0.8473327271700102
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMAD3,Mothers against decapentaplegic homolog 3,10539,27,0.94 [0.45-1.95],0.8706718577140878
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMAD5,Mothers against decapentaplegic homolog 5,12045,33,0.34 [0.09-1.29],0.1130938053670862
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMARCA2,Probable global transcription activator SNF2L2,11813,32,0.58 [0.35-0.97],0.0372949135943954
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMC3,Structural maintenance of chromosomes protein 3,10205,26,1.27 [0.76-2.11],0.356954127192603
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMNDC1,Survival of motor neuron-related-splicing factor 30,10536,26,0.45 [0.20-1.06],0.0666466001951657
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMOC1,SPARC-related modular calcium-binding protein 1,12192,33,0.97 [0.39-2.42],0.9537282800040344
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMOC2,SPARC-related modular calcium-binding protein 2,12159,32,0.98 [0.43-2.25],0.9666540574902904
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMPD1,Sphingomyelin phosphodiesterase,12141,33,1.33 [0.72-2.45],0.3668284493234548
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMPD3,Sphingomyelin phosphodiesterase 3,10292,27,1.16 [0.62-2.16],0.6354876406327199
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,12148,32,0.98 [0.60-1.59],0.9247841907681796
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,10539,27,1.08 [0.70-1.67],0.7285227958878084
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMS,Spermine synthase,10232,27,0.97 [0.53-1.77],0.9207961136510407
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMTN,Smoothelin,10571,26,1.21 [0.84-1.75],0.297262698176592
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNAP23,Synaptosomal-associated protein 23,12105,34,1.05 [0.74-1.51],0.7720242626060412
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNAP25,Synaptosomal-associated protein 25,10232,27,1.19 [0.54-2.60],0.6631395032074193
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNAP29,Synaptosomal-associated protein 29,12156,33,0.92 [0.66-1.29],0.622631173318984
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNAPIN,SNARE-associated protein Snapin,10575,26,0.94 [0.48-1.82],0.8515279124004473
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNCA,Alpha-synuclein,10385,26,1.14 [0.82-1.59],0.4460311960360171
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNCG,Gamma-synuclein,12018,33,1.34 [0.85-2.12],0.2116854594169187
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",10345,27,0.52 [0.15-1.72],0.2821211550187716
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNRPB2,U2 small nuclear ribonucleoprotein B'',10583,26,0.64 [0.20-2.09],0.4591460706102468
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNU13,NHP2-like protein 1,10255,26,0.76 [0.36-1.62],0.4810504335834095
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNX15,Sorting nexin-15,10385,26,1.13 [0.56-2.25],0.7348380219507167
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNX18,Sorting nexin-18,10536,26,0.52 [0.18-1.52],0.2309826345149606
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNX2,Sorting nexin-2,10539,27,1.45 [0.98-2.12],0.0597547996466026
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNX5,Sorting nexin-5,10345,27,1.01 [0.29-3.49],0.9926136808067942
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNX9,Sorting nexin-9,12105,34,0.96 [0.61-1.50],0.8494122918492666
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SOD1,Superoxide dismutase [Cu-Zn],11886,32,0.71 [0.37-1.40],0.3259245688655844
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SOD2,"Superoxide dismutase [Mn], mitochondrial",12110,33,1.26 [0.59-2.69],0.5527265163745281
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SOD3,Extracellular superoxide dismutase,10600,28,0.75 [0.32-1.75],0.5009157010570484
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SORBS1,Sorbin and SH3 domain-containing protein 1,10575,26,0.49 [0.14-1.76],0.2774934791776285
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SORCS2,VPS10 domain-containing receptor SorCS2,11821,32,1.26 [0.55-2.88],0.5830494577776757
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SORD,Sorbitol dehydrogenase,12132,33,0.95 [0.60-1.49],0.8159707347595716
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SORT1,Sortilin,12082,34,1.75 [0.79-3.87],0.1666290053666607
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SOST,Sclerostin,12082,34,1.37 [0.64-2.95],0.4207194138991488
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,10313,27,0.35 [0.12-1.05],0.0621538590637585
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SOX2,Transcription factor SOX-2,10553,26,0.47 [0.09-2.52],0.3804767623201963
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SOX9,Transcription factor SOX-9,10313,27,0.73 [0.19-2.80],0.6506768069049229
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,10575,26,1.63 [0.58-4.58],0.3584098152908639
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPAG1,Sperm-associated antigen 1,10575,26,0.86 [0.42-1.76],0.6735727487307068
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPARC,SPARC,12156,33,0.96 [0.63-1.48],0.8674372537966086
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPARCL1,SPARC-like protein 1,12122,34,1.07 [0.36-3.12],0.906557708810842
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPART,Spartin,10385,26,1.12 [0.68-1.82],0.6583731173621727
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPESP1,Sperm equatorial segment protein 1,10597,27,1.11 [0.32-3.85],0.8746985462337047
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPINK1,Serine protease inhibitor Kazal-type 1,12110,33,1.48 [0.81-2.69],0.2038356947147085
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPINK2,Serine protease inhibitor Kazal-type 2,10385,26,0.57 [0.22-1.50],0.2528893665714379
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPINK4,Serine protease inhibitor Kazal-type 4,12073,33,1.32 [0.87-2.00],0.1936643135121335
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPINK5,Serine protease inhibitor Kazal-type 5,12110,33,0.72 [0.27-1.88],0.4997831841328006
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPINK6,Serine protease inhibitor Kazal-type 6,12192,33,1.23 [0.68-2.20],0.4945677411917536
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPINK8,Serine protease inhibitor Kazal-type 8,10255,26,1.08 [0.42-2.77],0.8758860973197814
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPINT1,Kunitz-type protease inhibitor 1,12080,33,0.67 [0.19-2.30],0.523887510303333
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPINT2,Kunitz-type protease inhibitor 2,12159,32,1.21 [0.57-2.55],0.6170698195441706
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPINT3,Kunitz-type protease inhibitor 3,10536,26,1.20 [0.87-1.65],0.260799864103712
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPOCK1,Testican-1,12018,33,1.54 [0.46-5.12],0.4805320810000917
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPON1,Spondin-1,12122,31,0.97 [0.37-2.52],0.9512716980116968
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPON2,Spondin-2,12047,34,0.91 [0.38-2.15],0.8269968636684114
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPP1,Osteopontin,12230,34,0.74 [0.41-1.35],0.331266157065017
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",10292,27,1.81 [0.93-3.51],0.0804087846564773
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPRING1,SREBP regulating gene protein,10205,26,1.20 [0.69-2.06],0.5207116084919471
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPRR1B,Cornifin-B,10423,26,1.30 [0.93-1.81],0.1270840629344398
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPRR3,Small proline-rich protein 3,10583,26,0.58 [0.34-0.99],0.046733131595511
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPRY2,Protein sprouty homolog 2,11854,32,0.91 [0.64-1.29],0.5848384067559482
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",10232,27,0.70 [0.20-2.50],0.5843698842166846
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPTLC1,Serine palmitoyltransferase 1,10583,26,1.10 [0.43-2.81],0.8440204166165255
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SRC,Proto-oncogene tyrosine-protein kinase Src,12133,33,0.87 [0.68-1.12],0.2822852597809419
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SRP14,Signal recognition particle 14 kDa protein,12045,33,0.83 [0.49-1.42],0.5009590989887749
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SRPK2,SRSF protein kinase 2,12073,33,0.77 [0.51-1.17],0.2238368591974798
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SRPX,Sushi repeat-containing protein SRPX,10597,27,0.28 [0.10-0.83],0.0210965483558067
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SSB,Lupus La protein,11813,32,0.67 [0.33-1.33],0.2493854382021573
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",10292,27,1.82 [1.02-3.22],0.041408272053777
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,12082,34,0.88 [0.65-1.19],0.4108082746572766
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,12162,34,1.24 [0.60-2.55],0.560048990820538
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SSH3,Protein phosphatase Slingshot homolog 3,10205,26,0.59 [0.14-2.51],0.4788343394992379
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SSNA1,Sjoegren syndrome nuclear autoantigen 1,10536,26,0.51 [0.23-1.12],0.0922630990983752
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ST13,Hsc70-interacting protein,10385,26,0.76 [0.39-1.47],0.4110616974530475
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",12045,33,1.24 [0.62-2.50],0.5444024023276834
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",12244,34,1.44 [0.52-3.95],0.4791375323606882
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",10292,27,0.58 [0.18-1.89],0.3691981835396902
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STAB2,Stabilin-2,10614,27,1.16 [0.32-4.20],0.8227169305468092
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STAM,Signal transducing adapter molecule 1,10539,27,1.93 [0.99-3.77],0.0536607442665666
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STAMBP,STAM-binding protein,11997,33,0.79 [0.48-1.28],0.3378360185672882
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STAT2,Signal transducer and activator of transcription 2,10292,27,1.21 [0.75-1.96],0.4296862070084905
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STAT5B,Signal transducer and activator of transcription 5B,12045,33,0.92 [0.74-1.16],0.4897332674571563
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,10205,26,0.96 [0.52-1.75],0.8832829762315255
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STC1,Stanniocalcin-1,12199,33,0.62 [0.29-1.36],0.2344115772012195
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STC2,Stanniocalcin-2,12095,33,2.07 [0.62-6.99],0.2392005204111742
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STEAP4,Metalloreductase STEAP4,10232,27,1.33 [0.95-1.85],0.0943021646985147
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STIP1,Stress-induced-phosphoprotein 1,12095,33,0.66 [0.40-1.07],0.0915880734425683
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STK11,Serine/threonine-protein kinase STK11,11858,34,0.78 [0.51-1.19],0.2546271531030368
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STK24,Serine/threonine-protein kinase 24,11813,32,0.98 [0.59-1.63],0.9326852087836498
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STK4,Serine/threonine-protein kinase 4,12105,34,0.93 [0.66-1.33],0.7068099816766522
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STOML2,"Stomatin-like protein 2, mitochondrial",10205,26,0.91 [0.57-1.44],0.6754827672180042
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STX16,Syntaxin-16,11821,32,0.67 [0.35-1.26],0.2129166054160134
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STX1B,Syntaxin-1B,10313,27,1.13 [0.49-2.59],0.7760549089795331
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STX3,Syntaxin-3,10583,26,1.57 [0.79-3.14],0.2021791187141181
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STX4,Syntaxin-4,12045,33,0.78 [0.43-1.43],0.4220309453974599
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STX5,Syntaxin-5,10292,27,1.18 [0.53-2.62],0.6926048954989386
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STX6,Syntaxin-6,11821,32,0.77 [0.44-1.34],0.3471573612545519
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STX7,Syntaxin-7,10292,27,0.96 [0.45-2.03],0.9117223726711126
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STX8,Syntaxin-8,12073,33,0.72 [0.37-1.43],0.3524402922735633
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STXBP1,Syntaxin-binding protein 1,10575,26,0.99 [0.60-1.61],0.9561867636428246
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STXBP3,Syntaxin-binding protein 3,11821,32,0.44 [0.18-1.07],0.0689964406265874
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SUGP1,SURP and G-patch domain-containing protein 1,10536,26,0.65 [0.23-1.83],0.4179374740856255
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SUGT1,Protein SGT1 homolog,11821,32,0.76 [0.52-1.12],0.1634007523038793
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SULT1A1,Sulfotransferase 1A1,12199,33,0.91 [0.72-1.15],0.4524074807246788
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SULT2A1,Bile salt sulfotransferase,12073,33,0.82 [0.44-1.51],0.5179196195916942
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SUMF1,Formylglycine-generating enzyme,10292,27,1.03 [0.59-1.80],0.910108711507994
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,12199,33,1.12 [0.61-2.05],0.7105199591082263
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SUOX,"Sulfite oxidase, mitochondrial",10575,26,1.17 [0.67-2.05],0.5805902416284817
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SUSD1,Sushi domain-containing protein 1,11858,34,0.97 [0.52-1.82],0.9281567726227256
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SUSD2,Sushi domain-containing protein 2,12110,33,1.42 [0.56-3.56],0.4580001169483323
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SUSD4,Sushi domain-containing protein 4,10539,27,0.80 [0.33-1.97],0.6299192244546751
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SUSD5,Sushi domain-containing protein 5,10319,26,0.41 [0.15-1.17],0.0965642928796094
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SV2A,Synaptic vesicle glycoprotein 2A,10313,27,1.06 [0.60-1.88],0.8358995844379253
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SWAP70,Switch-associated protein 70,10536,26,0.31 [0.08-1.13],0.0768641374598634
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SYAP1,Synapse-associated protein 1,10385,26,1.40 [0.75-2.62],0.2955566401539391
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,10232,27,1.47 [0.98-2.18],0.0604491116004958
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SYT1,Synaptotagmin-1,10583,26,1.51 [0.82-2.78],0.1817513867666694
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SYTL4,Synaptotagmin-like protein 4,10597,27,1.15 [0.71-1.85],0.5646975383791748
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,10423,26,1.08 [0.75-1.54],0.682940271913681
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TACC3,Transforming acidic coiled-coil-containing protein 3,12045,33,0.96 [0.74-1.25],0.7543378450678822
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TACSTD2,Tumor-associated calcium signal transducer 2,10714,31,2.14 [1.18-3.88],0.0125720789082645
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TADA3,Transcriptional adapter 3,10539,27,1.01 [0.39-2.61],0.9881053204778054
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TAFA5,Chemokine-like protein TAFA-5,12045,33,1.38 [0.62-3.06],0.4254334619169375
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TAGLN3,Transgelin-3,10205,26,0.93 [0.50-1.73],0.8233375319028665
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TALDO1,Transaldolase,10561,27,0.67 [0.28-1.60],0.3652528865917768
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TANK,TRAF family member-associated NF-kappa-B activator,11854,32,0.85 [0.53-1.36],0.4936267451487107
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TAP1,Antigen peptide transporter 1,10423,26,0.52 [0.21-1.28],0.1559570726748744
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TARBP2,RISC-loading complex subunit TARBP2,11813,32,0.90 [0.60-1.35],0.5978300326119744
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",10313,27,1.11 [0.73-1.69],0.6180598744290967
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",10539,27,1.51 [0.68-3.37],0.3153387271886513
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TAX1BP1,Tax1-binding protein 1,10583,26,1.05 [0.58-1.89],0.8695739166780014
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TBC1D17,TBC1 domain family member 17,11813,32,0.59 [0.26-1.32],0.200495964150509
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TBC1D23,TBC1 domain family member 23,12045,33,0.92 [0.65-1.30],0.628632213634396
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TBC1D5,TBC1 domain family member 5,12073,33,0.97 [0.65-1.43],0.8621671376736628
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TBCA,Tubulin-specific chaperone A,10385,26,1.06 [0.69-1.65],0.7823075671574563
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TBCB,Tubulin-folding cofactor B,12018,33,0.94 [0.69-1.27],0.669787785230827
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TBCC,Tubulin-specific chaperone C,12018,33,0.89 [0.61-1.30],0.5428254045666872
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TBL1X,F-box-like/WD repeat-containing protein TBL1X,11821,32,0.91 [0.62-1.31],0.6018781002815299
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TBR1,T-box brain protein 1,10313,27,0.84 [0.33-2.12],0.7086285184856347
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TCL1A,T-cell leukemia/lymphoma protein 1A,12001,33,0.80 [0.58-1.10],0.168070680029592
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TCL1B,T-cell leukemia/lymphoma protein 1B,11858,34,0.82 [0.50-1.33],0.4176816083576556
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TCN1,Transcobalamin-1,10370,28,0.45 [0.15-1.35],0.1559105703473426
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TCN2,Transcobalamin-2,12230,34,1.59 [0.64-3.93],0.3166139712971778
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TCOF1,Treacle protein,10597,27,0.35 [0.09-1.30],0.1169600543306856
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TCP11,T-complex protein 11 homolog,10423,26,0.51 [0.18-1.45],0.2081590465570233
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TCTN3,Tectonic-3,10597,27,1.76 [0.51-6.09],0.3755666132331364
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TDGF1,Teratocarcinoma-derived growth factor 1,11813,32,0.90 [0.72-1.13],0.3803692729035638
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TDO2,"Tryptophan 2,3-dioxygenase",10313,27,1.29 [0.59-2.85],0.5211137896568481
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TDP1,Tyrosyl-DNA phosphodiesterase 1,10539,27,1.03 [0.60-1.77],0.9145157298702924
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TDRKH,Tudor and KH domain-containing protein,11813,32,0.89 [0.60-1.32],0.550404515690185
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TEF,Thyrotroph embryonic factor,10255,26,1.08 [0.47-2.49],0.8493369048138875
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TEK,Angiopoietin-1 receptor,12156,33,1.09 [0.26-4.60],0.9077301171823912
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TERF1,Telomeric repeat-binding factor 1,10292,27,1.86 [0.77-4.52],0.1690478502136411
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TET2,Methylcytosine dioxygenase TET2,10394,26,1.02 [0.71-1.47],0.8993897187555028
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TEX101,Testis-expressed protein 101,10313,27,1.03 [0.41-2.60],0.9501160604378877
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TEX33,Testis-expressed protein 33,10423,26,0.46 [0.12-1.69],0.2404851690519783
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TF,Serotransferrin,10621,28,1.96 [0.37-10.29],0.4276884125406163
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TFAP2A,Transcription factor AP-2-alpha,10232,27,0.99 [0.51-1.90],0.9676237044608416
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TFF1,Trefoil factor 1,12047,33,1.11 [0.78-1.58],0.5458364718134536
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TFF2,Trefoil factor 2,12136,31,1.00 [0.59-1.71],0.9990855091132658
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TFF3,Trefoil factor 3,12096,34,1.65 [1.05-2.59],0.0284908579795435
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TFPI,Tissue factor pathway inhibitor,12080,34,1.72 [0.69-4.26],0.2411154953520686
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TFPI2,Tissue factor pathway inhibitor 2,12122,33,1.25 [0.62-2.52],0.5417541770251301
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TFRC,Transferrin receptor protein 1,12159,34,0.51 [0.22-1.18],0.1161604473155302
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TG,Thyroglobulin,10539,27,1.12 [0.85-1.48],0.427666595221675
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TGFA,Protransforming growth factor alpha,12073,33,0.79 [0.41-1.54],0.4864595766740368
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TGFB1,Transforming growth factor beta-1 proprotein,12198,33,1.02 [0.46-2.29],0.9604708926070046
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TGFB2,Transforming growth factor beta-2 proprotein,10539,27,1.31 [0.72-2.39],0.3741400330962154
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TGFBI,Transforming growth factor-beta-induced protein ig-h3,12036,33,1.61 [0.53-4.88],0.396886240425025
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TGFBR1,TGF-beta receptor type-1,10292,27,1.44 [0.33-6.37],0.6287314116834823
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TGFBR2,TGF-beta receptor type-2,12156,33,0.86 [0.33-2.24],0.7630828360270026
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TGFBR3,Transforming growth factor beta receptor type 3,12244,34,1.44 [0.56-3.68],0.4480519686045449
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TGM2,Protein-glutamine gamma-glutamyltransferase 2,12089,34,0.71 [0.48-1.04],0.077892086945616
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TGOLN2,Trans-Golgi network integral membrane protein 2,10600,28,0.30 [0.09-1.01],0.0517766081122655
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",THAP12,52 kDa repressor of the inhibitor of the protein kinase,10187,26,1.00 [0.65-1.52],0.9950329055214988
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",THBD,Thrombomodulin,12105,34,0.55 [0.18-1.68],0.2957327164705503
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",THBS2,Thrombospondin-2,12110,33,1.19 [0.54-2.63],0.6635629386168846
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",THBS4,Thrombospondin-4,12113,34,0.93 [0.48-1.83],0.8381052085239685
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",THOP1,Thimet oligopeptidase,12032,34,0.79 [0.29-2.18],0.6540135271043126
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",THPO,Thrombopoietin,11858,34,2.03 [0.97-4.25],0.0602844251774136
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",THRAP3,Thyroid hormone receptor-associated protein 3,10255,26,1.09 [0.81-1.46],0.5707502592770857
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",THSD1,Thrombospondin type-1 domain-containing protein 1,10205,27,1.59 [0.60-4.21],0.3513611381785431
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",THTPA,Thiamine-triphosphatase,10526,27,1.18 [0.77-1.79],0.4503186209306108
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",THY1,Thy-1 membrane glycoprotein,12199,33,0.70 [0.24-2.06],0.5166508602522628
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TIA1,Nucleolysin TIA-1 isoform p40,11716,34,0.94 [0.73-1.21],0.6293089595784206
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TIE1,Tyrosine-protein kinase receptor Tie-1,12244,34,0.58 [0.33-1.02],0.0590372075258057
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",11792,32,1.02 [0.53-1.99],0.94760967958278
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,10423,26,2.21 [1.19-4.11],0.0121890123029344
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,12162,34,1.14 [0.59-2.23],0.69411338760321
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,10597,27,1.22 [0.51-2.91],0.655415026171967
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,10583,26,0.97 [0.62-1.51],0.8954874423168531
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TIMP1,Metalloproteinase inhibitor 1,11986,34,1.17 [0.42-3.26],0.7705820963058592
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TIMP2,Metalloproteinase inhibitor 2,10597,27,0.81 [0.15-4.25],0.8015343497476297
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TIMP3,Metalloproteinase inhibitor 3,12159,32,1.15 [0.93-1.44],0.2032271244825273
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TIMP4,Metalloproteinase inhibitor 4,12110,33,1.62 [0.87-3.01],0.1301548790141611
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TINAGL1,Tubulointerstitial nephritis antigen-like,12062,34,1.67 [0.44-6.41],0.4516306435454618
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TJAP1,Tight junction-associated protein 1,12156,33,0.83 [0.57-1.21],0.3356118254627294
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TJP3,Tight junction protein ZO-3,10232,27,0.77 [0.28-2.06],0.5970983168507462
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TK1,"Thymidine kinase, cytosolic",10423,26,1.62 [0.94-2.77],0.0802953392739673
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TLR1,Toll-like receptor 1,10292,27,1.09 [0.27-4.36],0.9071940694807616
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TLR2,Toll-like receptor 2,10423,26,1.59 [0.32-7.99],0.5753225177536134
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TLR3,Toll-like receptor 3,12214,33,0.76 [0.47-1.24],0.2752472170102403
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TLR4,Toll-like receptor 4,10292,27,1.73 [0.58-5.13],0.3227252011680376
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,10313,27,0.88 [0.43-1.79],0.7203679759044647
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMED1,Transmembrane emp24 domain-containing protein 1,10423,26,0.34 [0.15-0.76],0.0087958483755097
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMED10,Transmembrane emp24 domain-containing protein 10,10255,26,0.79 [0.29-2.18],0.6549778469135072
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMED4,Transmembrane emp24 domain-containing protein 4,10255,26,1.00 [0.51-1.98],0.998206648857168
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMED8,Protein TMED8,10536,26,0.89 [0.61-1.28],0.5172419050837009
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMEM106A,Transmembrane protein 106A,10539,27,0.95 [0.56-1.62],0.8485112206211363
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMEM132A,Transmembrane protein 132A,10345,27,0.99 [0.54-1.79],0.96380272791627
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMEM25,Transmembrane protein 25,10575,26,0.79 [0.32-1.96],0.6099873545643582
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMOD4,Tropomodulin-4,10205,26,0.70 [0.26-1.85],0.4681445396194255
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMPRSS11B,Transmembrane protease serine 11B,10232,27,0.55 [0.27-1.11],0.0969835659372494
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMPRSS11D,Transmembrane protease serine 11D,10569,26,0.57 [0.21-1.51],0.2580715040689808
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMPRSS15,Enteropeptidase,12045,33,0.99 [0.71-1.39],0.95316953917954
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMPRSS5,Transmembrane protease serine 5,11967,33,0.68 [0.31-1.51],0.3467129889627625
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMSB10,Thymosin beta-10,12110,33,0.90 [0.59-1.37],0.619184503615935
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNC,Tenascin,12162,34,0.72 [0.38-1.36],0.3051670693391645
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNF,Tumor necrosis factor,11835,33,1.27 [0.69-2.35],0.446126414959818
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,10536,26,0.54 [0.22-1.33],0.1813409434410348
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,11854,32,0.34 [0.14-0.84],0.0191509173474059
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,10385,26,1.32 [0.75-2.32],0.3432101409916329
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,12018,33,1.47 [0.61-3.55],0.3870690261886468
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,12018,33,1.21 [0.67-2.17],0.5273699861917585
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,12135,33,0.88 [0.49-1.59],0.6684471380837732
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,12214,33,1.21 [0.58-2.54],0.6162630975613556
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,12102,31,1.06 [0.36-3.12],0.9223386117938106
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,12156,33,1.90 [0.88-4.09],0.100061999525539
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,12122,31,0.92 [0.35-2.38],0.856254997350259
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,11854,32,0.71 [0.33-1.50],0.3668472654593064
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,12122,31,0.75 [0.26-2.18],0.6008204173060279
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,10385,26,0.51 [0.21-1.23],0.1340631157941736
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,12192,33,1.34 [0.56-3.25],0.5108257713988855
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,12110,33,0.89 [0.32-2.49],0.8268869459838863
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,12110,33,0.81 [0.34-1.95],0.63585725482817
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,12199,33,0.72 [0.23-2.23],0.5664251437190564
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,12198,33,0.79 [0.36-1.76],0.5663535397236246
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,12018,33,1.08 [0.64-1.82],0.7646572957869235
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,12199,33,0.72 [0.35-1.45],0.3551847834374851
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,12018,33,0.76 [0.35-1.65],0.4831520518879548
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFSF10,Tumor necrosis factor ligand superfamily member 10,12214,33,1.07 [0.32-3.57],0.908074204994832
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFSF11,Tumor necrosis factor ligand superfamily member 11,12073,33,0.74 [0.45-1.24],0.2557954307215958
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFSF12,Tumor necrosis factor ligand superfamily member 12,12214,33,1.23 [0.42-3.57],0.7028007861067374
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFSF13,Tumor necrosis factor ligand superfamily member 13,12159,32,1.50 [0.47-4.79],0.4892889455249724
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,12228,34,0.50 [0.16-1.57],0.2377665188952656
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFSF14,Tumor necrosis factor ligand superfamily member 14,12018,33,0.76 [0.44-1.32],0.3231286518150362
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFSF8,Tumor necrosis factor ligand superfamily member 8,10614,27,1.04 [0.37-2.91],0.9398824386158504
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNIP1,TNFAIP3-interacting protein 1,10583,26,0.93 [0.60-1.43],0.7302922801771077
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNN,Tenascin-N,10614,27,0.50 [0.21-1.17],0.1114323952108012
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNNI3,"Troponin I, cardiac muscle",11858,34,0.95 [0.67-1.35],0.7881848710629159
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNPO1,Transportin-1,10423,26,0.88 [0.29-2.63],0.8185110947490829
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNR,Tenascin-R,12018,33,0.63 [0.31-1.30],0.2164233942250552
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNXB,Tenascin-X,12110,33,1.88 [0.55-6.34],0.3117293689316952
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,10597,27,1.19 [0.76-1.85],0.4486340929262309
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TOP1,DNA topoisomerase 1,10536,26,0.97 [0.67-1.40],0.8730469987967445
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TOP1MT,"DNA topoisomerase I, mitochondrial",10205,26,0.84 [0.37-1.93],0.68616484888642
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TOP2B,DNA topoisomerase 2-beta,10292,27,1.08 [0.68-1.71],0.7499458516264628
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TOR1AIP1,Torsin-1A-interacting protein 1,10345,27,0.90 [0.43-1.91],0.7911840850166427
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TP53,Cellular tumor antigen p53,11821,32,0.95 [0.45-2.03],0.9030080652102772
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TP53BP1,TP53-binding protein 1,10292,27,1.13 [0.74-1.70],0.5768984860522122
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TP53I3,Quinone oxidoreductase PIG3,10165,26,0.93 [0.45-1.91],0.8385929919264514
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TP53INP1,Tumor protein p53-inducible nuclear protein 1,11858,34,1.48 [0.82-2.68],0.1936979157132128
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TP73,Tumor protein p73,10313,27,0.80 [0.27-2.37],0.6841237522637825
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPBGL,Trophoblast glycoprotein-like,10313,27,1.42 [0.69-2.93],0.3478927781059802
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPD52L2,Tumor protein D54,10385,26,1.15 [0.80-1.65],0.443131740706666
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPK1,Thiamin pyrophosphokinase 1,10597,27,0.54 [0.14-2.09],0.371491457152741
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPM3,Tropomyosin alpha-3 chain,10255,26,0.73 [0.26-2.07],0.555113891614075
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPMT,Thiopurine S-methyltransferase,11821,32,0.63 [0.39-1.01],0.0538819134305846
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPP1,Tripeptidyl-peptidase 1,12016,31,0.99 [0.48-2.04],0.9870541320156504
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPPP2,Tubulin polymerization-promoting protein family member 2,10423,26,0.98 [0.62-1.56],0.9354639301873636
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPPP3,Tubulin polymerization-promoting protein family member 3,11813,32,0.63 [0.24-1.63],0.338586974076948
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPR,Nucleoprotein TPR,10255,26,0.16 [0.05-0.53],0.0028020972259028
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPRKB,EKC/KEOPS complex subunit TPRKB,10205,26,1.15 [0.67-1.96],0.6131847921844964
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPSAB1,Tryptase alpha/beta-1,12197,32,1.08 [0.59-1.97],0.8055700992114693
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPSD1,Tryptase delta,10575,26,0.20 [0.05-0.76],0.0181259784156979
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPSG1,Tryptase gamma,10292,27,1.92 [0.66-5.58],0.2311953680040546
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPT1,Translationally-controlled tumor protein,11854,32,0.52 [0.27-1.03],0.0622624053279889
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRAF2,TNF receptor-associated factor 2,12073,33,0.64 [0.40-1.02],0.0609805037735756
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRAF3,"TNF receptor-associated factor 3, Isoform 2",10292,27,0.39 [0.11-1.41],0.1510862423898228
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,10255,26,0.48 [0.16-1.48],0.2008723772247043
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,10423,26,1.19 [0.82-1.72],0.3523141022312355
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TREH,Trehalase,10614,27,1.46 [0.87-2.45],0.1511002291721716
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TREM2,Triggering receptor expressed on myeloid cells 2,12102,31,1.06 [0.57-1.94],0.861821325700954
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TREML1,Trem-like transcript 1 protein,10600,28,1.41 [0.74-2.69],0.297317757935864
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TREML2,Trem-like transcript 2 protein,12110,33,0.62 [0.25-1.55],0.3093098740984754
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRIAP1,TP53-regulated inhibitor of apoptosis 1,12192,33,0.91 [0.55-1.50],0.7091618424141737
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRIM21,E3 ubiquitin-protein ligase TRIM21,12073,33,0.77 [0.56-1.06],0.108521826655865
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRIM24,Transcription intermediary factor 1-alpha,10403,26,1.67 [1.11-2.50],0.0133118131845186
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,10536,26,0.93 [0.66-1.33],0.700364089688368
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRIM26,Tripartite motif-containing protein 26,10205,26,1.26 [0.73-2.19],0.4058175073914545
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRIM40,E3 ubiquitin ligase TRIM40,10313,27,0.72 [0.42-1.25],0.2412373504196873
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRIM5,Tripartite motif-containing protein 5,12073,33,0.89 [0.62-1.29],0.5426050403946476
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRIM58,E3 ubiquitin-protein ligase TRIM58,10539,27,0.91 [0.59-1.39],0.6664648803511901
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRPV3,Transient receptor potential cation channel subfamily V member 3,10255,26,1.69 [1.06-2.69],0.0267664082392459
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TSC1,Hamartin,10292,27,0.99 [0.57-1.72],0.9663554310465508
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TSC22D1,TSC22 domain family protein 1,10575,26,1.28 [0.82-1.97],0.274569893223698
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TSHB,Thyrotropin subunit beta,12105,34,1.17 [0.84-1.63],0.3409192030128086
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TSLP,Thymic stromal lymphopoietin,11858,34,1.08 [0.68-1.72],0.7394521626844439
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TSNAX,Translin-associated protein X,10255,26,0.55 [0.20-1.49],0.2379978219092114
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TSPAN1,Tetraspanin-1,11858,34,1.37 [0.51-3.66],0.5283603417840383
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TSPAN15,Tetraspanin-15,10255,26,0.64 [0.25-1.65],0.360639817419217
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TSPAN7,Tetraspanin-7,10232,27,1.18 [0.82-1.68],0.3759991755084347
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TSPAN8,Tetraspanin-8,10536,26,1.16 [0.82-1.64],0.3932865902312814
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TSPYL1,Testis-specific Y-encoded-like protein 1,10292,27,1.40 [0.61-3.19],0.429054235170469
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TST,Thiosulfate sulfurtransferase,11786,32,0.91 [0.59-1.39],0.6533595664428341
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TTF2,Transcription termination factor 2,10313,27,0.92 [0.42-2.02],0.8318318717749762
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TTN,Titin,10255,26,1.33 [0.85-2.09],0.2129142910472136
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TTR,Transthyretin,10503,28,6.27 [1.52-25.82],0.0110147490284039
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TUBB3,Tubulin beta-3 chain,10232,27,1.10 [0.30-4.10],0.8841543005582412
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TWF2,Twinfilin-2,10614,27,1.01 [0.65-1.58],0.9492107824279774
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TXK,Tyrosine-protein kinase TXK,10423,26,0.88 [0.50-1.53],0.6432166005613209
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TXLNA,Alpha-taxilin,12018,33,0.93 [0.66-1.33],0.7062860187019806
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TXN,Thioredoxin,10428,28,0.59 [0.23-1.51],0.2682180229074817
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TXNDC15,Thioredoxin domain-containing protein 15,12156,33,0.66 [0.21-2.11],0.484666459672656
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TXNDC5,Thioredoxin domain-containing protein 5,12199,33,0.87 [0.55-1.40],0.5773360844740812
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TXNDC9,Thioredoxin domain-containing protein 9,10583,26,1.13 [0.57-2.22],0.7257236017833448
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TXNL1,Thioredoxin-like protein 1,10210,27,1.11 [0.78-1.58],0.5593985876319169
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",12110,33,0.65 [0.32-1.33],0.2396014604394309
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TYMP,Thymidine phosphorylase,12018,33,0.99 [0.62-1.59],0.9750550715357924
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TYRO3,Tyrosine-protein kinase receptor TYRO3,12105,34,0.78 [0.27-2.27],0.6456615682831286
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",10292,27,2.08 [1.12-3.88],0.0209894879830528
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UBAC1,Ubiquitin-associated domain-containing protein 1,12045,33,0.60 [0.25-1.42],0.2435620816595363
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UBE2B,Ubiquitin-conjugating enzyme E2 B,10539,27,1.62 [0.55-4.82],0.3817858001431479
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,10597,27,1.02 [0.55-1.87],0.9613557419275937
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,10292,27,1.24 [0.71-2.16],0.446328921803732
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UBQLN3,Ubiquilin-3,10255,26,0.91 [0.38-2.16],0.8224486094391289
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UBXN1,UBX domain-containing protein 1,10385,26,1.05 [0.60-1.82],0.8716829459280029
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,10536,26,0.99 [0.76-1.30],0.9545063913880906
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UGDH,UDP-glucose 6-dehydrogenase,10255,26,1.10 [0.77-1.56],0.6025520542199807
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UHRF2,E3 ubiquitin-protein ligase UHRF2,10255,26,0.66 [0.18-2.40],0.5298619306724457
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ULBP2,UL16-binding protein 2,12018,33,0.70 [0.31-1.61],0.4005735566187058
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UMOD,Uromodulin,12212,34,0.71 [0.43-1.18],0.1835503056184373
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UNC5D,Netrin receptor UNC5D,10292,27,1.48 [0.42-5.18],0.5399184245018126
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UNC79,Protein unc-79 homolog,10205,26,0.97 [0.49-1.92],0.9341419242693862
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UNG,Uracil-DNA glycosylase,10539,27,0.52 [0.16-1.69],0.2802410755878134
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UPB1,Beta-ureidopropionase,10597,27,1.06 [0.72-1.58],0.756346577966813
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UPK3A,Uroplakin-3a,10232,27,0.35 [0.15-0.83],0.0174018344635924
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UPK3BL1,Uroplakin-3b-like protein 1,10400,26,0.54 [0.19-1.56],0.254869773039599
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UROD,Uroporphyrinogen decarboxylase,10385,26,0.95 [0.55-1.62],0.8395249296517604
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UROS,Uroporphyrinogen-III synthase,10313,27,0.84 [0.46-1.51],0.5516520708118824
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",USO1,General vesicular transport factor p115,12045,33,0.84 [0.60-1.18],0.3088681995702076
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",USP25,Ubiquitin carboxyl-terminal hydrolase 25,10539,27,1.01 [0.60-1.70],0.9638689860371248
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",USP28,Ubiquitin carboxyl-terminal hydrolase 28,10583,26,0.76 [0.23-2.50],0.6463977108766217
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",USP47,Ubiquitin carboxyl-terminal hydrolase 47,10255,26,1.21 [0.86-1.71],0.2684212295476652
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",USP8,Ubiquitin carboxyl-terminal hydrolase 8,11858,34,0.96 [0.69-1.32],0.7986124505829788
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UXS1,UDP-glucuronic acid decarboxylase 1,11821,32,1.31 [0.81-2.13],0.276206821262246
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VAMP5,Vesicle-associated membrane protein 5,11858,34,1.21 [0.78-1.89],0.3914578163134701
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VAMP8,Vesicle-associated membrane protein 8,10292,27,1.12 [0.74-1.69],0.6011730540381592
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VASH1,Tubulinyl-Tyr carboxypeptidase 1,12073,33,0.90 [0.61-1.31],0.572465295708608
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VASN,Vasorin,11926,33,0.84 [0.26-2.67],0.7656204932285056
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VASP,Vasodilator-stimulated phosphoprotein,10600,28,1.13 [0.69-1.85],0.6200820721471083
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,12045,33,0.54 [0.11-2.62],0.4441517804012792
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VAV3,Guanine nucleotide exchange factor VAV3,10232,27,1.00 [0.69-1.46],0.9842578158145252
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VCAM1,Vascular cell adhesion protein 1,12136,34,0.42 [0.13-1.39],0.1568367884455838
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VCAN,Versican core protein,12199,33,1.21 [0.44-3.30],0.7164336117065904
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VCPKMT,Protein-lysine methyltransferase METTL21D,10205,26,1.22 [0.87-1.72],0.2547466688427192
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VEGFA,Vascular endothelial growth factor A,12174,32,0.90 [0.53-1.54],0.7101522222550858
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VEGFB,Vascular endothelial growth factor B,10292,27,1.41 [0.39-5.08],0.5972051494920284
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VEGFC,Vascular endothelial growth factor C,12156,33,1.20 [0.69-2.06],0.517679912514855
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VEGFD,Vascular endothelial growth factor D,12191,32,0.79 [0.32-1.95],0.6029460343348771
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VGF,Neurosecretory protein VGF,10575,26,1.42 [0.45-4.51],0.5485950267659554
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VIM,Vimentin,11858,34,1.15 [0.87-1.52],0.3370749530001728
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VIPR1,Vasoactive intestinal polypeptide receptor 1,10345,27,0.58 [0.11-2.98],0.5132227930036397
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VIT,Vitrin,10597,27,0.84 [0.31-2.27],0.7354681528028519
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VMO1,Vitelline membrane outer layer protein 1 homolog,12045,33,1.75 [1.07-2.87],0.0261567918161084
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VNN1,Pantetheinase,10600,28,1.29 [0.77-2.19],0.3352165078541951
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VNN2,Vascular non-inflammatory molecule 2,12045,33,0.69 [0.37-1.28],0.2395223123949648
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VPS28,Vacuolar protein sorting-associated protein 28 homolog,10423,26,1.26 [0.74-2.13],0.3927259251857997
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VPS37A,Vacuolar protein sorting-associated protein 37A,12045,33,1.11 [0.75-1.62],0.6053959256526404
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VPS4B,Vacuolar protein sorting-associated protein 4B,10539,27,1.02 [0.69-1.50],0.92819938434115
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VPS53,Vacuolar protein sorting-associated protein 53 homolog,12045,33,0.75 [0.49-1.15],0.1874781026944394
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VSIG10,V-set and immunoglobulin domain-containing protein 10,10539,27,0.48 [0.14-1.72],0.2614873676423282
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,10255,26,0.33 [0.09-1.22],0.0956629857047306
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VSIG2,V-set and immunoglobulin domain-containing protein 2,10539,27,0.80 [0.43-1.50],0.4845157869466322
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VSIG4,V-set and immunoglobulin domain-containing protein 4,12095,33,2.02 [1.07-3.80],0.0306527152134076
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,12084,34,1.19 [0.75-1.89],0.4659083882008563
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VSNL1,Visinin-like protein 1,10583,26,1.54 [0.63-3.75],0.3457266987864291
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VSTM1,V-set and transmembrane domain-containing protein 1,11813,32,1.17 [0.62-2.20],0.6258239191379823
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VSTM2B,V-set and transmembrane domain-containing protein 2B,10423,26,1.41 [0.70-2.85],0.3412013765244284
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,11858,34,0.68 [0.37-1.24],0.2068049564157964
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,12199,33,0.95 [0.62-1.45],0.8100394079553552
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VTCN1,V-set domain-containing T-cell activation inhibitor 1,11821,32,1.88 [0.82-4.30],0.1352849411512883
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,10385,26,1.12 [0.60-2.12],0.716733531767666
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VWA1,von Willebrand factor A domain-containing protein 1,12166,33,1.81 [0.90-3.64],0.0938762122305051
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VWA5A,von Willebrand factor A domain-containing protein 5A,10205,26,1.23 [0.86-1.77],0.2486793535689879
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VWC2,Brorin,11982,33,0.95 [0.44-2.03],0.8916872351566864
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VWC2L,von Willebrand factor C domain-containing protein 2-like,10575,26,0.67 [0.23-1.99],0.470374282504431
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VWF,von Willebrand factor,12244,34,0.70 [0.46-1.07],0.0977734050605718
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WARS,"Tryptophan--tRNA ligase, cytoplasmic",12110,33,0.64 [0.29-1.45],0.2864094448487799
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WAS,Wiskott-Aldrich syndrome protein,11854,32,0.85 [0.53-1.38],0.5139978208512439
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WASF1,Wiskott-Aldrich syndrome protein family member 1,11858,34,1.02 [0.73-1.42],0.9112579995689029
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WASF3,Wiskott-Aldrich syndrome protein family member 3,11813,32,1.17 [0.81-1.71],0.4081006577142826
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WASHC3,WASH complex subunit 3,10583,26,0.96 [0.58-1.60],0.87201278738791
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WASL,Neural Wiskott-Aldrich syndrome protein,10292,27,1.22 [0.74-1.98],0.4344283800300001
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WDR46,WD repeat-containing protein 46,10539,27,0.53 [0.16-1.78],0.3048432139279716
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WFDC1,WAP four-disulfide core domain protein 1,10318,27,1.24 [0.80-1.91],0.3420499374068501
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WFDC12,WAP four-disulfide core domain protein 12,12178,33,1.25 [0.79-1.96],0.3413503214820896
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WFDC2,WAP four-disulfide core domain protein 2,11498,33,1.09 [0.53-2.25],0.8073925136882445
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",11981,33,0.82 [0.39-1.72],0.602002448714341
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",12122,31,0.68 [0.27-1.69],0.4036862677376414
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WIF1,Wnt inhibitory factor 1,12192,33,0.96 [0.40-2.31],0.9310859262835772
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WNT9A,Protein Wnt-9a,11854,32,2.49 [1.08-5.77],0.0327935816393571
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,12018,33,0.76 [0.42-1.37],0.3558708898892392
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",XCL1,Lymphotactin,12192,33,0.89 [0.51-1.58],0.6944005220493559
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",XG,Glycoprotein Xg,12186,34,0.78 [0.29-2.12],0.6275085355069787
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",XIAP,E3 ubiquitin-protein ligase XIAP,10292,27,1.12 [0.59-2.14],0.725601280004025
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",XPNPEP2,Xaa-Pro aminopeptidase 2,12156,33,0.93 [0.66-1.33],0.7045733247828005
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",XRCC4,DNA repair protein XRCC4,11813,32,0.86 [0.36-2.06],0.7355165444028238
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",YAP1,Transcriptional coactivator YAP1,10583,26,1.02 [0.27-3.89],0.9815827194692134
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",10536,26,0.97 [0.75-1.25],0.7898143718135537
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",YES1,Tyrosine-protein kinase Yes,12045,33,0.95 [0.72-1.24],0.6874161648203796
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",YJU2,Splicing factor YJU2,10539,27,0.62 [0.18-2.10],0.4415773918933218
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",YOD1,Ubiquitin thioesterase OTU1,10255,26,0.71 [0.39-1.30],0.2725495767824835
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",YTHDF3,YTH domain-containing family protein 3,11854,32,0.83 [0.57-1.21],0.32865512871108
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",YWHAQ,14-3-3 protein theta,10385,26,1.09 [0.65-1.81],0.749939345586719
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",YY1,Transcriptional repressor protein YY1,10292,27,0.86 [0.23-3.19],0.8183313834012178
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZBP1,Z-DNA-binding protein 1,10292,27,1.15 [0.47-2.78],0.7629782558041897
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZBTB16,Zinc finger and BTB domain-containing protein 16,11821,32,0.93 [0.59-1.48],0.7684884761587486
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZBTB17,Zinc finger and BTB domain-containing protein 17,11858,34,0.67 [0.28-1.57],0.3554772519895248
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZCCHC8,Zinc finger CCHC domain-containing protein 8,10255,26,0.85 [0.42-1.70],0.6374651493566688
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZFYVE19,Abscission/NoCut checkpoint regulator,10536,26,0.93 [0.61-1.41],0.725895164256871
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZHX2,Zinc fingers and homeoboxes protein 2,10583,26,0.24 [0.04-1.39],0.1098393556181882
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZNF174,Zinc finger protein 174,10292,27,1.17 [0.51-2.71],0.7124487809678575
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZNF75D,Zinc finger protein 75D,10423,26,0.80 [0.40-1.59],0.5285717880905769
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZNF830,Zinc finger protein 830,10539,27,0.53 [0.25-1.10],0.0867483995673824
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZNRD2,Protein ZNRD2,10536,26,1.43 [0.89-2.32],0.1426279191813391
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,10539,27,0.79 [0.39-1.62],0.5272013704217533
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZP3,Zona pellucida sperm-binding protein 3,10345,27,0.97 [0.85-1.11],0.6539219047899248
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZP4,Zona pellucida sperm-binding protein 4,10205,26,0.51 [0.11-2.32],0.3814869990270022
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZPR1,Zinc finger protein ZPR1,10232,27,1.02 [0.69-1.49],0.9372518839559388
